Index - P/E - EPS (ttm) -3.80 Insider Own 6.33% Shs Outstand 119.58M Perf Week 5.80%
Market Cap 11.85B Forward P/E - EPS next Y -1.19 Insider Trans -15.59% Shs Float 114.52M Perf Month 5.00%
Income -434.80M PEG - EPS next Q -0.71 Inst Own 91.44% Short Float 5.03% Perf Quarter 43.19%
Sales 1.08B P/S 10.95 EPS this Y 38.74% Inst Trans 1.75% Short Ratio 4.20 Perf Half Y 144.34%
Book/sh 6.40 P/B 15.15 EPS next Y 48.70% ROA -30.28% Short Interest 5.76M Perf Year 86.00%
Cash/sh 7.19 P/C 13.49 EPS next 5Y - ROE -59.11% 52W Range 36.90 - 98.82 Perf YTD 54.82%
Dividend Est. - P/FCF - EPS past 5Y -11.28% ROI -38.99% 52W High -1.86% Beta 1.50
Dividend TTM - Quick Ratio 3.96 Sales past 5Y 33.95% Gross Margin 45.52% 52W Low 162.82% ATR (14) 3.39
Dividend Ex-Date - Current Ratio 4.10 EPS Y/Y TTM 31.79% Oper. Margin -41.22% RSI (14) 63.46 Volatility 3.56% 3.58%
Employees 3293 Debt/Eq 0.58 Sales Y/Y TTM 31.99% Profit Margin -40.16% Recom 1.50 Target Price 103.89
Option/Short Yes / Yes LT Debt/Eq 0.46 EPS Q/Q 52.15% Payout - Rel Volume 0.69 Prev Close 93.72
Sales Surprise 3.70% EPS Surprise 15.57% Sales Q/Q 43.20% Earnings May 09 AMC Avg Volume 1.37M Price 96.98
SMA20 4.85% SMA50 8.21% SMA200 53.56% Trades
Volume 939,653 Change 3.48%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-08-24 Resumed Craig Hallum
Buy
$117
Feb-20-24 Downgrade Raymond James
Strong Buy → Outperform
$68 → $85
Dec-29-23 Reiterated BTIG Research
Buy
$75 → $85
Dec-14-23 Initiated Guggenheim
Buy
$70
Dec-13-23 Initiated Wolfe Research
Outperform
$70
Nov-13-23 Upgrade Raymond James
Outperform → Strong Buy
$68
Sep-28-23 Initiated Bernstein
Mkt Perform
$48
Jul-05-23 Resumed JP Morgan
Overweight
$85
May-05-23 Initiated UBS
Buy
$76
Jan-18-23 Upgrade Raymond James
Mkt Perform → Outperform
$58
Aug-25-22 Initiated Credit Suisse
Outperform
$70
Apr-25-22 Initiated Stephens
Overweight
$54
Mar-08-22 Initiated Goldman
Buy
$90
Jan-06-22 Resumed Piper Sandler
Overweight
$110
Oct-15-21 Resumed Cowen
Outperform
$150
Jun-15-21 Initiated Raymond James
Mkt Perform
May-25-21 Initiated Wells Fargo
Overweight
$110
Jan-28-21 Initiated Truist
Buy
$143
Oct-08-20 Initiated BTIG Research
Buy
$90
Sep-28-20 Initiated Morgan Stanley
Overweight
$80
Show Previous Ratings
May-03-24 08:00AM
May-02-24 02:14PM
02:50AM
02:49AM
May-01-24 04:05PM
07:00AM
Loading…
07:00AM
Apr-27-24 02:42AM
Apr-26-24 06:32PM
Apr-24-24 08:36AM
02:38AM
02:38AM
Apr-22-24 08:00AM
Apr-18-24 02:05AM
Apr-17-24 08:31AM
Apr-11-24 08:00AM
07:37AM
Loading…
Apr-09-24 07:37AM
Apr-08-24 08:00AM
Apr-05-24 07:00AM
05:15AM
01:51AM
Apr-01-24 08:00AM
Mar-21-24 10:25AM
Mar-20-24 05:46AM
Mar-18-24 03:39PM
(Investor's Business Daily)
07:00AM
Mar-14-24 08:00AM
Mar-12-24 08:00AM
Mar-11-24 02:22PM
Mar-08-24 01:31AM
Mar-07-24 08:00AM
12:00PM
Loading…
Mar-04-24 12:00PM
Mar-01-24 12:09AM
Feb-29-24 11:06AM
(Thomson Reuters StreetEvents) +12.98%
08:12AM
08:00AM
Feb-28-24 06:30PM
04:32PM
04:05PM
Feb-27-24 08:12AM
08:00AM
01:07AM
Feb-26-24 07:00AM
Feb-20-24 08:00AM
Feb-17-24 12:07AM
Feb-06-24 04:00PM
Feb-05-24 08:00AM
Feb-02-24 11:02PM
Jan-31-24 05:02PM
Jan-30-24 09:15AM
07:00AM
Jan-29-24 07:00AM
Jan-25-24 07:00AM
Jan-24-24 12:20AM
Jan-22-24 07:00AM
07:00AM
Jan-18-24 08:00AM
Jan-17-24 04:03PM
(Investor's Business Daily) +7.30%
Jan-16-24 05:17PM
Jan-09-24 07:00AM
Dec-30-23 11:01AM
Dec-29-23 08:00AM
Dec-27-23 11:48PM
Dec-26-23 06:56PM
Dec-21-23 08:00AM
Dec-11-23 12:50PM
Dec-10-23 11:59AM
Dec-06-23 08:30AM
Dec-02-23 07:06AM
Nov-23-23 11:03AM
Nov-14-23 08:00AM
Nov-13-23 11:24AM
Nov-08-23 05:02PM
(Associated Press Finance) -5.27%
04:05PM
09:10AM
Nov-07-23 08:30AM
Nov-02-23 08:30AM
Oct-25-23 09:02AM
Oct-22-23 01:00PM
Oct-20-23 09:00AM
Oct-19-23 09:00AM
Oct-17-23 09:15AM
Oct-16-23 09:00AM
Oct-04-23 09:00AM
Oct-03-23 04:43PM
Oct-02-23 09:00AM
Sep-30-23 05:01AM
Sep-18-23 09:00AM
Sep-14-23 07:37PM
09:00AM
Sep-07-23 12:09AM
Sep-06-23 04:24PM
Sep-05-23 10:09AM
Sep-04-23 12:17PM
Sep-01-23 09:00AM
Aug-18-23 07:39AM
Aug-16-23 09:00AM
Aug-11-23 01:37PM
(Investor's Business Daily) +5.38%
Aug-05-23 06:27AM
Aug-04-23 11:15AM
06:58AM
(Thomson Reuters StreetEvents)
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in Austin, TX.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Brophy Michael Burkes CHIEF FINANCIAL OFFICER May 01 '24 Sale 93.97 1,866 175,344 67,542 May 03 09:35 PM Chapman Steven Leonard CEO AND PRESIDENT Apr 29 '24 Sale 93.14 4,084 380,378 226,235 May 01 09:05 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Apr 29 '24 Sale 93.14 1,238 115,306 69,408 May 01 09:05 PM Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Apr 29 '24 Sale 93.14 1,196 111,394 115,833 May 01 09:05 PM RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Apr 29 '24 Sale 93.14 1,057 98,448 204,495 May 01 09:05 PM Fesko John PRESIDENT, CHIEF BUS. OFFICER Apr 29 '24 Sale 93.14 929 86,526 110,748 May 01 09:05 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Apr 26 '24 Sale 92.00 751 69,092 70,646 Apr 26 09:35 PM Sheena Jonathan CO-FOUNDER Apr 25 '24 Sale 89.55 1,000 89,550 69,082 Apr 26 09:35 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Apr 25 '24 Sale 89.55 705 63,133 71,397 Apr 26 09:35 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Apr 24 '24 Sale 93.00 937 87,140 72,102 Apr 26 09:35 PM Chapman Steven Leonard CEO AND PRESIDENT Apr 23 '24 Sale 91.38 2,552 233,200 230,319 Apr 23 09:35 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Apr 23 '24 Sale 91.38 1,523 139,171 73,039 Apr 23 09:35 PM RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Apr 23 '24 Sale 91.38 787 71,915 205,552 Apr 23 09:35 PM Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Apr 23 '24 Sale 91.38 531 48,522 117,029 Apr 23 09:35 PM Fesko John PRESIDENT, CHIEF BUS. OFFICER Apr 23 '24 Sale 91.38 522 47,700 111,677 Apr 23 09:35 PM Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Apr 16 '24 Sale 90.82 80,000 7,265,651 117,560 Apr 17 09:05 PM Chapman Steven Leonard CEO AND PRESIDENT Apr 15 '24 Sale 93.13 6,816 634,797 227,710 Apr 17 09:05 PM Sheena Jonathan CO-FOUNDER Apr 03 '24 Sale 92.47 26,700 2,468,822 321,031 Apr 04 09:35 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Apr 02 '24 Sale 92.62 1,378 127,629 70,646 Apr 04 09:35 PM Chapman Steven Leonard CEO AND PRESIDENT Mar 28 '24 Sale 90.42 2,662 240,687 234,526 Mar 29 09:35 PM Sheena Jonathan CO-FOUNDER Mar 28 '24 Sale 90.13 1,000 90,130 69,582 Mar 29 09:35 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Mar 28 '24 Sale 90.42 914 82,640 72,024 Mar 29 09:35 PM RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Mar 28 '24 Sale 90.42 743 67,179 204,839 Mar 29 09:35 PM Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Mar 28 '24 Sale 90.42 707 63,924 197,560 Mar 29 09:35 PM Fesko John PRESIDENT, CHIEF BUS. OFFICER Mar 28 '24 Sale 90.42 464 41,953 112,199 Mar 29 09:35 PM Sheena Jonathan CO-FOUNDER Mar 28 '24 Sale 90.22 447 40,326 347,731 Mar 29 09:35 PM Chapman Steven Leonard CEO AND PRESIDENT Mar 15 '24 Option Exercise 19.37 68,270 1,322,406 315,227 Mar 15 09:05 PM BOTHA ROELOF Director Mar 15 '24 Option Exercise 42.17 19,924 840,197 20,276 Mar 15 09:05 PM Chapman Steven Leonard CEO AND PRESIDENT Mar 15 '24 Sale 88.96 83,223 7,403,534 232,004 Mar 15 09:05 PM Chapman Steven Leonard CEO AND PRESIDENT Mar 15 '24 Sale 89.02 50,910 4,532,065 0 Mar 29 09:35 PM Sheena Jonathan CO-FOUNDER Mar 06 '24 Sale 88.70 5,000 443,492 458,585 Mar 07 09:40 PM Rabinowitz Matthew EXECUTIVE CHAIRMAN Mar 05 '24 Sale 87.40 190,000 16,605,069 860,036 Mar 07 09:40 PM Chapman Steven Leonard CEO AND PRESIDENT Mar 05 '24 Sale 88.36 9,326 824,092 246,957 Mar 07 09:40 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Mar 05 '24 Sale 88.36 2,826 249,719 70,646 Mar 07 09:40 PM Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Mar 05 '24 Sale 88.36 2,245 198,361 198,267 Mar 07 09:40 PM RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Mar 05 '24 Sale 88.36 2,160 190,868 204,218 Mar 07 09:40 PM Fesko John PRESIDENT, CHIEF BUS. OFFICER Mar 05 '24 Sale 88.36 1,838 162,400 112,663 Mar 07 09:40 PM Sheena Jonathan CO-FOUNDER Mar 05 '24 Sale 88.36 1,028 90,839 463,585 Mar 07 09:40 PM Rabinowitz Matthew EXECUTIVE CHAIRMAN Mar 05 '24 Sale 88.36 1,012 89,416 1,075,648 Mar 07 09:40 PM RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Feb 29 '24 Option Exercise 9.29 20,526 190,687 224,744 Feb 29 09:15 PM RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Feb 29 '24 Sale 89.01 20,526 1,826,970 204,218 Feb 29 09:15 PM Sheena Jonathan CO-FOUNDER Feb 29 '24 Sale 86.34 10,000 863,433 463,585 Mar 01 08:45 PM Sheena Jonathan CO-FOUNDER Feb 29 '24 Sale 90.02 6,000 540,109 14,655 Mar 01 08:45 PM RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Feb 27 '24 Option Exercise 10.16 35,307 358,802 239,525 Feb 29 09:15 PM RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Feb 27 '24 Sale 75.09 35,307 2,651,298 204,218 Feb 29 09:15 PM Rabinowitz Matthew EXECUTIVE CHAIRMAN Feb 23 '24 Option Exercise 2.66 380,036 1,009,718 1,050,036 Feb 23 09:40 PM ROSENMAN HERM Director Feb 16 '24 Option Exercise 2.66 93,901 249,486 155,586 Feb 16 09:45 PM ROSENMAN HERM Director Feb 16 '24 Sale 69.37 93,901 6,514,371 61,685 Feb 16 09:45 PM Sheena Jonathan CO-FOUNDER Feb 07 '24 Sale 70.10 5,000 350,486 473,585 Feb 08 09:05 PM Sheena Jonathan CO-FOUNDER Feb 07 '24 Sale 70.10 1,000 70,099 17,655 Feb 08 09:05 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Feb 06 '24 Option Exercise 16.61 34,029 565,063 104,675 Feb 08 09:40 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Feb 06 '24 Sale 70.03 34,029 2,383,129 70,646 Feb 08 09:40 PM Sheena Jonathan CO-FOUNDER Feb 06 '24 Sale 70.00 6,000 420,011 18,155 Feb 08 09:05 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Feb 01 '24 Sale 67.73 22,281 1,509,081 70,646 Feb 02 09:40 PM Chapman Steven Leonard CEO AND PRESIDENT Jan 29 '24 Sale 65.09 14,813 964,194 246,957 Jan 30 09:05 PM RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Jan 29 '24 Sale 65.09 4,265 277,614 204,218 Jan 30 09:05 PM Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Jan 29 '24 Sale 65.09 3,426 223,002 194,977 Jan 30 09:02 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Jan 29 '24 Sale 65.09 3,235 210,570 92,927 Jan 30 09:15 PM Fesko John PRESIDENT, CHIEF BUS. OFFICER Jan 29 '24 Sale 65.09 2,358 153,485 108,494 Jan 30 08:57 PM Sheena Jonathan CO-FOUNDER Jan 29 '24 Sale 65.09 546 35,540 478,585 Jan 30 09:05 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Jan 24 '24 Sale 67.00 944 63,248 64,810 Jan 26 09:40 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Jan 23 '24 Sale 65.86 2,202 145,014 65,754 Jan 23 09:45 PM Chapman Steven Leonard CEO AND PRESIDENT Jan 22 '24 Sale 68.16 1,958 133,457 175,550 Jan 23 09:05 PM RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Jan 22 '24 Sale 68.16 892 60,799 181,050 Jan 23 09:05 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Jan 22 '24 Sale 68.16 771 52,551 67,956 Jan 23 09:45 PM Sheena Jonathan CO-FOUNDER Jan 22 '24 Sale 68.16 351 23,924 469,726 Jan 23 09:05 PM Sheena Jonathan CO-FOUNDER Jan 03 '24 Sale 60.30 5,000 301,499 469,743 Jan 05 08:05 PM Sheena Jonathan CO-FOUNDER Jan 03 '24 Sale 60.45 1,000 60,451 21,155 Jan 05 08:05 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Dec 29 '23 Sale 62.29 1,377 85,773 64,810 Dec 29 09:45 PM Chapman Steven Leonard CEO AND PRESIDENT Dec 28 '23 Sale 63.29 2,604 164,813 172,348 Dec 29 09:35 PM Sheena Jonathan CO-FOUNDER Dec 28 '23 Sale 62.12 1,000 62,120 21,655 Dec 29 09:05 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Dec 28 '23 Sale 63.29 915 57,912 66,187 Dec 29 09:45 PM RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Dec 28 '23 Sale 63.29 728 46,077 180,442 Dec 29 09:05 PM Sheena Jonathan CO-FOUNDER Dec 28 '23 Sale 62.44 447 27,909 474,743 Dec 29 09:05 PM HEALY JAMES Director Dec 13 '23 Sale 58.75 644,000 37,835,000 0 Dec 22 02:21 PM Marcus Gail Boxer Director Dec 08 '23 Sale 57.52 500 28,760 20,146 Dec 12 08:35 PM Sheena Jonathan CO-FOUNDER Dec 06 '23 Sale 58.22 5,000 291,078 474,743 Dec 08 08:35 PM Chapman Rowan E Director Nov 29 '23 Sale 55.97 1,998 111,831 9,373 Dec 01 08:35 PM Marcus Gail Boxer Director Nov 21 '23 Sale 54.31 1,000 54,314 20,646 Nov 22 08:05 PM Chapman Steven Leonard CEO AND PRESIDENT Nov 20 '23 Sale 55.00 2,566 141,130 217,554 Nov 22 08:05 PM Sheena Jonathan CO-FOUNDER Nov 02 '23 Sale 40.23 5,000 201,150 479,743 Nov 03 09:05 PM Sheena Jonathan CO-FOUNDER Nov 02 '23 Sale 40.35 1,000 40,351 22,155 Nov 03 09:05 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Oct 23 '23 Sale 40.40 3,940 159,195 64,810 Oct 24 09:45 PM Chapman Steven Leonard CEO AND PRESIDENT Oct 23 '23 Sale 40.39 2,595 104,813 220,120 Oct 24 09:35 PM Sheena Jonathan CO-FOUNDER Oct 23 '23 Sale 40.04 1,000 40,037 22,655 Oct 24 09:05 PM RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Oct 23 '23 Sale 40.39 803 32,433 179,807 Oct 24 09:05 PM Sheena Jonathan CO-FOUNDER Oct 23 '23 Sale 40.19 335 13,464 484,743 Oct 24 09:05 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Sep 29 '23 Sale 45.98 1,372 63,080 64,833 Sep 29 09:45 PM Sheena Jonathan CO-FOUNDER Sep 28 '23 Sale 46.06 5,448 250,909 484,745 Sep 29 09:35 PM Chapman Steven Leonard CEO AND PRESIDENT Sep 28 '23 Sale 45.82 2,617 119,901 217,554 Sep 29 09:45 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Sep 28 '23 Sale 45.82 919 42,105 66,205 Sep 29 09:45 PM RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Sep 28 '23 Sale 45.82 732 33,537 179,110 Sep 29 09:35 PM Sheena Jonathan CO-FOUNDER Sep 06 '23 Sale 59.07 5,000 295,365 489,746 Sep 08 09:05 PM Sheena Jonathan CO-FOUNDER Sep 06 '23 Sale 59.23 1,000 59,227 23,155 Sep 08 09:05 PM Sheena Jonathan CO-FOUNDER Sep 01 '23 Sale 60.01 10,000 600,062 494,746 Sep 01 09:30 PM Chapman Steven Leonard CEO AND PRESIDENT Aug 11 '23 Sale 55.00 2,578 141,790 214,988 Aug 14 09:05 PM Sheena Jonathan CO-FOUNDER Aug 02 '23 Sale 44.22 5,000 221,116 504,746 Aug 04 09:35 PM Sheena Jonathan CO-FOUNDER Aug 02 '23 Sale 44.15 1,000 44,149 23,655 Aug 04 09:35 PM Brophy Michael Burkes CHIEF FINANCIAL OFFICER Jul 25 '23 Sale 46.58 2,347 109,323 64,833 Jul 27 09:45 PM Chapman Steven Leonard CEO AND PRESIDENT Jul 24 '23 Sale 47.83 2,578 123,296 217,566 Jul 24 09:45 PM
Index RUT P/E 48.31 EPS (ttm) 0.44 Insider Own 8.90% Shs Outstand 29.95M Perf Week 2.98%
Market Cap 642.21M Forward P/E 20.83 EPS next Y 1.03 Insider Trans -0.07% Shs Float 27.34M Perf Month 6.36%
Income 13.38M PEG 1.18 EPS next Q 0.17 Inst Own 87.25% Short Float 1.28% Perf Quarter 38.42%
Sales 544.89M P/S 1.18 EPS this Y 19.86% Inst Trans -10.25% Short Ratio 2.35 Perf Half Y 99.07%
Book/sh 4.69 P/B 4.57 EPS next Y 17.43% ROA 2.21% Short Interest 0.35M Perf Year 60.78%
Cash/sh 0.20 P/C 105.98 EPS next 5Y 41.00% ROE 10.24% 52W Range 10.31 - 21.64 Perf YTD 53.74%
Dividend Est. - P/FCF 25.71 EPS past 5Y -4.58% ROI 2.95% 52W High -1.11% Beta 2.01
Dividend TTM - Quick Ratio 1.12 Sales past 5Y 13.81% Gross Margin 11.36% 52W Low 107.57% ATR (14) 0.66
Dividend Ex-Date - Current Ratio 1.12 EPS Y/Y TTM 100.27% Oper. Margin 4.72% RSI (14) 63.66 Volatility 3.71% 3.13%
Employees 5791 Debt/Eq 2.35 Sales Y/Y TTM 15.14% Profit Margin 2.46% Recom 1.50 Target Price 22.00
Option/Short Yes / Yes LT Debt/Eq 2.23 EPS Q/Q 24.61% Payout 0.00% Rel Volume 1.25 Prev Close 21.20
Sales Surprise 6.98% EPS Surprise 0.00% Sales Q/Q 17.08% Earnings May 06 AMC Avg Volume 149.46K Price 21.40
SMA20 4.16% SMA50 9.48% SMA200 47.14% Trades
Volume 187,380 Change 0.94%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-05-24 Upgrade Stephens
Equal-Weight → Overweight
$14 → $18
Feb-27-23 Upgrade Stifel
Hold → Buy
$15 → $16
Aug-25-22 Initiated Oppenheimer
Outperform
$22
Jun-21-22 Downgrade Stephens
Overweight → Equal-Weight
$23 → $17
Mar-01-22 Downgrade Stifel
Buy → Hold
$32 → $18
Sep-21-21 Initiated Stifel
Buy
$37
Jun-10-21 Upgrade RBC Capital Mkts
Sector Perform → Outperform
$50
Jul-21-20 Initiated Stephens
Overweight
$30
Jan-15-20 Initiated SunTrust
Hold
$28
Oct-22-19 Initiated RBC Capital Mkts
Sector Perform
$20
May-01-24 05:32PM
05:09PM
Apr-23-24 04:02PM
Apr-20-24 01:30PM
Apr-08-24 12:00PM
11:22AM
Loading…
Mar-12-24 11:22AM
Mar-07-24 12:00PM
Mar-05-24 12:00PM
Mar-01-24 03:58PM
08:21AM
Feb-28-24 04:05PM
Feb-26-24 09:15AM
Feb-14-24 04:00PM
Jan-25-24 08:50AM
Jan-02-24 04:48PM
05:09PM
Loading…
Dec-01-23 05:09PM
Nov-07-23 04:05PM
Nov-01-23 04:30PM
Oct-30-23 04:04PM
Sep-01-23 03:57PM
Aug-08-23 04:04PM
Jul-28-23 09:14PM
Jun-16-23 06:05PM
May-22-23 04:05PM
May-04-23 04:30PM
04:05PM
Apr-21-23 04:05PM
Mar-20-23 11:28AM
Mar-08-23 06:30AM
Mar-03-23 06:56PM
04:05PM
Loading…
Feb-28-23 04:05PM
Feb-23-23 04:05PM
Feb-17-23 04:05PM
Dec-13-22 04:05PM
Nov-15-22 04:10PM
Nov-11-22 10:58AM
07:00AM
Nov-07-22 04:05PM
Nov-03-22 05:30PM
Nov-01-22 07:30AM
Aug-16-22 04:43PM
Aug-08-22 04:24PM
Aug-04-22 06:30AM
Aug-03-22 07:38AM
Jun-22-22 06:59AM
Jun-07-22 05:20PM
Jun-01-22 09:55AM
May-30-22 12:43PM
May-16-22 06:30AM
May-12-22 11:38AM
May-09-22 04:10PM
May-04-22 04:00PM
May-02-22 05:35PM
08:00AM
Mar-10-22 07:30AM
Feb-28-22 04:10PM
Feb-24-22 11:05AM
Feb-23-22 04:30PM
Feb-02-22 05:38PM
Jan-27-22 08:00AM
Jan-24-22 06:30AM
Jan-10-22 12:52PM
Dec-23-21 07:30AM
Nov-29-21 07:30AM
Nov-08-21 04:10PM
Nov-02-21 03:02PM
Nov-01-21 05:10PM
03:39PM
Sep-17-21 11:47AM
Sep-02-21 08:30AM
Aug-09-21 04:53PM
Aug-03-21 03:01PM
07:53AM
Aug-02-21 05:30PM
Jun-28-21 09:04AM
Jun-22-21 08:33AM
Jun-17-21 08:00AM
May-13-21 04:30PM
May-12-21 05:56AM
May-06-21 04:15PM
May-04-21 08:00AM
May-03-21 08:00AM
Apr-06-21 08:24AM
Apr-01-21 04:30PM
Mar-04-21 05:33PM
04:30PM
Feb-25-21 12:15PM
Feb-24-21 04:10PM
Feb-23-21 04:30PM
Feb-18-21 04:30PM
Feb-04-21 04:33AM
Jan-19-21 08:00AM
Jan-15-21 06:00PM
Dec-21-20 06:50AM
Dec-15-20 07:27PM
Nov-13-20 07:45AM
Nov-10-20 04:15PM
Nov-05-20 04:54PM
04:30PM
Nov-02-20 04:30PM
The Pennant Group, Inc. is a holding company, which engages in the provision of healthcare services to patients of all ages. It operates through the following segments: Home Health and Hospice Services, Senior Living Services, and All Other. The Home Health and Hospice Services segment provides combination of clinical care services such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services. The Senior Living Services segment deals with assisted and independent living and memory care businesses. The All Other segment includes general and administrative expense from the service center. The company was founded on January 24, 2019 and is headquartered in Eagle, ID.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Stringfield JoAnne Director Apr 19 '24 Sale 19.78 380 7,516 22,565 Apr 23 06:59 PM Gochnour John J Chief Operating Officer Mar 15 '24 Option Exercise 18.43 10,700 197,148 119,250 Mar 19 05:57 PM Guerisoli Brent President Feb 23 '24 Option Exercise 5.31 2,514 13,349 81,527 Feb 27 06:54 PM Guerisoli Brent President Feb 23 '24 Sale 17.11 1,385 23,697 80,142 Feb 27 06:54 PM Freeman Jennifer SVP of Strategic Partnerships May 30 '23 Sale 11.65 611 7,118 34,807 Jun 01 06:51 PM Gochnour John J Chief Operating Officer May 11 '23 Buy 11.04 1,232 13,601 73,982 May 15 06:44 PM
Index - P/E - EPS (ttm) -4.31 Insider Own 19.38% Shs Outstand 13.20M Perf Week 1.58%
Market Cap 440.88M Forward P/E - EPS next Y - Insider Trans 160.49% Shs Float 10.64M Perf Month 19.20%
Income -36.67M PEG - EPS next Q - Inst Own 82.13% Short Float 0.45% Perf Quarter 259.53%
Sales 255.32M P/S 1.73 EPS this Y - Inst Trans 0.48% Short Ratio 1.73 Perf Half Y 263.83%
Book/sh -14.07 P/B - EPS next Y - ROA -3.79% Short Interest 0.05M Perf Year 270.70%
Cash/sh 1.50 P/C 22.21 EPS next 5Y 10.30% ROE - 52W Range 6.26 - 34.26 Perf YTD 245.75%
Dividend Est. - P/FCF - EPS past 5Y 31.36% ROI -7.04% 52W High -2.51% Beta 1.93
Dividend TTM - Quick Ratio - Sales past 5Y -9.43% Gross Margin 14.93% 52W Low 433.54% ATR (14) 1.98
Dividend Ex-Date - Current Ratio - EPS Y/Y TTM 54.87% Oper. Margin -8.22% RSI (14) 66.13 Volatility 4.77% 6.11%
Employees - Debt/Eq - Sales Y/Y TTM 7.08% Profit Margin -14.36% Recom 5.00 Target Price 5.00
Option/Short No / Yes LT Debt/Eq - EPS Q/Q 22.05% Payout - Rel Volume 0.39 Prev Close 33.60
Sales Surprise - EPS Surprise - Sales Q/Q 10.41% Earnings May 10 BMO Avg Volume 27.86K Price 33.40
SMA20 11.02% SMA50 31.68% SMA200 149.06% Trades
Volume 10,863 Change -0.60%
May-02-24 01:22PM
Mar-28-24 10:19AM
Mar-27-24 09:52AM
05:00AM
Mar-12-24 05:00AM
07:30AM
Loading…
Feb-06-24 07:30AM
Nov-14-23 06:00AM
Nov-03-23 02:26PM
08:49AM
Oct-10-23 06:00AM
Oct-02-23 07:30AM
Sep-09-23 01:02AM
Aug-14-23 06:00AM
Aug-02-23 11:52AM
Jul-05-23 08:00AM
04:30PM
Loading…
May-24-23 04:30PM
May-11-23 07:00AM
May-04-23 03:13PM
Apr-09-23 08:36AM
Apr-07-23 07:44AM
Apr-06-23 07:20AM
Mar-30-23 08:00AM
Mar-17-23 09:26AM
Nov-14-22 08:00AM
Nov-01-22 04:45PM
Sep-25-22 08:38AM
Aug-15-22 10:10AM
Aug-12-22 06:00AM
Aug-04-22 05:00AM
Jul-28-22 07:00AM
07:00AM
Loading…
Jun-24-22 07:00AM
Jun-16-22 05:11PM
May-23-22 06:00AM
May-12-22 04:32PM
May-04-22 04:15PM
Apr-18-22 07:00AM
Apr-13-22 04:15PM
Apr-11-22 04:15PM
Mar-30-22 05:13PM
Mar-10-22 05:36PM
Feb-01-22 06:30AM
Jan-20-22 04:30PM
Jan-18-22 05:30AM
Dec-22-21 06:30PM
Dec-16-21 08:37AM
Dec-14-21 06:00AM
Sonida Senior Living, Inc. engages in the operation of senior housing communities. Its senior living options include independent living, assisted living, and memory care. The company was founded in 1990 and is headquartered in Addison, TX.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Clark Reanae See Remarks Apr 18 '24 Buy 30.11 3,347 100,778 34,431 Apr 22 04:21 PM Ribar Brandon President & CEO Apr 17 '24 Buy 28.72 3,000 86,160 308,055 Apr 18 05:32 PM Fryar Michael SVP - Chief Revenue Officer Apr 09 '24 Sale 27.76 1,296 35,977 87,513 Apr 09 06:02 PM Fryar Michael SVP - Chief Revenue Officer Apr 08 '24 Sale 28.29 7,898 223,434 88,809 Apr 09 06:02 PM Levinson Sam 10% Owner Mar 22 '24 Buy 9.50 526,316 5,000,002 2,449,593 Mar 25 04:42 PM Levinson Sam 10% Owner Feb 01 '24 Buy 9.50 1,052,632 10,000,004 1,923,277 Feb 05 09:33 PM Ortelius Advisors, L.P. 10% Owner Dec 21 '23 Buy 10.00 268,630 2,686,300 679,580 Dec 22 04:05 PM Ortelius Advisors, L.P. 10% Owner Dec 21 '23 Sale 10.00 268,630 2,686,300 679,580 Dec 22 04:05 PM Simanovsky Michael Director Nov 01 '23 Option Exercise 10.00 400,000 4,000,000 3,764,936 Nov 03 05:52 PM Cober Timothy VP & Chief Accounting Officer Sep 07 '23 Buy 7.42 3,430 25,451 3,430 Sep 08 04:16 PM Simanovsky Michael Director Jul 03 '23 Option Exercise 10.00 600,000 6,000,000 3,404,839 Jul 05 09:28 PM Levinson Sam 10% Owner May 22 '23 Buy 6.94 4,049 28,100 870,645 May 22 05:22 PM Levinson Sam 10% Owner May 19 '23 Buy 6.66 3,800 25,308 866,596 May 22 05:22 PM Levinson Sam 10% Owner May 18 '23 Buy 6.50 25 162 862,796 May 22 05:22 PM
Index RUT P/E - EPS (ttm) -0.50 Insider Own 77.42% Shs Outstand 378.73M Perf Week 7.42%
Market Cap 2.55B Forward P/E - EPS next Y -0.23 Insider Trans -0.33% Shs Float 86.33M Perf Month 10.82%
Income -186.26M PEG - EPS next Q -0.08 Inst Own 23.52% Short Float 21.62% Perf Quarter 10.82%
Sales 1.06B P/S 2.41 EPS this Y 43.34% Inst Trans -1.84% Short Ratio 15.20 Perf Half Y 16.84%
Book/sh 3.77 P/B 1.77 EPS next Y 21.21% ROA -8.23% Short Interest 18.67M Perf Year -17.37%
Cash/sh 0.21 P/C 32.30 EPS next 5Y - ROE -12.64% 52W Range 4.74 - 9.59 Perf YTD -14.94%
Dividend Est. - P/FCF - EPS past 5Y -33.90% ROI -9.85% 52W High -30.55% Beta 1.29
Dividend TTM - Quick Ratio 1.11 Sales past 5Y 51.51% Gross Margin 21.00% 52W Low 40.65% ATR (14) 0.26
Dividend Ex-Date - Current Ratio 1.11 EPS Y/Y TTM 16.23% Oper. Margin -17.75% RSI (14) 64.65 Volatility 4.37% 3.98%
Employees 9325 Debt/Eq 0.36 Sales Y/Y TTM 22.82% Profit Margin -17.64% Recom 2.50 Target Price 8.79
Option/Short Yes / Yes LT Debt/Eq 0.32 EPS Q/Q 4.35% Payout - Rel Volume 1.08 Prev Close 6.53
Sales Surprise 6.73% EPS Surprise -38.41% Sales Q/Q 22.34% Earnings May 09 BMO Avg Volume 1.23M Price 6.66
SMA20 9.55% SMA50 3.60% SMA200 -3.14% Trades
Volume 1,332,465 Change 1.99%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-03-24 Initiated Barclays
Underweight
$7
May-15-23 Downgrade TD Cowen
Outperform → Market Perform
$8 → $9
Jan-06-23 Upgrade Morgan Stanley
Equal-Weight → Overweight
$8
Nov-07-22 Resumed Jefferies
Buy
$7.25
Mar-17-22 Downgrade UBS
Buy → Neutral
$19 → $10
Nov-09-21 Downgrade JP Morgan
Overweight → Neutral
$24 → $12
Sep-10-21 Initiated Cowen
Outperform
$18
Aug-16-21 Downgrade Morgan Stanley
Overweight → Equal-Weight
$36 → $16
Jul-06-21 Initiated William Blair
Outperform
Jul-06-21 Initiated Morgan Stanley
Overweight
$36
Jul-06-21 Initiated JP Morgan
Overweight
$36
Jul-06-21 Initiated Jefferies
Buy
$36
Jul-06-21 Initiated Goldman
Neutral
$25
Show Previous Ratings
May-01-24 09:00AM
Apr-18-24 04:10PM
Apr-08-24 02:49PM
Mar-12-24 09:00AM
Feb-29-24 10:32AM
07:15AM
Loading…
Feb-28-24 07:15AM
06:31AM
06:00AM
Feb-22-24 11:52AM
Feb-07-24 04:10PM
Feb-05-24 08:02AM
Feb-01-24 01:05PM
10:08AM
Jan-19-24 09:00AM
Dec-05-23 05:05AM
10:49AM
Loading…
Nov-12-23 10:49AM
Nov-09-23 01:23AM
(Thomson Reuters StreetEvents)
Nov-08-23 03:29PM
06:17AM
(Associated Press Finance)
06:00AM
Nov-07-23 03:03AM
Nov-01-23 10:01AM
Oct-26-23 09:08PM
Oct-23-23 03:44PM
Oct-18-23 04:10PM
Oct-03-23 09:32PM
Sep-21-23 04:10PM
Aug-28-23 04:10PM
Aug-11-23 09:24AM
Aug-10-23 01:47AM
(Thomson Reuters StreetEvents)
07:15AM
Loading…
Aug-09-23 07:15AM
06:13AM
(Associated Press Finance)
06:00AM
Jul-19-23 04:10PM
Jul-10-23 07:35AM
Jun-27-23 08:18AM
Jun-12-23 06:11AM
May-24-23 04:10PM
May-16-23 12:40PM
May-11-23 09:00AM
12:13AM
(Thomson Reuters StreetEvents)
May-10-23 07:15AM
06:11AM
06:00AM
Apr-19-23 04:10PM
Mar-31-23 06:14AM
Mar-22-23 08:29AM
Mar-11-23 07:01AM
Mar-09-23 01:22AM
(Thomson Reuters StreetEvents)
Mar-08-23 12:40PM
07:15AM
06:00AM
Mar-01-23 10:00AM
Feb-15-23 04:10PM
Jan-31-23 06:05AM
Jan-10-23 01:35PM
Dec-30-22 05:00AM
Dec-29-22 09:54AM
Dec-22-22 09:00AM
Dec-21-22 04:10PM
04:10PM
Nov-11-22 05:49AM
(Simply Wall St.) +11.21%
Nov-08-22 07:25PM
04:10PM
Nov-03-22 09:00AM
Oct-18-22 04:10PM
Sep-08-22 04:23PM
(American City Business Journals) +25.76%
09:00AM
Aug-30-22 04:10PM
Aug-15-22 08:34AM
Aug-10-22 12:30AM
Aug-09-22 07:45PM
04:10PM
Jul-19-22 05:00PM
Jul-08-22 08:13AM
Jul-07-22 09:00AM
Jul-04-22 02:53PM
Jun-08-22 04:10PM
May-23-22 09:00AM
May-20-22 06:09AM
May-18-22 04:10PM
May-09-22 08:30PM
04:10PM
Apr-18-22 04:10PM
Apr-01-22 12:15AM
Mar-30-22 09:00AM
Mar-25-22 07:40AM
Mar-21-22 01:00PM
Mar-10-22 11:00PM
04:10PM
Feb-17-22 04:10PM
Jan-27-22 09:38AM
Jan-03-22 04:10PM
Dec-27-21 07:15AM
(American City Business Journals)
Dec-23-21 12:07PM
Dec-15-21 01:38AM
Dec-12-21 09:00PM
Dec-10-21 09:38AM
Dec-07-21 09:00PM
Dec-05-21 08:15AM
Lifestance Health Group, Inc. provides outpatient mental health services. It offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. The firm operates outpatient mental health platform as well as offers patients care virtually through its online delivery platform or in-person at its centers in 32 states. The company was founded by Michael K. Lester, Gwen H. Booth and Danish J. Qureshi in 2017 and is headquartered in Scottsdale, AZ.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Qureshi Danish J. See Remarks Apr 01 '24 Sale 5.93 12,965 76,882 4,911,050 Apr 19 04:34 PM Pantaleoni Pablo Chief Digital Officer Apr 01 '24 Sale 5.93 10,116 59,988 1,299,927 Apr 19 04:29 PM Pardo Ryan See Remarks Apr 01 '24 Sale 5.93 9,830 58,292 807,947 Apr 19 04:29 PM Mullins Kevin Michael Chief Development Officer Apr 01 '24 Sale 5.93 9,688 57,450 4,735,664 Apr 19 04:27 PM Burdick Kenneth A Chief Executive Officer Mar 15 '24 Sale 6.28 214,605 1,347,719 2,934,372 Mar 19 04:30 PM Mullins Kevin Michael Chief Development Officer Mar 14 '24 Sale 6.33 44,540 281,938 4,745,352 Mar 18 05:11 PM Pardo Ryan See Remarks Mar 14 '24 Sale 6.33 39,384 249,301 817,777 Mar 18 05:09 PM Qureshi Danish J. See Remarks Mar 13 '24 Sale 6.32 153,943 972,920 4,924,015 Mar 15 04:34 PM Pantaleoni Pablo Chief Digital Officer Mar 12 '24 Sale 6.76 43,304 292,735 1,310,043 Mar 14 04:05 PM Bourdon David Chief Financial Officer Mar 11 '24 Sale 6.93 58,826 407,664 433,856 Mar 12 09:43 PM Varanakis Ann Chief People Officer Mar 11 '24 Sale 6.93 15,434 106,958 268,276 Mar 12 09:48 PM Cipollone Paula See Remarks Mar 11 '24 Sale 6.93 13,996 96,992 293,562 Mar 12 09:50 PM Mullins Kevin Michael Chief Development Officer Mar 01 '24 Sale 8.02 115,136 923,391 4,575,480 Mar 04 06:50 PM Cipollone Paula See Remarks Jan 03 '24 Sale 7.45 3,369 25,099 290,193 Apr 11 04:30 PM Mullins Kevin Michael Chief Development Officer Dec 01 '23 Sale 6.54 113,334 741,204 4,690,616 Dec 04 04:05 PM Mullins Kevin Michael Chief Development Officer Nov 07 '23 Sale 6.12 32,056 196,183 4,803,950 Nov 08 06:23 PM Mullins Kevin Michael Chief Development Officer Nov 06 '23 Sale 6.12 300 1,836 4,836,006 Nov 08 06:23 PM Mullins Kevin Michael Chief Development Officer Nov 03 '23 Sale 6.13 80,977 496,389 4,836,306 Nov 06 04:30 PM Mullins Kevin Michael Chief Development Officer Oct 02 '23 Sale 6.61 113,333 749,131 4,917,283 Oct 03 04:30 PM Gouk Warren Chief Administrative Officer Sep 01 '23 Sale 8.25 38,058 313,978 5,818,204 Sep 05 05:36 PM Gouk Warren Chief Administrative Officer Aug 31 '23 Sale 8.25 11,966 98,720 5,856,262 Sep 05 05:36 PM Varanakis Ann Chief People Officer Aug 24 '23 Sale 7.60 5,661 43,024 168,441 Aug 25 04:15 PM Mullins Kevin Michael Chief Development Officer Jul 06 '23 Sale 8.67 135,400 1,173,918 5,030,616 Jul 07 05:27 PM Mullins Kevin Michael Chief Development Officer Jul 05 '23 Sale 8.72 150,000 1,308,000 5,166,016 Jul 06 04:30 PM Mullins Kevin Michael Chief Development Officer Jul 03 '23 Sale 9.00 54,600 491,400 5,316,016 Jul 06 04:30 PM Patel-Dunn Anisha Chief Medical Officer Jun 28 '23 Sale 9.24 2,602 24,042 277,055 Jun 29 04:31 PM Pardo Ryan See Remarks Jun 26 '23 Sale 8.91 50,136 446,712 636,461 Jun 27 04:37 PM Mullins Kevin Michael Chief Development Officer Jun 23 '23 Sale 9.02 65,832 593,805 5,370,616 Jun 27 04:41 PM Gouk Warren Chief Administrative Officer Jun 22 '23 Sale 9.05 57,754 522,674 5,868,228 Jun 23 04:31 PM Qureshi Danish J. See Remarks Jun 21 '23 Sale 9.03 72,398 653,777 4,583,404 Jun 22 04:30 PM Gouk Warren Chief Administrative Officer Jun 14 '23 Sale 8.95 45,984 411,557 5,925,982 Jun 15 05:24 PM Gouk Warren Chief Administrative Officer Jun 13 '23 Sale 8.71 47,142 410,607 5,971,966 Jun 14 04:31 PM Gouk Warren Chief Administrative Officer Jun 12 '23 Sale 8.51 2,858 24,322 6,019,108 Jun 13 05:47 PM
Index RUT P/E 30.79 EPS (ttm) 3.80 Insider Own 3.57% Shs Outstand 56.60M Perf Week -0.31%
Market Cap 6.65B Forward P/E 19.76 EPS next Y 5.92 Insider Trans -6.67% Shs Float 54.89M Perf Month -1.59%
Income 218.38M PEG 2.05 EPS next Q 1.30 Inst Own 96.07% Short Float 5.90% Perf Quarter -3.22%
Sales 3.79B P/S 1.76 EPS this Y 13.16% Inst Trans 0.11% Short Ratio 11.75 Perf Half Y 21.12%
Book/sh 27.73 P/B 4.22 EPS next Y 9.59% ROA 5.35% Short Interest 3.24M Perf Year 24.71%
Cash/sh 9.25 P/C 12.64 EPS next 5Y 15.00% ROE 15.08% 52W Range 87.14 - 127.57 Perf YTD 4.17%
Dividend Est. - P/FCF 26.12 EPS past 5Y 16.56% ROI 6.38% 52W High -8.38% Beta 1.00
Dividend TTM 0.23 (0.20%) Quick Ratio 1.53 Sales past 5Y 15.98% Gross Margin 12.29% 52W Low 34.14% ATR (14) 2.79
Dividend Ex-Date Mar 27, 2024 Current Ratio 1.53 EPS Y/Y TTM -8.01% Oper. Margin 5.21% RSI (14) 42.66 Volatility 2.73% 2.25%
Employees 35300 Debt/Eq 1.23 Sales Y/Y TTM 21.84% Profit Margin 5.77% Recom 1.80 Target Price 133.40
Option/Short Yes / Yes LT Debt/Eq 1.17 EPS Q/Q 13.38% Payout 6.36% Rel Volume 1.96 Prev Close 116.55
Sales Surprise 0.61% EPS Surprise 1.17% Sales Q/Q 14.23% Earnings May 01 AMC Avg Volume 275.58K Price 116.89
SMA20 -1.21% SMA50 -3.79% SMA200 8.02% Trades
Volume 539,759 Change 0.29%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-28-23 Initiated Berenberg
Buy
$110
Jun-23-21 Resumed Stifel
Buy
$95
Nov-11-20 Upgrade Stephens
Equal-Weight → Overweight
Oct-31-19 Upgrade Stifel
Hold → Buy
$56 → $51
Oct-22-19 Resumed Stephens
Equal-Weight
Jun-04-19 Resumed SunTrust
Hold
$55
Aug-16-18 Reiterated Stifel
Hold
$26 → $34
Apr-28-17 Downgrade Wells Fargo
Market Perform → Underperform
Jan-04-17 Downgrade JMP Securities
Mkt Perform → Mkt Underperform
May-12-16 Reiterated RBC Capital Mkts
Outperform
$24 → $27
May-12-16 Downgrade Wells Fargo
Outperform → Market Perform
Feb-12-16 Reiterated RBC Capital Mkts
Outperform
$27.50 → $24
Aug-05-15 Reiterated Oppenheimer
Outperform
$47 → $58
Jun-09-15 Initiated Sun Trust Rbsn Humphrey
Buy
$58
Feb-23-15 Initiated RBC Capital Mkts
Outperform
$55
Jul-17-14 Reiterated Oppenheimer
Outperform
$51 → $38
Aug-13-13 Reiterated Cantor Fitzgerald
Buy
$40 → $45
Aug-09-13 Reiterated Oppenheimer
Outperform
$39 → $44
Jun-14-13 Initiated Cantor Fitzgerald
Buy
$40
Jul-15-11 Downgrade JMP Securities
Mkt Outperform → Mkt Perform
Show Previous Ratings
May-03-24 12:38PM
09:42AM
05:02AM
(Thomson Reuters StreetEvents)
03:55AM
May-02-24 07:23AM
07:00AM
Loading…
07:00AM
04:02AM
May-01-24 05:34PM
05:13PM
(Associated Press Finance)
05:00PM
04:07PM
06:00AM
06:00AM
06:00AM
06:00AM
06:00AM
Loading…
06:00AM
06:00AM
Apr-26-24 06:00AM
Apr-20-24 01:30PM
Apr-18-24 08:49AM
01:40AM
Apr-17-24 10:01AM
09:40AM
Apr-08-24 01:56PM
Apr-01-24 09:40AM
Mar-22-24 06:00AM
Mar-20-24 09:50AM
Mar-19-24 08:49AM
Mar-11-24 06:00AM
Mar-07-24 11:32AM
10:40AM
Loading…
10:40AM
Mar-05-24 12:26PM
Mar-04-24 06:00AM
06:00AM
Feb-19-24 09:15AM
Feb-16-24 08:19AM
Feb-12-24 09:40AM
Feb-05-24 02:03PM
Feb-03-24 08:34AM
Feb-01-24 05:35PM
04:51PM
04:47PM
(Associated Press Finance)
04:08PM
Jan-30-24 06:00AM
Jan-05-24 09:45AM
Jan-02-24 11:55AM
06:00AM
06:00AM
Dec-28-23 01:01PM
Dec-21-23 08:46AM
Dec-19-23 06:45AM
Dec-18-23 09:18AM
Dec-15-23 06:00AM
Dec-07-23 09:45AM
Nov-24-23 11:31AM
Nov-22-23 02:20PM
01:44PM
Nov-17-23 11:03PM
Nov-03-23 07:57AM
07:52AM
06:00AM
Nov-02-23 07:59AM
Oct-30-23 11:52AM
Oct-29-23 08:44AM
Oct-27-23 02:49AM
(Thomson Reuters StreetEvents)
Oct-25-23 06:03PM
05:30PM
04:20PM
(Associated Press Finance)
04:06PM
09:40AM
Oct-23-23 04:05PM
Oct-19-23 09:45AM
Oct-13-23 07:19AM
Oct-12-23 11:01PM
Oct-09-23 12:04PM
Oct-06-23 06:00AM
Oct-04-23 09:40AM
Oct-02-23 09:45AM
Sep-15-23 06:00AM
Sep-14-23 09:45AM
Sep-11-23 09:40AM
Sep-06-23 02:08PM
Sep-05-23 06:00AM
Aug-18-23 11:48AM
Aug-10-23 09:45AM
Aug-06-23 10:48AM
Aug-03-23 02:01PM
Aug-02-23 06:00AM
06:00AM
Jul-31-23 12:39PM
Jul-29-23 02:41AM
(Thomson Reuters StreetEvents)
Jul-27-23 05:45PM
04:40PM
04:06PM
Jul-25-23 06:00AM
Jul-21-23 09:40AM
Jul-19-23 09:40AM
Jul-12-23 12:17PM
Jul-11-23 08:17AM
Jun-30-23 11:44AM
The Ensign Group, Inc. engages in providing skilled nursing, senior living, and rehabilitative care services. It operates through the Skilled Services and Standard Bearer segments. The Skilled Services segments includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment refers to the leasing to skilled nursing and senior living operations. The company was founded by Roy E. Christensen, Christopher R. Christensen, and Gregory K. Stapley in 1999 and is headquartered in San Juan Capistrano, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Agwunobi John O Director Apr 30 '24 Buy 117.58 0 18 5,250 May 02 07:08 PM Shaw Daren Director Apr 15 '24 Option Exercise 10.89 4,463 48,602 36,713 Apr 17 06:36 PM Shaw Daren Director Apr 15 '24 Sale 118.96 4,463 530,918 32,250 Apr 17 06:36 PM Wittekind Beverly B. VP and General Counsel Mar 14 '24 Option Exercise 17.23 8,258 142,262 47,912 Mar 18 06:08 PM Wittekind Beverly B. VP and General Counsel Mar 14 '24 Sale 121.65 10,000 1,216,549 37,912 Mar 18 06:08 PM Shaw Daren Director Feb 15 '24 Option Exercise 10.89 4,000 43,560 37,375 Feb 20 05:18 PM Shaw Daren Director Feb 15 '24 Sale 119.67 6,000 718,005 31,375 Feb 20 05:18 PM Christensen Christopher R. Executive Chairman Feb 08 '24 Sale 117.56 10,800 1,269,616 147,400 Feb 08 07:40 PM Christensen Christopher R. Executive Chairman Feb 07 '24 Sale 118.04 41,918 4,948,181 149,400 Feb 08 07:40 PM Christensen Christopher R. Executive Chairman Feb 06 '24 Sale 118.05 57,982 6,844,653 155,703 Feb 08 07:40 PM Shaw Daren Director Dec 15 '23 Option Exercise 10.89 4,000 43,560 36,500 Dec 18 04:29 PM Shaw Daren Director Dec 15 '23 Sale 111.86 4,000 447,440 32,500 Dec 18 04:29 PM Burton Spencer President and COO Dec 14 '23 Option Exercise 18.47 5,899 108,955 53,651 Dec 18 04:34 PM Burton Spencer President and COO Dec 14 '23 Sale 111.28 8,138 905,581 45,513 Dec 18 04:34 PM Shaw Daren Director Nov 15 '23 Sale 105.78 2,000 211,560 32,500 Nov 17 04:17 PM Shaw Daren Director Oct 10 '23 Option Exercise 10.89 4,000 43,560 37,625 Oct 12 04:05 PM Shaw Daren Director Oct 10 '23 Sale 95.00 4,000 380,014 33,625 Oct 12 04:05 PM Keetch Chad CIO, EVP and Secretary Aug 30 '23 Option Exercise 10.89 11,155 121,478 97,346 Aug 30 07:02 PM Keetch Chad CIO, EVP and Secretary Aug 30 '23 Sale 100.60 11,155 1,122,220 86,191 Aug 30 07:02 PM Burton Spencer President and COO Aug 30 '23 Sale 99.50 2,513 250,044 50,209 Sep 01 05:26 PM Blouin Ann Scott Director Aug 30 '23 Sale 100.00 75 7,500 17,727 Aug 30 06:43 PM Shaw Daren Director Aug 29 '23 Sale 97.84 2,000 195,680 33,625 Aug 30 06:48 PM Keetch Chad CIO, EVP and Secretary Aug 28 '23 Option Exercise 10.89 934 10,171 87,125 Aug 30 07:02 PM Keetch Chad CIO, EVP and Secretary Aug 28 '23 Sale 99.01 934 92,474 86,191 Aug 30 07:02 PM Keetch Chad CIO, EVP and Secretary Aug 11 '23 Option Exercise 10.89 7,962 86,706 94,153 Aug 14 05:32 PM Keetch Chad CIO, EVP and Secretary Aug 11 '23 Sale 98.10 7,962 781,036 86,191 Aug 14 05:32 PM Keetch Chad CIO, EVP and Secretary Aug 10 '23 Option Exercise 10.89 3,413 37,168 89,604 Aug 14 05:32 PM Keetch Chad CIO, EVP and Secretary Aug 10 '23 Sale 98.04 3,413 334,615 86,191 Aug 14 05:32 PM Keetch Chad CIO, EVP and Secretary Aug 04 '23 Option Exercise 10.89 12,799 139,381 98,990 Aug 08 05:22 PM Keetch Chad CIO, EVP and Secretary Aug 04 '23 Sale 97.49 12,799 1,247,789 86,191 Aug 08 05:22 PM Blouin Ann Scott Director Aug 03 '23 Sale 98.00 75 7,350 17,802 Aug 03 06:04 PM Blouin Ann Scott Director Aug 01 '23 Sale 96.16 300 28,848 17,877 Aug 03 06:04 PM Christensen Christopher R. Executive Chairman Jun 29 '23 Sale 95.01 14,583 1,385,477 939,178 Jul 03 04:16 PM Christensen Christopher R. Executive Chairman Jun 16 '23 Sale 95.10 10,183 968,357 953,761 Jun 20 04:25 PM Shaw Daren Director May 16 '23 Sale 91.50 750 68,625 34,750 May 17 04:54 PM Shaw Daren Director May 15 '23 Sale 91.33 1,250 114,162 35,500 May 17 04:54 PM
Index - P/E - EPS (ttm) -1.40 Insider Own 1.09% Shs Outstand 169.59M Perf Week -1.77%
Market Cap 2.17B Forward P/E - EPS next Y -0.68 Insider Trans -13.08% Shs Float 167.74M Perf Month -10.32%
Income -233.03M PEG - EPS next Q -0.34 Inst Own 71.57% Short Float 15.98% Perf Quarter -35.42%
Sales 2.62B P/S 0.83 EPS this Y 20.92% Inst Trans -3.00% Short Ratio 5.12 Perf Half Y -23.24%
Book/sh 13.52 P/B 0.95 EPS next Y 35.94% ROA -5.40% Short Interest 26.81M Perf Year -50.31%
Cash/sh 6.47 P/C 1.97 EPS next 5Y - ROE -10.18% 52W Range 12.53 - 30.41 Perf YTD -40.70%
Dividend Est. - P/FCF 6.46 EPS past 5Y 1.91% ROI -6.02% 52W High -57.97% Beta 1.02
Dividend TTM - Quick Ratio 3.65 Sales past 5Y 48.49% Gross Margin 56.87% 52W Low 2.00% ATR (14) 0.60
Dividend Ex-Date - Current Ratio 3.73 EPS Y/Y TTM 96.78% Oper. Margin -8.57% RSI (14) 36.24 Volatility 4.86% 4.26%
Employees 5600 Debt/Eq 0.69 Sales Y/Y TTM 6.01% Profit Margin -8.90% Recom 2.55 Target Price 17.23
Option/Short Yes / Yes LT Debt/Eq 0.69 EPS Q/Q -14.90% Payout - Rel Volume 1.18 Prev Close 12.99
Sales Surprise 1.38% EPS Surprise -6.85% Sales Q/Q 2.68% Earnings Apr 25 AMC Avg Volume 5.23M Price 12.78
SMA20 -6.21% SMA50 -11.50% SMA200 -32.76% Trades
Volume 6,195,906 Change -1.62%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-29-24 Initiated Cantor Fitzgerald
Overweight
$22
Feb-26-24 Initiated Leerink Partners
Market Perform
$17
Jan-17-24 Downgrade DA Davidson
Buy → Neutral
$33 → $22
Jan-03-24 Initiated Barclays
Overweight
$26
Apr-12-23 Initiated Stephens
Equal-Weight
$25
Feb-23-23 Upgrade SVB Securities
Market Perform → Outperform
$34
Oct-24-22 Upgrade Guggenheim
Sell → Neutral
Sep-16-22 Initiated KeyBanc Capital Markets
Sector Weight
Sep-07-22 Initiated Truist
Hold
$35
Aug-17-22 Downgrade Guggenheim
Neutral → Sell
$25
Aug-12-22 Initiated DA Davidson
Buy
$45
Aug-02-22 Downgrade Cowen
Outperform → Market Perform
$58 → $34
Aug-02-22 Downgrade Berenberg
Buy → Hold
$35
Jul-28-22 Downgrade Needham
Buy → Hold
Jul-28-22 Downgrade Goldman
Buy → Neutral
$55 → $36
Jul-06-22 Reiterated BofA Securities
Neutral
$36 → $42
May-05-22 Downgrade Argus
Buy → Hold
Apr-28-22 Downgrade William Blair
Outperform → Mkt Perform
Apr-28-22 Downgrade Wells Fargo
Overweight → Equal Weight
$104 → $40
Apr-28-22 Downgrade SVB Leerink
Outperform → Mkt Perform
Show Previous Ratings
May-03-24 03:44PM
01:11PM
02:30AM
May-02-24 06:00AM
May-01-24 04:50PM
12:39PM
Loading…
Apr-30-24 12:39PM
10:24AM
08:31AM
(Investor's Business Daily)
Apr-29-24 08:16AM
Apr-26-24 06:20PM
12:22PM
12:05PM
09:11AM
08:40AM
(Thomson Reuters StreetEvents)
08:00AM
03:43AM
Loading…
03:43AM
03:00AM
Apr-25-24 06:00PM
05:49PM
05:30PM
04:29PM
(Associated Press Finance)
04:11PM
04:05PM
11:34AM
Apr-24-24 03:01AM
Apr-23-24 11:32AM
Apr-19-24 07:45AM
06:56AM
Apr-18-24 10:02AM
Apr-17-24 06:15PM
02:47PM
Loading…
Apr-16-24 02:47PM
11:55AM
Apr-15-24 04:05PM
Apr-12-24 01:51PM
08:30AM
04:50AM
Apr-10-24 11:45AM
05:00AM
Apr-07-24 03:06AM
Apr-05-24 02:00PM
12:41PM
(Associated Press Finance)
11:53AM
11:43AM
10:02AM
06:30AM
06:06AM
Apr-04-24 04:47AM
Apr-03-24 05:48AM
Apr-02-24 10:15AM
Apr-01-24 05:50PM
Mar-31-24 05:47PM
Mar-28-24 06:37PM
11:44AM
09:56AM
Mar-26-24 07:00PM
Mar-25-24 05:50PM
Mar-24-24 10:08AM
Mar-22-24 05:52PM
Mar-21-24 11:30AM
Mar-18-24 05:50PM
Mar-15-24 04:13AM
Mar-12-24 05:50PM
Mar-11-24 12:22PM
03:30AM
Mar-10-24 09:35AM
Mar-09-24 10:30AM
09:15AM
Mar-08-24 10:32AM
08:30AM
Mar-07-24 03:30PM
08:30AM
Mar-06-24 05:45PM
Mar-05-24 05:00PM
Mar-04-24 11:25AM
(Investor's Business Daily)
Mar-02-24 09:00AM
Mar-01-24 07:56AM
Feb-29-24 05:45PM
Feb-26-24 04:30PM
Feb-23-24 12:59PM
05:15AM
Feb-22-24 05:03PM
(The Wall Street Journal)
05:03AM
Feb-21-24 04:36PM
04:22PM
02:33PM
02:12PM
01:44PM
12:30PM
11:55AM
11:02AM
10:00AM
09:55AM
09:55AM
(The Wall Street Journal)
09:38AM
09:21AM
08:41AM
08:35AM
(Thomson Reuters StreetEvents)
07:30AM
02:02AM
02:01AM
Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002, by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in Purchase, NY.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Kornwasser Laizer PRESIDENT, ENTERPRISE GROWTH May 02 '24 Sale 12.69 10,411 132,095 86,070 May 02 04:06 PM Waters Michael Willem CHIEF OPERATING OFFICER May 02 '24 Sale 12.69 5,793 73,502 64,881 May 02 04:05 PM Raman-Tangella Vidya CHIEF MEDICAL OFFICER May 02 '24 Sale 12.69 3,691 46,831 29,160 May 02 04:05 PM Trencher Daniel CHIEF STRATEGY OFFICER Apr 17 '24 Sale 13.21 1,000 13,210 26,192 Apr 17 04:54 PM Nanis Nikolaos P. Chief Technology Officer Apr 02 '24 Sale 14.31 461 6,599 70,621 Apr 03 04:05 PM Geshuri Arnnon CHIEF PEOPLE OFFICER Mar 25 '24 Option Exercise 2.73 7,500 20,475 45,970 Mar 26 04:05 PM Geshuri Arnnon CHIEF PEOPLE OFFICER Mar 25 '24 Sale 15.06 7,500 112,950 38,470 Mar 26 04:05 PM Trencher Daniel CHIEF STRATEGY OFFICER Mar 18 '24 Sale 15.18 1,000 15,180 27,192 Mar 18 04:56 PM Turitz Andrew EVP, CORPORATE DEVELOPMENT Mar 05 '24 Sale 14.53 5,647 82,051 33,782 Mar 06 04:05 PM GOREVIC JASON N CHIEF EXECUTIVE OFFICER Mar 04 '24 Sale 14.52 53,755 780,308 653,073 Mar 05 04:09 PM Murthy Mala CHIEF FINANCIAL OFFICER Mar 04 '24 Sale 14.52 29,888 433,854 71,716 Mar 05 04:07 PM Kornwasser Laizer PRESIDENT, ENTERPRISE GROWTH Mar 04 '24 Sale 14.52 18,349 266,354 76,283 Mar 05 04:11 PM Vandervoort Adam C CHIEF LEGAL OFFICER, SECRETARY Mar 04 '24 Sale 14.52 15,653 227,219 37,476 Mar 05 04:09 PM Waters Michael Willem CHIEF OPERATING OFFICER Mar 04 '24 Sale 14.52 12,468 180,985 59,355 Mar 05 04:10 PM Verstraete Stephany CHIEF MARKETING OFFICER Mar 04 '24 Sale 14.52 7,945 115,330 56,486 Mar 05 04:10 PM Trencher Daniel CHIEF STRATEGY OFFICER Mar 04 '24 Sale 14.52 6,780 98,418 28,192 Mar 05 04:08 PM Turitz Andrew EVP, CORPORATE DEVELOPMENT Mar 04 '24 Sale 14.52 6,190 89,854 39,429 Mar 05 04:08 PM Geshuri Arnnon CHIEF PEOPLE OFFICER Mar 04 '24 Sale 14.52 6,108 88,664 38,470 Mar 05 04:07 PM Raman-Tangella Vidya CHIEF MEDICAL OFFICER Mar 04 '24 Sale 14.52 4,599 66,759 22,607 Mar 05 04:08 PM Napolitano Richard J CHIEF ACCOUNTING OFFICER Mar 04 '24 Sale 14.52 3,765 54,653 18,077 Mar 05 04:11 PM Nanis Nikolaos P. Chief Technology Officer Mar 04 '24 Sale 14.52 2,866 41,603 69,850 Mar 05 04:09 PM Turitz Andrew EVP, CORPORATE DEVELOPMENT Mar 01 '24 Sale 15.06 475 7,154 25,193 Mar 05 04:08 PM Geshuri Arnnon CHIEF PEOPLE OFFICER Feb 26 '24 Sale 14.50 404 5,859 28,020 Feb 27 04:06 PM Trencher Daniel CHIEF STRATEGY OFFICER Feb 20 '24 Sale 20.64 1,000 20,640 16,788 Feb 20 05:02 PM Kornwasser Laizer PRESIDENT, ENTERPRISE GROWTH Feb 02 '24 Sale 19.18 7,882 151,161 57,223 Feb 02 05:04 PM Waters Michael Willem CHIEF OPERATING OFFICER Feb 02 '24 Sale 19.18 4,523 86,742 38,570 Feb 02 05:04 PM Raman-Tangella Vidya CHIEF MEDICAL OFFICER Feb 02 '24 Sale 19.18 4,128 79,167 14,737 Feb 02 05:03 PM Napolitano Richard J CHIEF ACCOUNTING OFFICER Feb 02 '24 Sale 19.18 872 16,723 11,749 Feb 02 05:04 PM Trencher Daniel CHIEF STRATEGY OFFICER Jan 17 '24 Sale 19.46 1,000 19,460 17,788 Jan 18 04:06 PM Nanis Nikolaos P. Chief Technology Officer Jan 03 '24 Sale 21.36 520 11,107 65,031 Jan 04 04:05 PM Raman-Tangella Vidya CHIEF MEDICAL OFFICER Dec 26 '23 Sale 22.00 27,310 600,820 8,621 Dec 27 04:05 PM Daniel Karen L Director Dec 20 '23 Sale 21.41 14,073 301,303 36,995 Dec 21 04:05 PM Trencher Daniel CHIEF STRATEGY OFFICER Dec 18 '23 Sale 20.36 1,000 20,360 18,788 Dec 19 04:05 PM Murthy Mala CHIEF FINANCIAL OFFICER Dec 04 '23 Sale 18.90 3,004 56,782 49,315 Dec 05 04:07 PM GOREVIC JASON N CHIEF EXECUTIVE OFFICER Dec 04 '23 Sale 18.90 2,877 54,381 601,734 Dec 05 04:06 PM Vandervoort Adam C CHIEF LEGAL OFFICER, SECRETARY Dec 04 '23 Sale 18.90 965 18,240 23,467 Dec 05 04:07 PM Napolitano Richard J CHIEF ACCOUNTING OFFICER Dec 04 '23 Sale 18.90 652 12,324 10,601 Dec 05 04:08 PM Verstraete Stephany CHIEF MARKETING OFFICER Dec 04 '23 Sale 18.90 509 9,621 43,117 Dec 05 04:07 PM Nanis Nikolaos P. Chief Technology Officer Dec 04 '23 Sale 18.90 508 9,602 64,319 Dec 05 04:06 PM Trencher Daniel CHIEF STRATEGY OFFICER Dec 04 '23 Sale 18.90 427 8,071 19,788 Dec 05 04:06 PM Geshuri Arnnon CHIEF PEOPLE OFFICER Dec 04 '23 Sale 18.90 410 7,750 28,424 Dec 05 04:06 PM Turitz Andrew EVP, CORPORATE DEVELOPMENT Dec 04 '23 Sale 18.90 397 7,504 25,668 Dec 05 04:05 PM Geshuri Arnnon CHIEF PEOPLE OFFICER Nov 27 '23 Sale 17.04 346 5,896 27,655 Nov 28 09:36 PM Trencher Daniel CHIEF STRATEGY OFFICER Nov 17 '23 Sale 17.07 1,000 17,070 19,036 Nov 20 04:05 PM Kornwasser Laizer PRESIDENT, ENTERPRISE GROWTH Nov 02 '23 Sale 17.05 35,887 611,730 44,907 Nov 03 05:13 PM Waters Michael Willem CHIEF OPERATING OFFICER Nov 02 '23 Sale 17.05 5,482 93,446 31,774 Nov 03 05:15 PM Raman-Tangella Vidya CHIEF MEDICAL OFFICER Nov 02 '23 Sale 17.05 4,962 84,582 35,931 Nov 03 05:15 PM Geshuri Arnnon CHIEF PEOPLE OFFICER Oct 31 '23 Sale 16.28 365 5,943 77,097 Nov 01 04:06 PM Trencher Daniel CHIEF STRATEGY OFFICER Oct 17 '23 Sale 18.74 1,000 18,740 20,036 Oct 18 04:07 PM Napolitano Richard J CHIEF ACCOUNTING OFFICER Sep 25 '23 Sale 18.68 219 4,091 9,457 Sep 26 04:14 PM Trencher Daniel CHIEF STRATEGY OFFICER Sep 18 '23 Sale 21.00 1,000 21,000 21,036 Sep 19 04:05 PM Murthy Mala CHIEF FINANCIAL OFFICER Sep 05 '23 Sale 22.89 3,221 73,742 46,907 Sep 06 04:13 PM GOREVIC JASON N CHIEF EXECUTIVE OFFICER Sep 05 '23 Sale 22.89 2,864 65,568 598,996 Sep 06 04:11 PM Jensen Claus Torp CHIEF INNOVATION OFFICER Sep 05 '23 Sale 22.89 2,093 47,917 15,853 Sep 06 04:12 PM Vandervoort Adam C CHIEF LEGAL OFFICER, SECRETARY Sep 05 '23 Sale 22.89 961 22,001 22,551 Sep 06 04:17 PM Napolitano Richard J CHIEF ACCOUNTING OFFICER Sep 05 '23 Sale 22.89 649 14,858 9,075 Sep 06 04:16 PM Verstraete Stephany CHIEF MARKETING OFFICER Sep 05 '23 Sale 22.89 506 11,584 42,222 Sep 06 04:18 PM Trencher Daniel CHIEF STRATEGY OFFICER Sep 05 '23 Sale 22.89 426 9,753 22,036 Sep 06 04:16 PM Geshuri Arnnon CHIEF PEOPLE OFFICER Sep 05 '23 Sale 22.89 408 9,341 76,401 Sep 06 04:11 PM Turitz Andrew EVP, CORPORATE DEVELOPMENT Sep 05 '23 Sale 22.89 396 9,066 24,718 Sep 06 04:17 PM Geshuri Arnnon CHIEF PEOPLE OFFICER Aug 28 '23 Sale 22.31 336 7,496 75,630 Aug 29 04:06 PM Trencher Daniel CHIEF STRATEGY OFFICER Aug 17 '23 Sale 22.81 1,000 22,810 21,283 Aug 18 04:06 PM Waters Michael Willem CHIEF OPERATING OFFICER Aug 02 '23 Sale 27.03 19,340 522,741 25,937 Aug 03 04:15 PM Raman-Tangella Vidya CHIEF MEDICAL OFFICER Aug 02 '23 Sale 27.03 5,215 140,956 30,649 Aug 03 04:14 PM Geshuri Arnnon CHIEF PEOPLE OFFICER Jul 27 '23 Option Exercise 2.73 3,750 10,238 79,716 Jul 28 04:11 PM GOREVIC JASON N CHIEF EXECUTIVE OFFICER Jul 27 '23 Sale 30.03 10,000 300,303 596,246 Jul 28 04:09 PM Geshuri Arnnon CHIEF PEOPLE OFFICER Jul 27 '23 Sale 30.00 3,750 112,500 75,966 Jul 28 04:11 PM Jensen Claus Torp CHIEF INNOVATION OFFICER Jul 26 '23 Sale 29.00 6,547 189,863 13,096 Jul 27 04:06 PM Jensen Claus Torp CHIEF INNOVATION OFFICER Jul 18 '23 Sale 27.00 6,547 176,769 19,643 Jul 19 04:06 PM Trencher Daniel CHIEF STRATEGY OFFICER Jul 17 '23 Sale 24.66 1,000 24,660 22,283 Jul 18 04:17 PM Trencher Daniel CHIEF STRATEGY OFFICER Jun 20 '23 Sale 24.61 1,000 24,610 23,283 Jun 21 04:06 PM Murthy Mala CHIEF FINANCIAL OFFICER Jun 02 '23 Sale 24.38 6,241 152,162 44,716 Jun 05 04:08 PM Jensen Claus Torp CHIEF INNOVATION OFFICER Jun 02 '23 Sale 24.38 4,635 113,006 26,190 Jun 05 04:06 PM GOREVIC JASON N CHIEF EXECUTIVE OFFICER Jun 02 '23 Sale 24.38 2,802 68,316 606,246 Jun 05 04:07 PM Napolitano Richard J CHIEF ACCOUNTING OFFICER Jun 02 '23 Sale 24.38 1,579 38,498 7,928 Jun 05 04:09 PM Vandervoort Adam C CHIEF LEGAL OFFICER, SECRETARY Jun 02 '23 Sale 24.38 939 22,894 21,631 Jun 05 04:12 PM Verstraete Stephany CHIEF MARKETING OFFICER Jun 02 '23 Sale 24.38 495 12,069 41,325 Jun 05 04:13 PM Trencher Daniel CHIEF STRATEGY OFFICER Jun 02 '23 Sale 24.38 416 10,142 24,283 Jun 05 04:10 PM Geshuri Arnnon CHIEF PEOPLE OFFICER Jun 02 '23 Sale 24.38 399 9,728 75,966 Jun 05 04:07 PM Turitz Andrew EVP, CORPORATE DEVELOPMENT Jun 02 '23 Sale 24.38 386 9,411 23,767 Jun 05 04:11 PM Geshuri Arnnon CHIEF PEOPLE OFFICER May 26 '23 Sale 22.78 1,092 24,876 75,186 May 30 04:07 PM Jensen Claus Torp CHIEF INNOVATION OFFICER May 23 '23 Sale 24.44 2,888 70,580 19,843 May 24 04:06 PM Trencher Daniel CHIEF STRATEGY OFFICER May 17 '23 Sale 23.81 1,000 23,810 23,520 May 18 04:11 PM
Index RUT P/E - EPS (ttm) -1.15 Insider Own 6.69% Shs Outstand 27.41M Perf Week 19.62%
Market Cap 671.75M Forward P/E - EPS next Y -1.95 Insider Trans -14.67% Shs Float 25.76M Perf Month 14.55%
Income -30.80M PEG - EPS next Q -0.35 Inst Own 82.80% Short Float 5.66% Perf Quarter 3.93%
Sales 250.72M P/S 2.68 EPS this Y 26.09% Inst Trans -2.02% Short Ratio 6.23 Perf Half Y 54.97%
Book/sh 14.59 P/B 1.67 EPS next Y -23.58% ROA -6.96% Short Interest 1.46M Perf Year 6.20%
Cash/sh 8.66 P/C 2.81 EPS next 5Y - ROE -7.82% 52W Range 9.26 - 26.70 Perf YTD 12.74%
Dividend Est. - P/FCF - EPS past 5Y -28.57% ROI -7.22% 52W High -8.88% Beta 0.93
Dividend TTM - Quick Ratio 9.02 Sales past 5Y 60.93% Gross Margin 76.33% 52W Low 162.74% ATR (14) 1.17
Dividend Ex-Date - Current Ratio 9.25 EPS Y/Y TTM 57.68% Oper. Margin -16.72% RSI (14) 70.07 Volatility 7.05% 4.68%
Employees 610 Debt/Eq 0.06 Sales Y/Y TTM 64.71% Profit Margin -12.28% Recom 1.11 Target Price 34.33
Option/Short Yes / Yes LT Debt/Eq 0.06 EPS Q/Q 91.60% Payout - Rel Volume 3.59 Prev Close 22.84
Sales Surprise 7.17% EPS Surprise 72.89% Sales Q/Q 73.59% Earnings May 02 AMC Avg Volume 234.05K Price 24.33
SMA20 19.60% SMA50 16.44% SMA200 26.45% Trades
Volume 839,813 Change 6.52%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-14-23 Initiated Guggenheim
Buy
$25
Jan-05-23 Initiated Scotiabank
Sector Outperform
$54
Jan-07-22 Initiated Stephens
Overweight
$59
Apr-30-21 Initiated Lake Street
Buy
$94
Nov-10-20 Initiated KeyBanc Capital Markets
Overweight
$70
Dec-27-19 Reiterated Canaccord Genuity
Buy
$34 → $35
Aug-19-19 Initiated SVB Leerink
Outperform
$28
Aug-19-19 Initiated Robert W. Baird
Outperform
$27
Aug-19-19 Initiated Canaccord Genuity
Buy
$26
Aug-19-19 Initiated BTIG Research
Buy
$25
May-03-24 07:00AM
May-02-24 08:56PM
05:59PM
05:50PM
04:05PM
04:30PM
Loading…
Apr-30-24 04:30PM
Apr-11-24 07:00AM
Apr-10-24 05:00PM
07:00AM
Apr-05-24 04:43AM
Apr-04-24 04:30PM
Apr-02-24 07:00AM
Mar-27-24 05:00PM
Mar-25-24 07:00AM
Mar-22-24 04:30PM
05:17AM
Loading…
Mar-20-24 05:17AM
Mar-19-24 07:00AM
Mar-15-24 04:30PM
Mar-12-24 07:00AM
Mar-08-24 04:30PM
Mar-07-24 07:00AM
Feb-29-24 10:37AM
08:43AM
(Thomson Reuters StreetEvents)
Feb-28-24 06:30PM
05:40PM
04:42PM
04:05PM
Feb-26-24 09:16AM
07:00AM
Feb-07-24 07:00AM
07:00AM
Loading…
Jan-18-24 07:00AM
Jan-14-24 04:30AM
Jan-09-24 07:00AM
Jan-07-24 08:00PM
Dec-20-23 07:00AM
Dec-12-23 09:55AM
Dec-01-23 07:00AM
Nov-14-23 07:00AM
Nov-13-23 07:00AM
Nov-08-23 04:30PM
01:00PM
Nov-04-23 09:18AM
Nov-03-23 08:11AM
(Thomson Reuters StreetEvents) +7.99%
07:00AM
Nov-02-23 07:30PM
07:24PM
04:06PM
04:05PM
Oct-24-23 07:00AM
Oct-19-23 07:00AM
Oct-18-23 04:30PM
Oct-05-23 07:00AM
Oct-03-23 07:00AM
Oct-02-23 07:00AM
Sep-25-23 07:00AM
Sep-19-23 07:00AM
Sep-14-23 07:00AM
Sep-12-23 07:00AM
Sep-09-23 08:00PM
Sep-08-23 04:30PM
Sep-06-23 07:00AM
Sep-05-23 07:00AM
Aug-07-23 07:00AM
Aug-03-23 11:17AM
08:31AM
Aug-02-23 07:30PM
06:15PM
04:05PM
Aug-01-23 07:00AM
Jul-26-23 10:02AM
Jul-19-23 07:00AM
Jul-18-23 07:00AM
Jul-17-23 07:00AM
Jul-13-23 05:18PM
Jul-07-23 12:16PM
12:14PM
07:00AM
Jun-30-23 07:00AM
Jun-21-23 09:58AM
Jun-20-23 07:00AM
Jun-12-23 07:00AM
Jun-11-23 08:04AM
Jun-08-23 06:34AM
Jun-05-23 03:04PM
07:00AM
Jun-03-23 07:00AM
Jun-02-23 05:04PM
May-31-23 07:00AM
May-30-23 07:00AM
May-26-23 07:00AM
May-24-23 07:07PM
(American City Business Journals)
07:07PM
(American City Business Journals)
May-22-23 07:00AM
May-15-23 07:00AM
May-05-23 06:21AM
May-03-23 05:45PM
04:05PM
07:00AM
Apr-28-23 07:00AM
Apr-25-23 07:00AM
Castle Biosciences, Inc. is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients. The firm offers DecisionDx-Melanoma, a proprietary multi-gene expression profile (GEP) test that predicts the risk of metastasis and recurrence for patients diagnosed with invasive cutaneous melanoma. It also markets DecisionDx-UM, Decision Dx DiffDx-Melanoma, DecisonDx-CMSeq, DecisionDx-SCC, DecsionDx-UMSeq, and DecisonDX-PRAME. The company was founded by Derek J. Maetzold in September 2007 and is headquartered in Friendswood, TX.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
MAETZOLD DEREK J Pres. & Chief Exec. Officer Apr 23 '24 Sale 20.11 705 14,177 9,683 Apr 25 04:54 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Apr 23 '24 Sale 20.11 421 8,466 64,997 Apr 25 04:54 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Apr 12 '24 Sale 20.35 3,263 66,402 9,752 Apr 16 04:46 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Apr 12 '24 Sale 20.35 1,947 39,621 65,418 Apr 16 04:46 PM BRADBURY DANIEL Director Apr 08 '24 Sale 20.45 2,400 49,087 17,944 Apr 10 04:35 PM BRADBURY DANIEL Director Apr 05 '24 Sale 20.86 11,771 245,543 18,763 Apr 08 04:31 PM BRADBURY DANIEL Director Apr 04 '24 Sale 21.45 9,152 196,310 22,782 Apr 08 04:31 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Apr 03 '24 Sale 21.70 3,968 86,106 10,069 Apr 05 04:37 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Apr 03 '24 Sale 21.70 2,368 51,386 67,365 Apr 05 04:37 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Mar 21 '24 Sale 20.70 121 2,505 10,455 Mar 22 05:16 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Mar 21 '24 Sale 20.70 73 1,511 69,733 Mar 22 05:16 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Mar 20 '24 Sale 20.27 3,847 77,979 10,467 Mar 22 05:16 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Mar 20 '24 Sale 20.27 2,295 46,520 69,806 Mar 22 05:16 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Mar 07 '24 Sale 20.77 3,996 82,997 10,841 Mar 11 05:18 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Mar 07 '24 Sale 20.77 2,372 49,266 72,101 Mar 11 05:18 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Mar 05 '24 Option Exercise 3.72 10,686 39,752 78,604 Mar 06 05:58 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Mar 05 '24 Sale 21.41 4,131 88,461 74,473 Mar 06 05:58 PM BRADBURY DANIEL Director Mar 04 '24 Sale 20.68 23,323 482,285 25,907 Mar 06 05:52 PM BRADBURY DANIEL Director Feb 07 '24 Sale 23.20 2,074 48,117 33,870 Feb 09 04:49 PM BRADBURY DANIEL Director Feb 06 '24 Sale 23.63 9,847 232,685 34,578 Feb 07 04:19 PM BRADBURY DANIEL Director Feb 05 '24 Sale 22.90 11,402 261,134 37,940 Feb 07 04:19 PM BRADBURY DANIEL Director Jan 05 '24 Sale 20.36 5,100 103,836 41,833 Jan 08 04:19 PM BRADBURY DANIEL Director Jan 04 '24 Sale 20.40 18,223 371,749 43,574 Jan 08 04:19 PM Juvenal Tobin W Chief Commercial Officer Jan 02 '24 Option Exercise 2.89 6,701 19,381 46,857 Jan 04 05:16 PM Oelschlager Kristen M Chief Operating Officer Dec 29 '23 Option Exercise 3.01 12,615 38,034 150,302 Jan 03 04:11 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Dec 28 '23 Sale 22.17 3,954 87,660 64,084 Dec 29 04:05 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Dec 28 '23 Sale 22.17 557 12,349 11,629 Dec 29 04:05 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Dec 27 '23 Sale 21.90 8,076 176,864 68,038 Dec 29 04:05 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Dec 27 '23 Sale 21.90 1,137 24,900 11,688 Dec 29 04:05 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Dec 26 '23 Sale 21.93 5,180 113,597 76,114 Dec 27 04:18 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Dec 26 '23 Sale 21.93 729 15,987 11,807 Dec 27 04:18 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Dec 22 '23 Sale 21.96 5,224 114,719 81,294 Dec 27 04:18 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Dec 22 '23 Sale 21.96 736 16,163 11,884 Dec 27 04:18 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Dec 21 '23 Sale 21.40 10,999 235,412 86,518 Dec 22 04:06 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Dec 21 '23 Sale 21.40 1,549 33,153 11,962 Dec 22 04:06 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Dec 20 '23 Sale 21.05 5,201 109,455 97,517 Dec 22 04:06 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Dec 20 '23 Sale 21.05 733 15,426 12,125 Dec 22 04:06 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Dec 19 '23 Sale 20.84 5,719 119,161 102,718 Dec 20 04:46 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Dec 19 '23 Sale 20.84 3,314 69,051 12,202 Dec 20 04:46 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Dec 18 '23 Sale 20.27 5,720 115,962 108,437 Dec 20 04:46 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Dec 18 '23 Sale 20.27 1,498 30,369 12,552 Dec 20 04:46 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Dec 15 '23 Sale 20.21 3,709 74,959 114,157 Dec 18 04:06 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Dec 15 '23 Sale 20.21 1,113 22,494 12,710 Dec 18 04:06 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Dec 14 '23 Sale 20.89 9,976 208,363 12,827 Dec 18 04:06 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Dec 14 '23 Sale 20.89 9,152 191,151 117,866 Dec 18 04:06 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Dec 13 '23 Sale 20.21 3,980 80,436 13,879 Dec 14 05:39 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Dec 13 '23 Sale 20.21 3,652 73,807 127,018 Dec 14 05:39 PM BRADBURY DANIEL Director Dec 13 '23 Sale 20.04 1,168 23,407 49,796 Dec 14 05:32 PM BRADBURY DANIEL Director Dec 12 '23 Sale 20.01 1,200 24,012 50,195 Dec 14 05:32 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Dec 12 '23 Sale 20.01 546 10,925 130,670 Dec 14 05:39 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Dec 12 '23 Sale 20.01 254 5,083 14,298 Dec 14 05:39 PM Oelschlager Kristen M Chief Operating Officer Dec 10 '23 Option Exercise 0.00 7,920 0 138,149 Dec 12 07:39 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Dec 10 '23 Option Exercise 0.00 20,787 0 133,327 Dec 12 07:23 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Dec 09 '23 Option Exercise 0.00 33,496 0 128,391 Dec 12 07:23 PM Oelschlager Kristen M Chief Operating Officer Dec 09 '23 Option Exercise 0.00 15,961 0 136,061 Dec 12 07:39 PM BRADBURY DANIEL Director Dec 08 '23 Sale 20.09 6,875 138,119 50,605 Dec 12 07:19 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Dec 08 '23 Sale 20.10 2,530 50,853 14,325 Dec 12 07:23 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Dec 08 '23 Sale 20.10 2,322 46,672 94,895 Dec 12 07:23 PM BRADBURY DANIEL Director Dec 06 '23 Sale 20.02 200 4,004 52,952 Dec 08 04:35 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Dec 06 '23 Sale 20.02 52 1,041 14,592 Dec 08 04:38 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Dec 06 '23 Sale 20.02 48 961 97,217 Dec 08 04:38 PM BRADBURY DANIEL Director Dec 04 '23 Sale 20.08 4,340 87,165 53,020 Dec 05 05:46 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Dec 04 '23 Sale 20.08 1,504 30,200 14,597 Dec 05 05:49 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Dec 04 '23 Sale 20.08 1,379 27,690 97,265 Dec 05 05:49 PM BRADBURY DANIEL Director Dec 01 '23 Sale 20.05 9,545 191,425 54,502 Dec 05 05:46 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Dec 01 '23 Sale 20.06 3,526 70,732 14,756 Dec 05 05:49 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Dec 01 '23 Sale 20.06 3,235 64,894 98,644 Dec 05 05:49 PM BRADBURY DANIEL Director Nov 30 '23 Sale 20.08 12,179 244,566 57,761 Dec 01 04:30 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Nov 30 '23 Sale 20.07 4,915 98,644 15,127 Dec 01 04:34 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Nov 30 '23 Sale 20.07 4,510 90,516 101,879 Dec 01 04:34 PM BRADBURY DANIEL Director Nov 29 '23 Sale 20.12 17,342 349,008 60,197 Dec 01 04:30 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Nov 29 '23 Sale 20.13 6,261 126,034 15,645 Dec 01 04:34 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Nov 29 '23 Sale 20.13 5,743 115,607 106,389 Dec 01 04:34 PM BRADBURY DANIEL Director Nov 24 '23 Sale 20.02 800 16,016 63,665 Nov 28 04:31 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Nov 24 '23 Sale 20.03 313 6,269 16,305 Nov 28 04:43 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Nov 24 '23 Sale 20.03 287 5,749 112,132 Nov 28 04:43 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Nov 21 '23 Sale 20.01 826 16,528 16,338 Nov 22 04:20 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Nov 21 '23 Sale 20.01 758 15,168 112,419 Nov 22 04:20 PM BRADBURY DANIEL Director Nov 21 '23 Sale 20.00 300 6,000 63,825 Nov 22 04:22 PM BRADBURY DANIEL Director Nov 20 '23 Sale 20.04 5,755 115,330 63,885 Nov 22 04:22 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Nov 20 '23 Sale 20.04 2,100 42,084 16,425 Nov 22 04:20 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Nov 20 '23 Sale 20.04 1,926 38,597 113,177 Nov 22 04:20 PM BRADBURY DANIEL Director Sep 01 '23 Sale 20.04 1,802 36,112 65,037 Sep 06 04:28 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Sep 01 '23 Sale 20.05 782 15,681 16,646 Sep 06 04:40 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Sep 01 '23 Sale 20.05 718 14,397 115,103 Sep 06 04:40 PM BRADBURY DANIEL Director Aug 31 '23 Sale 20.05 7,286 146,106 65,397 Sep 01 04:23 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Aug 31 '23 Sale 20.06 4,471 89,679 16,729 Sep 01 04:26 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Aug 31 '23 Sale 20.06 4,084 81,917 115,821 Sep 01 04:26 PM BRADBURY DANIEL Director Aug 30 '23 Sale 20.03 4,632 92,779 66,854 Sep 01 04:23 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Aug 30 '23 Sale 20.03 1,778 35,619 17,202 Sep 01 04:26 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Aug 30 '23 Sale 20.03 1,622 32,494 119,905 Sep 01 04:26 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Aug 03 '23 Sale 20.10 314 6,311 17,391 Aug 07 05:07 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Aug 03 '23 Sale 20.10 286 5,749 121,527 Aug 07 05:07 PM BRADBURY DANIEL Director Jul 07 '23 Sale 20.39 50,000 1,019,500 67,780 Jul 11 05:06 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Jul 07 '23 Sale 20.04 16,740 335,537 17,424 Jul 11 05:10 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer Jul 07 '23 Sale 20.04 8,376 167,889 121,813 Jul 11 05:10 PM Goldberg Ellen Director Jun 05 '23 Buy 14.38 4,800 69,004 9,065 Jun 06 04:48 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer May 16 '23 Sale 22.82 2,506 57,187 19,515 May 17 05:07 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer May 16 '23 Sale 22.82 1,254 28,616 149,189 May 17 05:07 PM MAETZOLD DEREK J Pres. & Chief Exec. Officer May 15 '23 Sale 23.45 3,074 72,076 19,828 May 17 05:07 PM
Index RUT P/E - EPS (ttm) -0.11 Insider Own 34.85% Shs Outstand 205.10M Perf Week -9.92%
Market Cap 2.41B Forward P/E 27.63 EPS next Y 0.41 Insider Trans -3.91% Shs Float 139.59M Perf Month -23.30%
Income -23.55M PEG - EPS next Q 0.01 Inst Own 38.57% Short Float 12.51% Perf Quarter 26.94%
Sales 872.00M P/S 2.77 EPS this Y 200.87% Inst Trans 4.53% Short Ratio 3.31 Perf Half Y 91.17%
Book/sh 1.61 P/B 6.99 EPS next Y 267.30% ROA -5.83% Short Interest 17.47M Perf Year -5.06%
Cash/sh 1.03 P/C 10.92 EPS next 5Y - ROE -7.18% 52W Range 5.65 - 17.16 Perf YTD 26.52%
Dividend Est. - P/FCF 51.34 EPS past 5Y - ROI -6.68% 52W High -34.38% Beta 0.96
Dividend TTM - Quick Ratio 2.74 Sales past 5Y 60.52% Gross Margin 80.90% 52W Low 99.29% ATR (14) 0.71
Dividend Ex-Date - Current Ratio 3.00 EPS Y/Y TTM 64.84% Oper. Margin -4.12% RSI (14) 28.26 Volatility 6.35% 5.00%
Employees 1046 Debt/Eq 0.03 Sales Y/Y TTM 65.49% Profit Margin -2.70% Recom 1.92 Target Price 16.02
Option/Short Yes / Yes LT Debt/Eq 0.03 EPS Q/Q 110.59% Payout - Rel Volume 2.27 Prev Close 12.24
Sales Surprise 0.06% EPS Surprise 144.84% Sales Q/Q 47.50% Earnings May 06 AMC Avg Volume 5.27M Price 11.26
SMA20 -13.64% SMA50 -18.73% SMA200 21.96% Trades
Volume 11,974,276 Change -8.01%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-16-24 Downgrade Jefferies
Buy → Hold
$17 → $15
Apr-10-24 Initiated Canaccord Genuity
Buy
$20
Feb-28-24 Upgrade Imperial Capital
In-line → Outperform
$16
Feb-26-24 Initiated Leerink Partners
Market Perform
$10
Dec-07-23 Initiated Imperial Capital
In-line
$9
Jul-28-23 Initiated TD Cowen
Outperform
$11
Apr-11-23 Initiated Robert W. Baird
Neutral
$10
Feb-09-23 Upgrade Jefferies
Hold → Buy
$7 → $11
Nov-08-22 Upgrade SVB Leerink
Mkt Perform → Outperform
$5
Nov-08-22 Upgrade BofA Securities
Neutral → Buy
$7.50 → $8.50
Oct-17-22 Downgrade Piper Sandler
Overweight → Neutral
$8 → $6
Sep-07-22 Initiated Truist
Hold
$7
Jul-15-22 Initiated SVB Leerink
Underperform
$4
Apr-14-22 Initiated Guggenheim
Buy
$10
Apr-01-22 Resumed Credit Suisse
Outperform
$8
Mar-10-22 Initiated Deutsche Bank
Hold
$7
Dec-02-21 Initiated Jefferies
Hold
$7
Nov-11-21 Upgrade Piper Sandler
Neutral → Overweight
$10 → $12
Jul-06-21 Initiated BofA Securities
Neutral
$12
May-20-21 Upgrade Credit Suisse
Neutral → Outperform
$16
Show Previous Ratings
May-03-24 12:04PM
09:55AM
May-02-24 09:30AM
09:00AM
Apr-22-24 06:00PM
06:15PM
Loading…
Apr-18-24 06:15PM
Apr-16-24 03:54PM
Apr-15-24 04:05PM
Apr-11-24 05:50PM
Apr-04-24 05:14PM
Apr-03-24 09:00AM
Mar-28-24 01:38PM
Mar-22-24 03:53PM
Mar-11-24 08:00AM
Mar-05-24 12:00PM
12:20PM
Loading…
Feb-29-24 12:20PM
Feb-26-24 05:08PM
(Yahoo Finance Video) +7.67%
04:05PM
Feb-20-24 08:00AM
Feb-05-24 04:05PM
Jan-11-24 09:00AM
Jan-04-24 12:23PM
Dec-04-23 09:15AM
Nov-06-23 04:05PM
04:05PM
09:15AM
Oct-19-23 10:00AM
Oct-16-23 09:00AM
Oct-13-23 11:31AM
Sep-06-23 04:05PM
10:32AM
Loading…
Aug-08-23 10:32AM
(Yahoo Finance Video) -5.82%
Aug-07-23 04:40PM
04:15PM
Jul-31-23 12:30PM
Jul-28-23 10:13AM
Jul-24-23 09:00AM
Jun-13-23 11:01AM
May-08-23 04:15PM
Apr-17-23 04:05PM
Mar-23-23 12:00PM
Mar-16-23 02:00PM
Mar-15-23 12:00PM
Mar-14-23 12:00PM
Mar-10-23 07:37PM
Feb-28-23 04:02PM
(Yahoo Finance Video) +16.79%
10:59AM
Feb-27-23 05:02PM
04:15PM
Feb-06-23 09:00AM
Jan-18-23 08:59AM
Jan-12-23 08:59AM
Dec-20-22 09:00AM
Dec-05-22 09:00AM
Nov-10-22 09:00AM
Nov-08-22 11:08AM
(Yahoo Finance Video) +19.70%
Nov-07-22 04:15PM
Oct-17-22 04:05PM
Oct-12-22 09:00AM
Sep-27-22 09:00AM
Sep-06-22 09:00AM
Aug-11-22 06:26AM
Aug-09-22 11:16AM
(Yahoo Finance Video) -5.10%
Aug-08-22 04:15PM
Jul-07-22 09:00AM
Jun-13-22 11:53AM
Jun-08-22 08:57AM
Jun-07-22 08:57AM
May-09-22 04:15PM
Apr-28-22 03:35PM
Apr-11-22 09:00AM
Mar-30-22 09:00AM
Mar-29-22 08:57AM
Mar-04-22 10:39AM
(American City Business Journals) -5.93%
Mar-02-22 08:57AM
Mar-01-22 09:00AM
Feb-26-22 07:29AM
Feb-23-22 04:06PM
09:56AM
Feb-22-22 04:06PM
Feb-15-22 08:57AM
Feb-07-22 08:57AM
Feb-01-22 08:00AM
Jan-24-22 08:57AM
Jan-21-22 09:38AM
Jan-20-22 08:57AM
Jan-19-22 09:00AM
Jan-13-22 08:57AM
Jan-05-22 04:49PM
Dec-17-21 05:33PM
Dec-16-21 04:25AM
Dec-15-21 01:15PM
08:57AM
Nov-29-21 08:57AM
Nov-18-21 08:57AM
Nov-17-21 08:57AM
Nov-15-21 10:09AM
(American City Business Journals) +10.41%
Nov-10-21 04:02PM
04:01PM
Nov-05-21 06:30AM
Nov-04-21 08:57AM
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Baird Melissa Chief Operating Officer May 03 '24 Option Exercise 0.40 11,750 4,700 550,682 May 03 06:38 PM Baird Melissa Chief Operating Officer May 03 '24 Sale 11.64 11,750 136,826 538,932 May 03 06:38 PM Baird Melissa Chief Operating Officer May 02 '24 Option Exercise 0.40 11,750 4,700 550,682 May 03 06:38 PM Baird Melissa Chief Operating Officer May 02 '24 Sale 12.08 11,750 141,923 538,932 May 03 06:38 PM Dudum Andrew Chief Executive Officer May 01 '24 Option Exercise 2.43 188,888 458,998 188,888 May 03 06:38 PM Baird Melissa Chief Operating Officer May 01 '24 Option Exercise 0.40 11,750 4,700 550,682 May 03 06:38 PM Dudum Andrew Chief Executive Officer May 01 '24 Sale 12.54 188,888 2,367,891 0 May 03 06:38 PM Dudum Andrew Chief Executive Officer May 01 '24 Sale 12.69 144,444 1,832,417 1,310,422 May 03 06:38 PM Baird Melissa Chief Operating Officer May 01 '24 Sale 12.61 11,750 148,122 538,932 May 03 06:38 PM Boughton Soleil Chief Legal Officer Apr 29 '24 Sale 12.56 2,503 31,438 161,860 May 01 04:32 PM Boughton Soleil Chief Legal Officer Apr 15 '24 Sale 13.95 2,503 34,917 164,363 Apr 16 04:22 PM Baird Melissa Chief Operating Officer Apr 08 '24 Option Exercise 0.40 11,751 4,700 550,683 Apr 08 06:38 PM Baird Melissa Chief Operating Officer Apr 08 '24 Sale 14.74 11,751 173,254 538,932 Apr 08 06:38 PM Baird Melissa Chief Operating Officer Apr 05 '24 Option Exercise 0.40 11,751 4,700 550,683 Apr 08 06:38 PM Baird Melissa Chief Operating Officer Apr 05 '24 Sale 14.58 11,751 171,372 538,932 Apr 08 06:38 PM Dudum Andrew Chief Executive Officer Apr 04 '24 Option Exercise 2.43 188,888 458,998 188,888 Apr 08 06:33 PM Baird Melissa Chief Operating Officer Apr 04 '24 Option Exercise 0.40 11,751 4,700 550,683 Apr 08 06:38 PM Dudum Andrew Chief Executive Officer Apr 04 '24 Sale 14.97 188,888 2,828,075 0 Apr 08 06:33 PM Dudum Andrew Chief Executive Officer Apr 04 '24 Sale 14.78 144,444 2,134,619 1,454,866 Apr 08 06:33 PM Baird Melissa Chief Operating Officer Apr 04 '24 Sale 14.89 11,751 174,933 538,932 Apr 08 06:38 PM Boughton Soleil Chief Legal Officer Apr 01 '24 Sale 15.65 2,503 39,172 166,866 Apr 02 05:09 PM Dudum Andrew Chief Executive Officer Mar 20 '24 Sale 16.34 50,361 823,055 0 Mar 21 07:08 PM Okupe Oluyemi Chief Financial Officer Mar 20 '24 Sale 15.82 9,912 156,816 168,627 Mar 21 07:07 PM Becklund Irene PAO Mar 19 '24 Sale 15.52 13,353 207,239 0 Mar 19 06:37 PM O'Keefe Lynne Chou Director Mar 19 '24 Sale 15.52 10,044 155,883 0 Mar 19 06:37 PM Becklund Irene PAO Mar 18 '24 Option Exercise 9.41 472 4,442 13,825 Mar 19 06:37 PM Becklund Irene PAO Mar 18 '24 Sale 14.70 472 6,938 13,353 Mar 19 06:37 PM Boughton Soleil Chief Legal Officer Mar 13 '24 Option Exercise 2.43 63,621 154,599 217,966 Mar 15 04:12 PM Boughton Soleil Chief Legal Officer Mar 13 '24 Sale 15.17 63,621 965,016 154,345 Mar 15 04:12 PM Baird Melissa Chief Operating Officer Mar 07 '24 Option Exercise 0.40 11,751 4,700 519,216 Mar 07 08:10 PM Baird Melissa Chief Operating Officer Mar 07 '24 Sale 14.35 11,751 168,684 507,465 Mar 07 08:10 PM Becklund Irene PAO Mar 07 '24 Sale 14.19 2,747 38,980 0 Mar 07 08:10 PM Baird Melissa Chief Operating Officer Mar 06 '24 Option Exercise 0.40 11,751 4,700 519,216 Mar 07 08:10 PM Baird Melissa Chief Operating Officer Mar 06 '24 Sale 13.99 11,751 164,360 507,465 Mar 07 08:10 PM Baird Melissa Chief Operating Officer Mar 05 '24 Option Exercise 0.40 11,751 4,700 519,216 Mar 07 08:10 PM Baird Melissa Chief Operating Officer Mar 05 '24 Sale 14.22 11,751 167,062 507,465 Mar 07 08:10 PM Okupe Oluyemi Chief Financial Officer Mar 04 '24 Option Exercise 5.01 40,527 203,040 197,248 Mar 05 04:41 PM Becklund Irene PAO Mar 04 '24 Option Exercise 9.41 17,930 168,721 20,677 Mar 05 04:39 PM Okupe Oluyemi Chief Financial Officer Mar 04 '24 Sale 13.55 50,574 685,288 146,674 Mar 05 04:41 PM Becklund Irene PAO Mar 04 '24 Sale 14.50 17,930 259,985 2,747 Mar 05 04:39 PM Dudum Andrew Chief Executive Officer Mar 01 '24 Option Exercise 2.43 188,896 459,017 240,549 Mar 04 04:43 PM Dudum Andrew Chief Executive Officer Mar 01 '24 Sale 13.07 240,549 3,144,120 0 Mar 04 04:43 PM Dudum Andrew Chief Executive Officer Mar 01 '24 Sale 13.07 144,448 1,888,022 1,599,310 Mar 04 04:43 PM Becklund Irene PAO Mar 01 '24 Sale 13.16 2,747 36,151 2,747 Mar 05 04:39 PM Dudum Andrew Chief Executive Officer Feb 29 '24 Option Exercise 2.43 577,007 1,402,127 628,660 Mar 01 04:06 PM Dudum Andrew Chief Executive Officer Feb 29 '24 Sale 12.96 577,007 7,480,261 51,653 Mar 01 04:06 PM WELLS DAVID B Director Feb 28 '24 Sale 13.16 260,000 3,421,210 146,195 Mar 01 04:05 PM Chi Michael Chief Marketing Officer Feb 28 '24 Sale 13.19 47,687 628,992 146,089 Mar 01 04:06 PM Carroll Patrick Harrison Chief Medical Officer Feb 28 '24 Sale 13.19 20,000 263,800 154,835 Mar 01 04:07 PM Becklund Irene PAO Feb 27 '24 Sale 12.08 2,747 33,184 5,494 Feb 28 04:33 PM Boughton Soleil Chief Legal Officer Feb 15 '24 Option Exercise 2.43 5,972 14,512 160,317 Feb 16 04:47 PM Boughton Soleil Chief Legal Officer Feb 15 '24 Sale 10.04 5,972 59,944 154,345 Feb 16 04:47 PM Dudum Andrew Chief Executive Officer Feb 14 '24 Option Exercise 2.43 77,382 188,038 129,035 Feb 14 08:50 PM Boughton Soleil Chief Legal Officer Feb 14 '24 Option Exercise 2.43 17,109 41,575 171,454 Feb 16 04:47 PM Dudum Andrew Chief Executive Officer Feb 14 '24 Sale 9.90 77,382 766,268 51,653 Feb 14 08:50 PM Boughton Soleil Chief Legal Officer Feb 14 '24 Sale 10.00 17,109 171,090 154,345 Feb 16 04:47 PM Dudum Andrew Chief Executive Officer Feb 13 '24 Option Exercise 2.43 97,208 236,215 148,861 Feb 14 08:50 PM Dudum Andrew Chief Executive Officer Feb 13 '24 Sale 9.58 97,208 931,010 51,653 Feb 14 08:50 PM Dudum Andrew Chief Executive Officer Feb 12 '24 Option Exercise 2.43 81,541 198,145 133,194 Feb 14 08:50 PM Okupe Oluyemi Chief Financial Officer Feb 12 '24 Option Exercise 5.01 26,385 132,189 188,084 Feb 13 07:26 PM Boughton Soleil Chief Legal Officer Feb 12 '24 Option Exercise 2.43 22,839 55,499 177,184 Feb 13 07:27 PM Dudum Andrew Chief Executive Officer Feb 12 '24 Sale 9.98 81,541 814,040 51,653 Feb 14 08:50 PM Okupe Oluyemi Chief Financial Officer Feb 12 '24 Sale 10.03 31,363 314,640 156,721 Feb 13 07:26 PM Boughton Soleil Chief Legal Officer Feb 12 '24 Sale 10.03 22,839 229,125 154,345 Feb 13 07:27 PM Boughton Soleil Chief Legal Officer Feb 09 '24 Option Exercise 2.43 4,080 9,914 158,425 Feb 13 07:27 PM Okupe Oluyemi Chief Financial Officer Feb 09 '24 Sale 10.03 8,509 85,344 161,699 Feb 13 07:26 PM Boughton Soleil Chief Legal Officer Feb 09 '24 Sale 10.03 4,080 40,921 154,345 Feb 13 07:27 PM Dudum Andrew Chief Executive Officer Jan 29 '24 Option Exercise 2.43 15,100 36,693 66,753 Jan 29 06:40 PM Dudum Andrew Chief Executive Officer Jan 29 '24 Sale 9.01 15,100 136,024 51,653 Jan 29 06:40 PM Dudum Andrew Chief Executive Officer Jan 26 '24 Option Exercise 2.43 52,940 128,644 104,593 Jan 29 06:40 PM Dudum Andrew Chief Executive Officer Jan 26 '24 Sale 9.11 52,940 482,114 51,653 Jan 29 06:40 PM Dudum Andrew Chief Executive Officer Jan 25 '24 Option Exercise 2.43 127,688 310,282 179,341 Jan 29 06:40 PM Dudum Andrew Chief Executive Officer Jan 25 '24 Sale 9.08 127,688 1,159,343 51,653 Jan 29 06:40 PM Boughton Soleil Chief Legal Officer Jan 02 '24 Sale 8.80 13,744 120,947 154,345 Jan 03 04:42 PM Baird Melissa Chief Operating Officer Dec 29 '23 Option Exercise 2.01 93,000 186,999 507,465 Jan 03 04:40 PM Dudum Andrew Chief Executive Officer Dec 29 '23 Option Exercise 2.43 21,432 52,080 73,085 Dec 29 06:09 PM Dudum Andrew Chief Executive Officer Dec 29 '23 Sale 9.06 21,432 194,223 51,653 Dec 29 06:09 PM Dudum Andrew Chief Executive Officer Dec 28 '23 Option Exercise 2.43 25,750 62,573 77,403 Dec 29 06:09 PM Dudum Andrew Chief Executive Officer Dec 28 '23 Sale 9.01 25,750 232,002 51,653 Dec 29 06:09 PM Dudum Andrew Chief Executive Officer Dec 27 '23 Option Exercise 2.43 7,700 18,711 59,353 Dec 29 06:09 PM Dudum Andrew Chief Executive Officer Dec 27 '23 Sale 9.02 7,700 69,462 51,653 Dec 29 06:09 PM Boughton Soleil Chief Legal Officer Dec 20 '23 Sale 8.71 15,450 134,570 168,089 Dec 21 04:09 PM Okupe Oluyemi Chief Financial Officer Dec 20 '23 Sale 8.58 6,784 58,204 170,208 Dec 21 04:10 PM Becklund Irene PAO Dec 19 '23 Sale 8.73 10,597 92,512 8,241 Dec 20 04:02 PM O'Keefe Lynne Chou Director Dec 19 '23 Sale 8.73 10,045 87,693 0 Dec 20 04:02 PM Baird Melissa Chief Operating Officer Dec 06 '23 Sale 9.02 9,133 82,402 382,574 Dec 06 06:41 PM Baird Melissa Chief Operating Officer Dec 05 '23 Sale 8.78 9,133 80,221 391,707 Dec 06 06:41 PM Baird Melissa Chief Operating Officer Dec 04 '23 Option Exercise 0.40 3,624 1,450 407,473 Dec 06 06:41 PM Baird Melissa Chief Operating Officer Dec 04 '23 Sale 8.81 9,133 80,485 400,840 Dec 06 06:41 PM Dudum Andrew Chief Executive Officer Dec 01 '23 Option Exercise 2.43 24,300 59,049 24,300 Dec 04 06:27 PM Dudum Andrew Chief Executive Officer Dec 01 '23 Sale 9.03 24,300 219,376 0 Dec 04 06:27 PM Dudum Andrew Chief Executive Officer Nov 30 '23 Option Exercise 2.43 3,800 9,234 3,800 Dec 04 06:27 PM Dudum Andrew Chief Executive Officer Nov 30 '23 Sale 9.01 3,800 34,221 0 Dec 04 06:27 PM Okupe Oluyemi Chief Financial Officer Nov 21 '23 Sale 7.62 6,698 51,010 144,284 Nov 22 04:23 PM Baird Melissa Chief Operating Officer Nov 08 '23 Option Exercise 0.40 9,133 3,653 412,982 Nov 08 07:21 PM Baird Melissa Chief Operating Officer Nov 08 '23 Sale 7.09 9,133 64,735 403,849 Nov 08 07:21 PM Baird Melissa Chief Operating Officer Nov 07 '23 Option Exercise 0.40 9,133 3,653 412,982 Nov 08 07:21 PM Baird Melissa Chief Operating Officer Nov 07 '23 Sale 7.07 9,133 64,539 403,849 Nov 08 07:21 PM Baird Melissa Chief Operating Officer Nov 06 '23 Option Exercise 0.40 9,133 3,653 412,982 Nov 08 07:21 PM Baird Melissa Chief Operating Officer Nov 06 '23 Sale 6.34 9,133 57,948 403,849 Nov 08 07:21 PM
Index - P/E - EPS (ttm) - Insider Own 88.43% Shs Outstand 150.15M Perf Week 0.32%
Market Cap 3.73B Forward P/E - EPS next Y - Insider Trans -2.36% Shs Float 17.37M Perf Month -
Income - PEG - EPS next Q - Inst Own - Short Float 0.93% Perf Quarter -
Sales - P/S - EPS this Y - Inst Trans - Short Ratio 0.15 Perf Half Y -
Book/sh - P/B - EPS next Y - ROA - Short Interest 0.16M Perf Year -
Cash/sh - P/C - EPS next 5Y - ROE - 52W Range 22.61 - 25.72 Perf YTD 7.87%
Dividend Est. - P/FCF - EPS past 5Y - ROI - 52W High -3.54% Beta -
Dividend TTM - Quick Ratio - Sales past 5Y 68.04% Gross Margin - 52W Low 9.73% ATR (14) 1.07
Dividend Ex-Date - Current Ratio - EPS Y/Y TTM - Oper. Margin - RSI (14) - Volatility 4.01% -
Employees 32433 Debt/Eq - Sales Y/Y TTM - Profit Margin - Recom - Target Price -
Option/Short Yes / Yes LT Debt/Eq - EPS Q/Q - Payout - Rel Volume 0.37 Prev Close 24.99
Sales Surprise - EPS Surprise - Sales Q/Q - Earnings - Avg Volume 1.09M Price 24.81
SMA20 3.03% SMA50 3.03% SMA200 3.03% Trades
Volume 399,072 Change -0.72%
Apr-15-24 07:54PM
Apr-10-24 11:36PM
11:25PM
PACS Group, Inc. is a post-acute healthcare company, primarily focuses on delivering skilled nursing care through a portfolio of independently operated facilities. It also provides senior care, assisted living, and independent living options in some communities. The company provides services under brand name is :Pacs post acute, Pacs serives, Pacs properties and Pacs ventures. PACS Group was founded by Jason Murray and Mark Hancock on January 1, 2013 and is headquartered in Farmington, UT.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Murray Jason Hulse Co-Founder, CEO & Chairman Apr 15 '24 Sale 21.00 1,607,142 33,749,982 62,754,551 Apr 15 04:02 PM Hancock Mark Co-Founder & Exec. Vice Chair. Apr 15 '24 Sale 21.00 1,607,142 33,749,982 62,754,551 Apr 15 04:02 PM
Index - P/E - EPS (ttm) -0.00 Insider Own 95.22% Shs Outstand 5.49M Perf Week -4.60%
Market Cap 74.65M Forward P/E - EPS next Y - Insider Trans 2.37% Shs Float 0.25M Perf Month 14.40%
Income 0.34M PEG - EPS next Q - Inst Own 31.17% Short Float 4.26% Perf Quarter 32.28%
Sales 0.00M P/S - EPS this Y - Inst Trans - Short Ratio 2.18 Perf Half Y 36.32%
Book/sh 1.75 P/B 8.19 EPS next Y - ROA 0.48% Short Interest 0.01M Perf Year 41.58%
Cash/sh 0.05 P/C 266.59 EPS next 5Y - ROE 0.52% 52W Range 10.15 - 15.00 Perf YTD 32.78%
Dividend Est. - P/FCF - EPS past 5Y - ROI 2.33% 52W High -4.67% Beta 0.01
Dividend TTM - Quick Ratio 0.15 Sales past 5Y 0.00% Gross Margin - 52W Low 40.89% ATR (14) 0.98
Dividend Ex-Date - Current Ratio 0.15 EPS Y/Y TTM -103.54% Oper. Margin 0.00% RSI (14) 60.32 Volatility 7.10% 5.34%
Employees 2 Debt/Eq 0.07 Sales Y/Y TTM - Profit Margin - Recom - Target Price -
Option/Short No / No LT Debt/Eq 0.00 EPS Q/Q -216.22% Payout 0.00% Rel Volume 2.68 Prev Close 13.72
Sales Surprise - EPS Surprise - Sales Q/Q - Earnings - Avg Volume 4.88K Price 14.30
SMA20 9.52% SMA50 17.52% SMA200 30.93% Trades
Volume 13,109 Change 4.23%
Pono Capital Two, Inc. operates as a blank check company, which was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on March 11, 2022 and is headquartered in Honolulu, HI.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
ZUU Co. Ltd. 10% Owner Apr 30 '24 Buy 13.00 47 611 1,457,722 May 02 09:03 PM ZUU Co. Ltd. 10% Owner Apr 23 '24 Buy 12.97 2,615 33,911 1,457,675 Apr 25 09:00 PM ZUU Co. Ltd. 10% Owner Apr 11 '24 Buy 12.80 4 51 1,455,060 Apr 11 09:00 PM ZUU Co. Ltd. 10% Owner Apr 09 '24 Buy 12.80 1 13 1,455,056 Apr 11 09:00 PM ZUU Co. Ltd. 10% Owner Apr 05 '24 Buy 12.80 2 26 1,455,055 Apr 08 09:48 PM ZUU Co. Ltd. 10% Owner Apr 04 '24 Buy 12.80 2 26 1,455,053 Apr 08 09:48 PM ZUU Co. Ltd. 10% Owner Apr 02 '24 Buy 12.80 4 51 1,455,051 Apr 03 08:00 PM ZUU Co. Ltd. 10% Owner Apr 01 '24 Buy 12.80 19,236 246,221 1,455,047 Apr 03 08:00 PM ZUU Co. Ltd. 10% Owner Mar 28 '24 Buy 12.50 1 12 1,435,811 Mar 28 09:05 PM ZUU Co. Ltd. 10% Owner Mar 27 '24 Buy 12.50 18 225 1,435,810 Mar 28 09:05 PM ZUU Co. Ltd. 10% Owner Mar 26 '24 Buy 12.50 46 575 1,435,792 Mar 26 09:36 PM ZUU Co. Ltd. 10% Owner Mar 25 '24 Buy 12.50 3 38 1,435,746 Mar 26 09:36 PM ZUU Co. Ltd. 10% Owner Mar 22 '24 Buy 12.50 917 11,462 1,435,743 Mar 26 09:36 PM ZUU Co. Ltd. 10% Owner Mar 21 '24 Buy 12.50 1,734 21,675 1,434,826 Mar 21 07:19 PM ZUU Co. Ltd. 10% Owner Mar 20 '24 Buy 12.50 1,552 19,400 1,433,092 Mar 21 07:19 PM ZUU Co. Ltd. 10% Owner Mar 19 '24 Buy 12.50 31,535 394,188 1,431,540 Mar 21 07:19 PM ZUU Co. Ltd. 10% Owner Mar 12 '24 Buy 12.00 11 132 1,400,005 Mar 13 08:59 PM ZUU Co. Ltd. 10% Owner Mar 11 '24 Buy 12.00 1,831 21,972 1,399,994 Mar 13 08:59 PM ZUU Co. Ltd. 10% Owner Mar 08 '24 Buy 12.00 22 264 1,398,163 Mar 08 09:14 PM ZUU Co. Ltd. 10% Owner Mar 07 '24 Buy 12.00 8 96 1,398,141 Mar 08 09:14 PM ZUU Co. Ltd. 10% Owner Mar 06 '24 Buy 12.00 23 276 1,398,133 Mar 08 09:14 PM ZUU Co. Ltd. 10% Owner Mar 05 '24 Buy 12.00 20 240 1,398,110 Mar 05 07:36 PM ZUU Co. Ltd. 10% Owner Mar 04 '24 Buy 12.40 38 471 1,398,090 Mar 05 07:36 PM ZUU Co. Ltd. 10% Owner Mar 01 '24 Buy 12.50 192 2,400 1,398,052 Mar 05 07:36 PM ZUU Co. Ltd. 10% Owner Feb 29 '24 Buy 12.00 5,556 66,672 1,392,860 Feb 29 07:24 PM ZUU Co. Ltd. 10% Owner Feb 28 '24 Buy 12.42 857 10,648 1,392,304 Feb 29 07:24 PM ZUU Co. Ltd. 10% Owner Feb 27 '24 Buy 12.50 2,014 25,175 1,391,447 Feb 29 07:24 PM ZUU Co. Ltd. 10% Owner Feb 09 '24 Buy 11.78 46,593 548,964 1,385,607 Feb 13 07:28 PM
Index - P/E - EPS (ttm) -3.54 Insider Own 27.60% Shs Outstand 6.77M Perf Week 9.20%
Market Cap 9.24M Forward P/E - EPS next Y -2.10 Insider Trans 18.21% Shs Float 4.90M Perf Month 1.87%
Income -14.42M PEG - EPS next Q -0.51 Inst Own 11.90% Short Float 0.82% Perf Quarter -51.25%
Sales 0.15M P/S 61.61 EPS this Y 37.72% Inst Trans 2.02% Short Ratio 0.04 Perf Half Y -24.17%
Book/sh 2.45 P/B 0.56 EPS next Y 1.17% ROA -99.26% Short Interest 0.04M Perf Year -66.04%
Cash/sh 1.64 P/C 0.83 EPS next 5Y - ROE -105.30% 52W Range 1.20 - 7.13 Perf YTD -21.55%
Dividend Est. - P/FCF - EPS past 5Y 77.95% ROI -124.83% 52W High -80.86% Beta 62.34
Dividend TTM - Quick Ratio 10.71 Sales past 5Y 23.65% Gross Margin -53.47% 52W Low 13.75% ATR (14) 0.14
Dividend Ex-Date - Current Ratio 10.71 EPS Y/Y TTM 30.87% Oper. Margin -10439.49% RSI (14) 51.05 Volatility 14.90% 10.22%
Employees 11 Debt/Eq 0.01 Sales Y/Y TTM 21.70% Profit Margin -9887.16% Recom 1.00 Target Price 10.50
Option/Short No / Yes LT Debt/Eq 0.00 EPS Q/Q 49.37% Payout - Rel Volume 0.07 Prev Close 1.46
Sales Surprise - EPS Surprise - Sales Q/Q 421.62% Earnings - Avg Volume 950.94K Price 1.37
SMA20 2.50% SMA50 1.54% SMA200 -25.30% Trades
Volume 69,048 Change -6.51%
Apr-30-24 04:15PM
07:30AM
Apr-16-24 07:45AM
Apr-14-24 03:00PM
Apr-08-24 07:45AM
04:38PM
Loading…
Apr-03-24 04:38PM
Apr-02-24 09:53AM
Apr-01-24 07:45AM
Mar-11-24 04:15PM
Feb-14-24 09:15AM
Feb-06-24 08:05AM
Feb-05-24 07:30AM
Feb-01-24 07:30AM
Dec-12-23 09:15AM
Dec-03-23 01:11PM
12:10PM
Loading…
Oct-09-23 12:10PM
Oct-02-23 09:14AM
Sep-18-23 09:00AM
Sep-12-23 10:30AM
09:00AM
Sep-08-23 08:30AM
Aug-30-23 09:00AM
Aug-08-23 06:05PM
Aug-02-23 09:00AM
Jul-31-23 08:05AM
Jul-26-23 01:01PM
Jul-21-23 07:10AM
Jul-11-23 08:30AM
Jul-07-23 07:00AM
Jun-27-23 08:30AM
07:00AM
Loading…
07:00AM
Jun-26-23 07:30AM
Jun-17-23 08:36AM
Jun-16-23 07:00AM
Jun-15-23 07:48AM
Jun-12-23 08:31AM
07:00AM
Jun-01-23 09:15AM
May-31-23 08:30AM
07:00AM
May-15-23 08:31AM
07:00AM
May-12-23 07:15AM
May-08-23 07:00AM
May-04-23 07:00AM
Apr-24-23 08:30AM
07:00AM
Mar-31-23 08:30AM
Mar-28-23 07:01AM
Mar-22-23 09:15AM
Mar-13-23 08:30AM
07:00AM
Mar-09-23 06:30AM
Mar-07-23 06:30AM
Mar-02-23 09:00AM
07:30AM
Feb-10-23 08:45AM
Feb-08-23 09:00AM
08:30AM
Feb-03-23 09:25AM
Jan-26-23 08:30AM
Jan-17-23 09:29AM
Dec-06-22 07:00AM
06:31AM
Dec-05-22 07:00AM
06:30AM
Nov-29-22 11:20AM
Nov-16-22 08:56AM
05:16AM
Nov-10-22 08:00AM
Oct-31-22 08:15AM
Oct-20-22 09:30AM
Oct-14-22 08:00AM
Sep-28-22 07:00AM
Sep-27-22 07:00AM
Sep-07-22 07:00AM
Sep-01-22 09:00AM
Aug-25-22 03:49PM
Aug-24-22 06:30AM
Jun-30-22 07:30AM
Jun-22-22 07:30AM
07:00AM
Jun-13-22 07:00AM
Apr-29-22 08:00AM
Apr-18-22 08:00AM
Apr-04-22 08:00AM
Mar-10-22 08:00AM
Feb-16-22 08:30AM
Feb-07-22 09:00AM
07:45AM
Feb-02-22 08:00AM
Jan-26-22 06:00AM
Jan-11-22 06:00AM
Jan-06-22 06:00AM
Jan-04-22 06:00AM
Dec-22-21 07:28AM
05:53AM
Dec-21-21 04:01PM
06:00AM
Dec-20-21 06:00AM
BioRestorative Therapies, Inc. engages in the development of therapeutic products and medical therapies using cell and tissue protocols. Its programs provide quality of care for chronic back pain caused by disc degeneration and metabolic disorders, including obesity and diabetes. The company's initial investigational therapeutic product being called BRTX-100 focuses on treating damage by an autologous stem cell product that uses own stem cells that are harvested, cultured, and then injected directly into the affected disc to start the repair process. BioRestorative Therapies was founded on June 13, 1997 and is headquartered in Melville, NY.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Silva Francisco VP of Research and Development Apr 09 '24 Buy 1.25 6,600 8,250 155,759 Apr 10 05:16 PM Silva Francisco VP of Research and Development Apr 08 '24 Buy 1.16 1,708 1,979 149,159 Apr 10 05:16 PM Broadrick Dale 10% Owner Feb 09 '24 Buy 1.32 86,041 113,574 477,972 Feb 12 09:26 AM Broadrick Dale 10% Owner Feb 08 '24 Buy 1.34 83,626 112,059 447,045 Feb 09 08:00 AM Broadrick Dale 10% Owner Feb 08 '24 Buy 1.25 73,959 92,449 391,931 Feb 12 09:26 AM Broadrick Dale 10% Owner Feb 07 '24 Buy 1.38 36,374 50,196 363,419 Feb 09 08:00 AM Broadrick Dale 10% Owner Dec 01 '23 Sale 1.88 250 469 327,045 Dec 05 04:32 PM Broadrick Dale 10% Owner Nov 27 '23 Sale 1.89 278 525 327,295 Dec 01 05:04 PM Broadrick Dale 10% Owner Sep 15 '23 Buy 1.66 10,000 16,600 327,573 Sep 18 09:20 AM ALSTODT LANCE President, CEO, COB Sep 15 '23 Buy 1.70 2,200 3,740 189,505 Sep 18 09:17 AM Broadrick Dale 10% Owner Sep 14 '23 Buy 1.54 10,000 15,400 317,573 Sep 18 09:20 AM ALSTODT LANCE President, CEO, COB Sep 13 '23 Buy 1.53 800 1,226 188,105 Sep 13 05:00 PM Broadrick Dale 10% Owner Sep 07 '23 Buy 1.91 1,000 1,910 317,972 Sep 14 04:08 PM Broadrick Dale 10% Owner Sep 07 '23 Buy 1.81 1,000 1,810 307,573 Sep 14 04:08 PM ALSTODT LANCE President, CEO, COB Sep 06 '23 Buy 1.96 2,887 5,659 187,305 Sep 06 05:53 PM Silva Francisco VP of Research and Development Aug 31 '23 Buy 2.22 4,954 10,998 164,644 Aug 31 01:54 PM Broadrick Dale 10% Owner Jul 28 '23 Buy 2.89 500 1,445 306,573 Sep 14 04:08 PM Broadrick Dale 10% Owner Jul 27 '23 Buy 2.80 1,000 2,800 306,073 Jul 28 11:17 AM ALSTODT LANCE President, CEO, COB Jul 25 '23 Buy 2.44 4,200 10,248 184,418 Jul 25 05:56 PM
Index RUT P/E 14.92 EPS (ttm) 2.11 Insider Own 21.84% Shs Outstand 128.37M Perf Week 14.67%
Market Cap 4.09B Forward P/E 14.48 EPS next Y 2.17 Insider Trans -1.22% Shs Float 101.63M Perf Month 6.54%
Income 259.97M PEG 0.47 EPS next Q 0.64 Inst Own 77.23% Short Float 2.24% Perf Quarter 19.05%
Sales 6.79B P/S 0.60 EPS this Y 2.35% Inst Trans -3.27% Short Ratio 4.47 Perf Half Y 39.32%
Book/sh 10.65 P/B 2.95 EPS next Y 6.58% ROA 3.34% Short Interest 2.28M Perf Year 7.12%
Cash/sh 0.71 P/C 44.12 EPS next 5Y 31.82% ROE 20.49% 52W Range 21.28 - 33.51 Perf YTD 33.74%
Dividend Est. 0.33 (1.06%) P/FCF 16.95 EPS past 5Y 13.25% ROI 4.23% 52W High -6.21% Beta 1.41
Dividend TTM 0.50 (1.59%) Quick Ratio 1.22 Sales past 5Y 5.64% Gross Margin 11.34% 52W Low 47.70% ATR (14) 0.87
Dividend Ex-Date Feb 29, 2024 Current Ratio 1.22 EPS Y/Y TTM 49.84% Oper. Margin 8.74% RSI (14) 70.51 Volatility 4.31% 2.89%
Employees 54600 Debt/Eq 3.74 Sales Y/Y TTM 6.08% Profit Margin 3.83% Recom 1.40 Target Price 36.00
Option/Short Yes / Yes LT Debt/Eq 3.49 EPS Q/Q 35.58% Payout 26.22% Rel Volume 3.92 Prev Close 28.45
Sales Surprise 2.90% EPS Surprise 35.66% Sales Q/Q 7.44% Earnings May 02 AMC Avg Volume 508.91K Price 31.43
SMA20 12.26% SMA50 11.15% SMA200 18.97% Trades
Volume 1,993,496 Change 10.47%
Date
Action
Analyst
Rating Change
Price Target Change
May-13-21 Reiterated The Benchmark Company
Buy
$40 → $44
Feb-26-21 Upgrade BofA Securities
Underperform → Buy
$30 → $36
Jun-16-20 Downgrade BofA/Merrill
Neutral → Underperform
$18 → $15
Sep-17-19 Initiated Deutsche Bank
Buy
$22
May-17-19 Upgrade JMP Securities
Mkt Perform → Mkt Outperform
$18
Dec-14-18 Initiated Barclays
Equal Weight
Oct-16-18 Initiated Credit Suisse
Neutral
$18
Feb-27-18 Upgrade JMP Securities
Mkt Underperform → Mkt Perform
Jan-30-18 Resumed Wells Fargo
Outperform
Jan-04-18 Upgrade BofA/Merrill
Underperform → Neutral
Aug-07-17 Upgrade Robert W. Baird
Neutral → Outperform
$15 → $21
Aug-07-17 Reiterated The Benchmark Company
Buy
$17 → $20
Mar-31-17 Initiated The Benchmark Company
Buy
$13
Jan-30-17 Downgrade Wells Fargo
Outperform → Market Perform
Sep-28-16 Downgrade JMP Securities
Mkt Perform → Mkt Underperform
May-09-16 Reiterated UBS
Reduce
$8 → $11
Nov-02-15 Reiterated RBC Capital Mkts
Outperform
$21 → $17
Oct-20-15 Upgrade JMP Securities
Mkt Underperform → Mkt Perform
Oct-06-15 Upgrade Wells Fargo
Market Perform → Outperform
Aug-10-15 Reiterated RBC Capital Mkts
Outperform
$19 → $21
Show Previous Ratings
May-04-24 09:50AM
03:06AM
May-03-24 10:32PM
(Thomson Reuters StreetEvents) +10.47%
May-02-24 10:53PM
06:12PM
04:53PM
Loading…
04:53PM
(Associated Press Finance)
04:30PM
Apr-05-24 08:00AM
Apr-03-24 10:38AM
Mar-19-24 12:09PM
Mar-18-24 09:44AM
08:00AM
Feb-27-24 06:16PM
08:24AM
Feb-23-24 11:03PM
(Thomson Reuters StreetEvents) +9.83%
12:22PM
Loading…
12:22PM
Feb-22-24 05:55PM
05:12PM
04:58PM
(Associated Press Finance)
04:30PM
Feb-20-24 11:42AM
Feb-15-24 10:00AM
Jan-22-24 04:30PM
Jan-06-24 10:20AM
Jan-05-24 09:49AM
Jan-04-24 11:55AM
09:50AM
Jan-03-24 04:15PM
Jan-01-24 09:40AM
Dec-07-23 09:40AM
10:57PM
Loading…
Dec-06-23 10:57PM
Dec-01-23 08:59AM
Nov-07-23 12:26PM
Nov-05-23 01:45PM
Nov-03-23 10:18PM
(Thomson Reuters StreetEvents)
09:08AM
08:08AM
Nov-02-23 06:53PM
06:44PM
(Associated Press Finance)
04:30PM
11:05AM
Oct-26-23 10:02AM
Oct-25-23 09:40AM
Oct-19-23 12:00PM
04:29AM
Oct-18-23 09:40AM
Oct-17-23 08:35AM
06:03AM
Oct-16-23 08:45AM
Oct-13-23 06:27AM
Oct-10-23 06:23AM
Oct-04-23 08:00AM
Oct-02-23 09:40AM
Sep-29-23 08:24AM
07:39AM
Sep-28-23 07:26AM
Sep-19-23 04:51AM
Sep-18-23 12:20PM
Sep-14-23 08:38AM
04:46AM
Sep-13-23 10:06AM
Sep-12-23 01:01AM
Sep-07-23 04:30PM
Aug-31-23 01:44PM
Aug-29-23 08:50AM
Aug-25-23 09:40AM
Aug-24-23 10:05AM
Aug-09-23 06:09AM
Aug-07-23 06:03AM
Aug-05-23 12:13AM
(Thomson Reuters StreetEvents)
Aug-04-23 12:08PM
Aug-03-23 06:44PM
04:30PM
Jul-30-23 08:40AM
Jul-21-23 11:52AM
Jul-19-23 04:15PM
Jul-14-23 11:59AM
Jul-07-23 08:00AM
Jul-05-23 09:24AM
Jun-21-23 08:00PM
Jun-16-23 10:14AM
Jun-06-23 09:54AM
May-12-23 06:12AM
May-08-23 06:02AM
May-06-23 12:41AM
(Thomson Reuters StreetEvents)
May-05-23 10:49AM
May-04-23 07:35PM
06:32PM
04:30PM
Apr-29-23 09:16AM
Apr-27-23 10:03AM
Apr-26-23 08:00PM
Apr-11-23 06:22AM
Apr-07-23 08:00AM
Apr-06-23 12:00PM
Apr-05-23 10:00AM
Mar-21-23 11:55AM
11:52AM
Mar-20-23 09:05AM
Mar-14-23 08:36AM
Select Medical Holdings Corp. engages in the provision of medical rehabilitation services. It operates through the following business segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation and Concentra. The Critical Illness Recovery Hospital segment serves patients with debilitating injuries and rehabilitation needs that cannot be adequately cared for in a medically intensive environment, such as a skilled nursing facility. The Rehabilitation Hospital segment provides physical medicine, as well as rehabilitation programs and services, which serve to optimize patient health, function, and quality of life. The Outpatient Rehabilitation segment offers physical, occupational, and speech rehabilitation services through its clinics. The Concentra segment operates through its medical centers and contract services provided at employer worksites and Department of Veterans Affairs community-based outpatient clinics, which deliver occupational medicine, physical therapy, veteran's healthcare, and consumer health services. The company was founded by Robert A. Ortenzio and Rocco A. Ortenzio in 1996 and is headquartered in Mechanicsburg, PA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
ORTENZIO ROBERT A EXECUTIVE CHAIRMAN Apr 08 '24 Sale 29.90 50,000 1,495,000 6,689,668 Apr 10 04:44 PM ORTENZIO ROBERT A EXECUTIVE CHAIRMAN Mar 08 '24 Sale 28.30 50,000 1,415,000 6,739,668 Mar 11 04:43 PM ORTENZIO ROBERT A EXECUTIVE CHAIRMAN Feb 08 '24 Sale 26.00 50,000 1,300,000 6,789,668 Feb 09 04:34 PM ORTENZIO ROBERT A EXECUTIVE CHAIRMAN Jan 08 '24 Sale 26.63 100,000 2,663,000 6,839,668 Jan 09 04:42 PM ORTENZIO ROBERT A EXECUTIVE CHAIRMAN Dec 14 '23 Sale 25.00 100,000 2,500,000 6,939,668 Dec 14 04:57 PM ORTENZIO ROBERT A EXECUTIVE CHAIRMAN Sep 08 '23 Sale 26.82 50,000 1,341,000 7,039,668 Sep 11 04:01 PM ORTENZIO ROBERT A EXECUTIVE CHAIRMAN Aug 08 '23 Sale 29.52 50,000 1,476,000 7,089,668 Aug 09 05:40 PM ORTENZIO ROBERT A EXECUTIVE CHAIRMAN Jul 10 '23 Sale 30.36 50,000 1,518,000 6,889,668 Jul 11 06:43 PM ORTENZIO ROBERT A EXECUTIVE CHAIRMAN Jun 29 '23 Sale 32.00 100,000 3,200,000 1,279,000 Jun 30 05:27 PM ORTENZIO ROBERT A EXECUTIVE CHAIRMAN Jun 21 '23 Sale 30.00 33,967 1,019,010 1,379,000 Jun 22 06:00 PM ORTENZIO ROBERT A EXECUTIVE CHAIRMAN Jun 08 '23 Sale 28.63 50,000 1,431,500 6,939,668 Jun 09 05:13 PM ORTENZIO ROBERT A EXECUTIVE CHAIRMAN May 08 '23 Sale 29.80 116,033 3,457,783 1,412,967 May 09 06:28 PM ORTENZIO ROBERT A EXECUTIVE CHAIRMAN May 08 '23 Sale 29.68 50,000 1,484,000 6,989,668 May 09 06:28 PM Breighner Robert G. JR VICE PRESIDENT, COMPLIANCE May 08 '23 Sale 29.45 10,044 295,796 32,989 May 09 06:27 PM
Index RUT P/E 101.19 EPS (ttm) 0.19 Insider Own 14.10% Shs Outstand 118.22M Perf Week 2.63%
Market Cap 2.22B Forward P/E 56.49 EPS next Y 0.33 Insider Trans -0.58% Shs Float 101.85M Perf Month 1.96%
Income 23.08M PEG - EPS next Q 0.05 Inst Own 95.74% Short Float 6.01% Perf Quarter -9.42%
Sales 1.66B P/S 1.34 EPS this Y 27.41% Inst Trans 4.64% Short Ratio 6.88 Perf Half Y -8.23%
Book/sh 4.75 P/B 3.95 EPS next Y 37.03% ROA 2.55% Short Interest 6.12M Perf Year -30.85%
Cash/sh 3.29 P/C 5.70 EPS next 5Y - ROE 4.35% 52W Range 17.54 - 30.15 Perf YTD -18.63%
Dividend Est. - P/FCF 27.54 EPS past 5Y - ROI 4.07% 52W High -37.84% Beta 0.82
Dividend TTM - Quick Ratio 1.81 Sales past 5Y 20.87% Gross Margin 9.35% 52W Low 6.84% ATR (14) 0.70
Dividend Ex-Date - Current Ratio 1.81 EPS Y/Y TTM 324.32% Oper. Margin 1.25% RSI (14) 50.55 Volatility 3.27% 3.47%
Employees 1102 Debt/Eq 0.01 Sales Y/Y TTM 22.19% Profit Margin 1.39% Recom 1.20 Target Price 27.58
Option/Short Yes / Yes LT Debt/Eq 0.01 EPS Q/Q -84.15% Payout 0.00% Rel Volume 1.05 Prev Close 18.41
Sales Surprise 3.21% EPS Surprise -51.92% Sales Q/Q 20.97% Earnings May 09 BMO Avg Volume 889.56K Price 18.74
SMA20 2.23% SMA50 -4.60% SMA200 -15.94% Trades
Volume 936,657 Change 1.79%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-22-24 Initiated Citigroup
Buy
$25
Mar-06-24 Initiated Barclays
Equal Weight
$22
Feb-26-24 Resumed Jefferies
Buy
$33 → $25
Feb-22-24 Downgrade BofA Securities
Buy → Neutral
$21
Dec-06-23 Initiated JMP Securities
Mkt Outperform
$27
Jun-13-23 Initiated Evercore ISI
Outperform
$34
Apr-12-23 Initiated Stephens
Overweight
$33
Mar-10-23 Initiated RBC Capital Mkts
Outperform
$36
Feb-03-23 Initiated Goldman
Buy
$32
Dec-09-22 Initiated Stifel
Buy
$28
Dec-08-22 Initiated UBS
Buy
$30
Sep-07-22 Resumed Truist
Buy
$48 → $54
May-03-22 Initiated BofA Securities
Buy
$27
Apr-28-22 Initiated BTIG Research
Buy
$35
Apr-01-22 Resumed Credit Suisse
Outperform
$43
Mar-30-22 Initiated Guggenheim
Buy
$35
Feb-22-22 Upgrade Cowen
Market Perform → Outperform
$35
Jan-03-22 Initiated Jefferies
Buy
$33
Sep-27-21 Initiated SVB Leerink
Outperform
$35
Sep-10-21 Initiated Cowen
Market Perform
$31
Show Previous Ratings
Apr-09-24 09:00AM
Feb-28-24 09:30AM
Feb-27-24 10:18PM
(Thomson Reuters StreetEvents) +9.75%
09:30AM
07:25AM
06:36AM
Loading…
06:36AM
(Associated Press Finance)
06:33AM
06:00AM
Feb-23-24 05:15AM
Jan-29-24 08:30AM
Jan-23-24 08:30AM
Jan-03-24 11:46AM
Dec-12-23 09:00AM
Nov-06-23 09:54AM
Nov-04-23 01:52AM
(Thomson Reuters StreetEvents)
11:40AM
Loading…
Nov-03-23 11:40AM
09:30AM
08:45AM
08:15AM
06:43AM
(Associated Press Finance)
06:30AM
Oct-11-23 08:30AM
Sep-20-23 11:40AM
Sep-14-23 09:00AM
Sep-06-23 09:00AM
Sep-04-23 11:40AM
Aug-25-23 08:33AM
Aug-17-23 11:40AM
Aug-10-23 02:04PM
Aug-04-23 08:42AM
07:55AM
Loading…
Aug-03-23 07:55AM
06:43AM
06:30AM
Aug-01-23 09:00AM
Jul-31-23 09:00AM
Jul-26-23 11:40AM
Jul-11-23 09:00AM
07:09AM
Jun-29-23 09:00AM
Jun-27-23 09:36AM
Jun-21-23 08:00PM
Jun-07-23 06:37PM
May-31-23 09:00AM
May-14-23 10:00AM
May-04-23 09:14AM
08:30AM
07:45AM
06:40AM
06:32AM
06:30AM
May-02-23 09:42AM
(Thomson Reuters StreetEvents)
Apr-27-23 10:03AM
Apr-12-23 06:54PM
(American City Business Journals)
08:00AM
Apr-11-23 09:00AM
Mar-28-23 02:51AM
Mar-07-23 09:00AM
Mar-06-23 01:06AM
Mar-02-23 06:48AM
Mar-01-23 01:13AM
(Thomson Reuters StreetEvents)
Feb-28-23 06:30AM
Feb-17-23 09:00AM
Jan-26-23 09:00AM
Jan-18-23 06:07AM
Jan-17-23 04:45PM
04:35PM
Jan-03-23 09:00AM
Nov-28-22 09:00AM
Nov-25-22 08:17AM
Nov-16-22 08:22PM
Nov-15-22 04:40PM
08:00AM
Nov-12-22 07:47AM
Nov-10-22 06:30AM
Nov-03-22 04:30PM
Oct-06-22 09:00AM
Oct-03-22 04:11PM
(Investor's Business Daily)
Sep-16-22 11:55AM
(Investor's Business Daily) -5.09%
Sep-12-22 04:07PM
(Investor's Business Daily)
Sep-09-22 09:05AM
Sep-08-22 08:45AM
Sep-07-22 08:30AM
Sep-04-22 10:00AM
(The Wall Street Journal)
Aug-30-22 08:43PM
05:13PM
Aug-22-22 04:08PM
(Investor's Business Daily) +15.05%
Aug-11-22 07:30PM
04:18PM
(Investor's Business Daily)
08:25AM
07:00AM
Aug-04-22 10:00AM
Jul-13-22 08:30AM
Jul-06-22 08:10AM
08:08AM
(Investor's Business Daily)
Jul-05-22 04:55PM
(Investor's Business Daily) +7.40%
Jun-28-22 10:13AM
Jun-27-22 09:00AM
Jun-20-22 07:42AM
Jun-13-22 06:31PM
(Investor's Business Daily)
Jun-01-22 09:00AM
Privia Health Group, Inc. engages in the provision of healthcare services. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experience, and reward doctors for delivering care both in-person and via its Privia Platform, virtual care settings. The company was founded by Jeffrey Butler on November 7, 2007 and is headquartered in Arlington, VA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Mehrotra Parth Chief Executive Officer Apr 30 '24 Sale 18.42 12,219 225,074 261,640 May 02 05:23 PM Morris Matthew Shawn Director Apr 30 '24 Sale 18.42 11,059 203,707 70,101 May 02 05:19 PM Mountcastle David EVP & Chief Financial Officer Apr 30 '24 Sale 18.42 2,320 42,734 259,959 May 02 05:25 PM Bartrum Thomas Former EVP, General Counsel Apr 30 '24 Sale 18.42 2,252 41,482 103,862 May 02 05:24 PM Mountcastle David EVP & Chief Financial Officer Apr 02 '24 Sale 17.77 3,933 69,889 262,279 Apr 04 04:21 PM Sullivan William M Director Mar 11 '24 Sale 23.02 400 9,208 5,445,018 Mar 12 04:56 PM Sullivan William M Director Mar 08 '24 Sale 23.03 7,115 163,858 5,445,418 Mar 12 04:56 PM Sullivan William M Director Jan 25 '24 Sale 23.13 12,000 277,560 5,452,533 Jan 26 04:20 PM Sullivan William M Director Jan 24 '24 Sale 23.03 9,951 229,172 5,464,533 Jan 26 04:20 PM Sullivan William M Director Dec 28 '23 Sale 23.97 12,000 287,640 5,474,484 Dec 29 05:08 PM Sullivan William M Director Dec 14 '23 Sale 24.00 12,000 288,000 5,486,484 Dec 15 04:07 PM Sullivan William M Director Dec 13 '23 Sale 23.08 12,000 276,960 5,498,484 Dec 15 04:07 PM Sullivan William M Director Sep 15 '23 Sale 25.03 18,153 454,432 5,510,484 Sep 19 04:40 PM Bartrum Thomas EVP, General Counsel Sep 05 '23 Option Exercise 2.00 15,000 30,000 121,114 Sep 07 05:08 PM Bartrum Thomas EVP, General Counsel Sep 05 '23 Sale 25.77 15,000 386,550 106,114 Sep 07 05:08 PM Sullivan William M Director Sep 01 '23 Sale 26.46 18,153 480,328 5,528,637 Sep 06 04:27 PM Sullivan William M Director Aug 18 '23 Sale 25.06 18,153 454,914 5,546,790 Aug 22 04:50 PM Sullivan William M Director Aug 04 '23 Sale 27.10 18,153 491,935 5,564,943 Aug 08 04:55 PM Bartrum Thomas EVP, General Counsel Aug 03 '23 Option Exercise 2.00 15,000 30,000 121,114 Aug 07 04:42 PM Bartrum Thomas EVP, General Counsel Aug 03 '23 Sale 26.51 15,000 397,689 106,114 Aug 07 04:42 PM Mehrotra Parth Chief Executive Officer Jul 31 '23 Option Exercise 2.00 31,744 63,488 185,718 Aug 02 04:56 PM Mehrotra Parth Chief Executive Officer Jul 31 '23 Sale 28.03 31,744 889,784 153,974 Aug 02 04:56 PM Sullivan William M Director Jul 21 '23 Sale 26.82 18,153 486,863 5,583,096 Jul 25 04:30 PM Mehrotra Parth Chief Executive Officer Jul 19 '23 Option Exercise 2.00 12,414 24,828 166,388 Jul 21 05:42 PM Mehrotra Parth Chief Executive Officer Jul 19 '23 Sale 28.06 12,414 348,337 153,974 Jul 21 05:42 PM Sullivan William M Director Jul 07 '23 Sale 25.01 18,153 454,063 5,601,249 Jul 11 05:24 PM Bartrum Thomas EVP, General Counsel Jul 03 '23 Option Exercise 2.00 15,000 30,000 121,114 Jul 06 04:34 PM Bartrum Thomas EVP, General Counsel Jul 03 '23 Sale 25.68 15,000 385,200 106,114 Jul 06 04:34 PM Sullivan William M Director Jun 27 '23 Sale 25.08 5,638 141,401 5,619,402 Jun 29 05:06 PM Sullivan William M Director Jun 26 '23 Sale 25.01 400 10,004 5,625,040 Jun 27 05:26 PM Sullivan William M Director Jun 23 '23 Sale 24.55 12,115 297,423 5,625,440 Jun 27 05:26 PM Morris Matthew Shawn Chief Executive Officer Jun 13 '23 Option Exercise 2.00 173,633 347,266 279,278 Jun 14 04:39 PM Morris Matthew Shawn Chief Executive Officer Jun 13 '23 Sale 28.59 173,633 4,963,857 105,645 Jun 14 04:39 PM Morris Matthew Shawn Chief Executive Officer Jun 12 '23 Option Exercise 2.00 162,168 324,336 267,813 Jun 14 04:39 PM Morris Matthew Shawn Chief Executive Officer Jun 12 '23 Sale 28.46 162,168 4,615,301 105,645 Jun 14 04:39 PM Mehrotra Parth President and COO Jun 09 '23 Option Exercise 2.00 91,605 183,210 230,062 Jun 12 04:42 PM Mehrotra Parth President and COO Jun 09 '23 Sale 28.36 91,605 2,597,918 138,457 Jun 12 04:42 PM Sullivan William M Director Jun 09 '23 Sale 28.35 18,153 514,638 5,637,555 Jun 13 05:13 PM Mehrotra Parth President and COO Jun 08 '23 Option Exercise 2.00 8,395 16,790 146,852 Jun 12 04:42 PM Mehrotra Parth President and COO Jun 08 '23 Sale 28.00 8,395 235,060 138,457 Jun 12 04:42 PM Bartrum Thomas EVP, General Counsel Jun 07 '23 Option Exercise 2.00 15,000 30,000 121,114 Jun 09 05:08 PM Bartrum Thomas EVP, General Counsel Jun 07 '23 Sale 25.38 15,000 380,700 106,114 Jun 09 05:08 PM Sullivan William M Director Jun 07 '23 Sale 25.04 985 24,664 5,655,708 Jun 09 05:06 PM Sullivan William M Director May 31 '23 Sale 25.01 5,053 126,376 5,656,693 Jun 02 04:36 PM Sullivan William M Director May 26 '23 Sale 24.44 12,115 296,091 5,661,746 May 31 04:36 PM Sullivan William M Director May 12 '23 Sale 26.54 18,153 481,781 5,673,861 May 16 05:23 PM Mehrotra Parth President and COO May 11 '23 Option Exercise 2.00 225 450 138,682 May 15 04:21 PM Mehrotra Parth President and COO May 11 '23 Sale 28.00 225 6,300 138,457 May 15 04:21 PM Bartrum Thomas EVP, General Counsel May 09 '23 Option Exercise 2.00 68 136 87,800 May 10 05:41 PM Sullivan William M Director May 09 '23 Sale 30.07 1,300 39,091 5,692,014 May 10 05:45 PM Bartrum Thomas EVP, General Counsel May 09 '23 Sale 30.00 68 2,040 87,732 May 10 05:41 PM Bartrum Thomas EVP, General Counsel May 08 '23 Option Exercise 2.00 5,376 10,752 93,108 May 10 05:41 PM BERNSTEIN JEFFREY DANIEL Director May 08 '23 Sale 21.61 24,819,473 536,472,909 110,337 May 10 04:37 PM GOLDMAN SACHS GROUP INC 10% Owner May 08 '23 Sale 21.61 24,819,473 536,472,909 110,337 May 10 04:40 PM MBD Advisors, L.L.C. 10% Owner May 08 '23 Sale 21.61 24,819,473 536,472,909 110,337 May 10 04:41 PM Pamplona Capital Partners III, 10% Owner May 08 '23 Sale 21.61 17,741,723 383,487,343 0 May 11 04:05 PM Sullivan William M Director May 08 '23 Sale 30.01 6,545 196,415 5,693,314 May 10 05:45 PM Bartrum Thomas EVP, General Counsel May 08 '23 Sale 30.00 5,376 161,280 87,732 May 10 05:41 PM
Index - P/E - EPS (ttm) -1.14 Insider Own 1.04% Shs Outstand 183.85M Perf Week 5.47%
Market Cap 11.41B Forward P/E 472.73 EPS next Y 0.13 Insider Trans -5.37% Shs Float 181.94M Perf Month -11.53%
Income -204.15M PEG - EPS next Q -0.48 Inst Own 84.61% Short Float 5.44% Perf Quarter -3.09%
Sales 2.50B P/S 4.57 EPS this Y 20.56% Inst Trans -1.72% Short Ratio 3.99 Perf Half Y -2.28%
Book/sh 17.34 P/B 3.58 EPS next Y 114.63% ROA -3.00% Short Interest 9.89M Perf Year -2.54%
Cash/sh 4.23 P/C 14.67 EPS next 5Y - ROE -6.60% 52W Range 56.05 - 100.77 Perf YTD -16.10%
Dividend Est. - P/FCF 357.39 EPS past 5Y 4.59% ROI -3.63% 52W High -38.40% Beta 1.32
Dividend TTM - Quick Ratio 2.07 Sales past 5Y 43.88% Gross Margin 70.14% 52W Low 10.74% ATR (14) 2.92
Dividend Ex-Date - Current Ratio 2.32 EPS Y/Y TTM 67.92% Oper. Margin -12.20% RSI (14) 46.55 Volatility 3.96% 4.31%
Employees 6600 Debt/Eq 0.82 Sales Y/Y TTM 19.93% Profit Margin -8.17% Recom 1.33 Target Price 90.66
Option/Short Yes / Yes LT Debt/Eq 0.79 EPS Q/Q 61.80% Payout - Rel Volume 0.65 Prev Close 60.54
Sales Surprise 1.26% EPS Surprise 36.16% Sales Q/Q 16.98% Earnings May 08 AMC Avg Volume 2.48M Price 62.07
SMA20 -4.22% SMA50 -1.62% SMA200 -10.49% Trades
Volume 1,612,443 Change 2.53%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-02-24 Upgrade The Benchmark Company
Hold → Buy
$91
Dec-14-23 Initiated Guggenheim
Buy
$90
Dec-13-23 Initiated Wolfe Research
Outperform
$95
Oct-10-23 Upgrade Piper Sandler
Neutral → Overweight
$90
Sep-28-23 Initiated Bernstein
Outperform
$83
Aug-02-23 Downgrade The Benchmark Company
Buy → Hold
May-10-23 Upgrade Craig Hallum
Hold → Buy
$55 → $85
May-05-23 Initiated UBS
Neutral
$73
Mar-09-23 Upgrade Citigroup
Neutral → Buy
$70 → $90
Feb-10-23 Downgrade Credit Suisse
Outperform → Neutral
$50 → $70
Jan-18-23 Downgrade Raymond James
Outperform → Mkt Perform
Oct-19-22 Downgrade Craig Hallum
Buy → Hold
$60 → $35
Aug-25-22 Initiated Credit Suisse
Outperform
$55
Jun-03-22 Initiated Piper Sandler
Neutral
$50
Nov-03-21 Downgrade Raymond James
Strong Buy → Outperform
$160 → $130
Jul-29-21 Reiterated Stifel
Buy
$165 → $145
Jul-29-21 Reiterated Oppenheimer
Outperform
$161 → $155
Jul-29-21 Reiterated Canaccord Genuity
Buy
$185 → $160
Jul-29-21 Reiterated BTIG Research
Buy
$155 → $145
Jun-15-21 Initiated Raymond James
Strong Buy
$160
Show Previous Ratings
May-01-24 06:00AM
Apr-25-24 08:05PM
(Morningstar Research) -7.04%
Apr-24-24 06:15PM
07:16AM
Apr-22-24 12:44PM
11:10AM
Loading…
11:10AM
Apr-17-24 06:15PM
Apr-15-24 06:52AM
06:00AM
Apr-12-24 07:00AM
06:49AM
06:40AM
Apr-11-24 06:00AM
Apr-10-24 06:15PM
08:16AM
12:00AM
Loading…
12:00AM
Apr-09-24 07:37AM
Apr-08-24 12:05PM
07:00AM
(The Wall Street Journal)
06:00AM
Apr-05-24 10:16AM
Apr-04-24 10:15AM
06:05AM
Apr-03-24 09:57AM
Apr-02-24 04:02PM
(Investor's Business Daily)
Mar-29-24 08:09AM
Mar-28-24 06:00AM
Mar-27-24 08:05AM
Mar-26-24 07:00AM
Mar-25-24 09:55AM
11:30AM
Loading…
Mar-22-24 11:30AM
Mar-18-24 08:19AM
04:30AM
Mar-14-24 04:16PM
(Investor's Business Daily)
Mar-13-24 05:03PM
Mar-11-24 12:59AM
Mar-08-24 09:55AM
Mar-07-24 07:59AM
Mar-04-24 11:52PM
03:49PM
10:38AM
Mar-03-24 10:32AM
Feb-26-24 06:00AM
Feb-23-24 12:01PM
Feb-22-24 11:08AM
10:30AM
(Thomson Reuters StreetEvents)
10:22AM
01:30AM
12:06AM
Feb-21-24 06:20PM
05:41PM
(Associated Press Finance)
05:12PM
04:05PM
Feb-20-24 02:39AM
Feb-15-24 07:47AM
Feb-14-24 10:00AM
Feb-13-24 08:12PM
Feb-10-24 05:06PM
Feb-07-24 09:00AM
Feb-01-24 06:00AM
Jan-28-24 09:25AM
Jan-22-24 08:00AM
Jan-18-24 05:04AM
Jan-13-24 02:05PM
Jan-08-24 02:48PM
Jan-07-24 04:30PM
Jan-02-24 06:00AM
Dec-21-23 09:43AM
Dec-20-23 01:49PM
Dec-17-23 05:43AM
Dec-14-23 04:02AM
Dec-13-23 12:52PM
08:45AM
Dec-07-23 08:05AM
Dec-05-23 09:11AM
Dec-04-23 12:13PM
Dec-01-23 11:32AM
05:26AM
Nov-30-23 04:05PM
Nov-25-23 09:45AM
Nov-23-23 12:02PM
Nov-20-23 03:06PM
09:55AM
07:30AM
Nov-17-23 08:04PM
(Morningstar Research) +8.39%
07:10AM
Nov-14-23 05:20AM
Nov-10-23 07:00AM
Nov-09-23 08:10PM
(Morningstar Research) -5.09%
Nov-06-23 09:35AM
Nov-03-23 08:09PM
(Morningstar Research) +7.30%
Nov-02-23 07:23PM
04:02PM
(Investor's Business Daily)
11:03AM
09:40AM
(Thomson Reuters StreetEvents)
01:14AM
12:30AM
Nov-01-23 06:06PM
04:05PM
06:00AM
EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Conroy Kevin T President and CEO May 01 '24 Sale 60.15 1,155 69,473 1,156,191 May 02 07:00 PM Cunningham Everett Chief Commercial Officer May 01 '24 Sale 60.15 136 8,180 47,042 May 02 07:00 PM Elliott Jeffrey Thomas Chief Financial Officer May 01 '24 Sale 60.15 136 8,180 11,795 May 02 07:00 PM Baranick Brian EVP, GM., Precision Oncology May 01 '24 Sale 60.15 110 6,616 13,279 May 02 07:00 PM ORVILLE JACOB A General Manager, Screening May 01 '24 Sale 60.15 102 6,135 14,440 May 02 07:00 PM Condella Sarah EVP, Human Resources May 01 '24 Sale 60.15 102 6,135 72,611 May 02 07:00 PM COWARD D SCOTT Director May 01 '24 Sale 60.15 67 4,030 44,644 May 02 07:00 PM Herriott James SVP, General Counsel & Sec May 01 '24 Sale 60.15 30 1,804 9,866 May 02 07:00 PM Baranick Brian EVP, GM., Precision Oncology Apr 02 '24 Sale 79.43 924 73,393 13,171 Apr 03 07:30 PM Condella Sarah EVP, Human Resources Apr 01 '24 Sale 70.00 2,000 140,000 71,787 Apr 03 07:30 PM Condella Sarah EVP, Human Resources Mar 28 '24 Sale 70.00 2,000 140,000 73,787 Apr 01 04:30 PM Conroy Kevin T President and CEO Mar 01 '24 Sale 59.32 8,271 490,636 1,299,496 Mar 04 08:38 PM LEVANGIE DANIEL J Director Mar 01 '24 Sale 57.50 5,000 287,500 22,975 Mar 04 08:42 PM Elliott Jeffrey Thomas Chief Financial Officer Mar 01 '24 Sale 59.32 2,412 143,080 10,933 Mar 04 08:40 PM Cunningham Everett Chief Commercial Officer Mar 01 '24 Sale 59.32 2,412 143,080 46,179 Mar 04 08:38 PM Baranick Brian Gen. Mgr., Precision Oncology Mar 01 '24 Sale 59.32 2,323 137,800 14,095 Mar 04 08:36 PM ORVILLE JACOB A General Manager, Screening Mar 01 '24 Sale 59.32 2,154 127,775 14,324 Mar 04 08:42 PM Doyle James Edward Director Mar 01 '24 Sale 57.50 2,000 115,000 50,110 Mar 04 08:39 PM Condella Sarah EVP, Human Resources Mar 01 '24 Sale 59.32 1,724 102,268 75,787 Mar 04 08:37 PM Herriott James General Counsel Mar 01 '24 Sale 59.32 862 51,134 9,125 Mar 04 08:41 PM Herriott James General Counsel Feb 29 '24 Option Exercise 0.00 1,890 0 9,987 Mar 04 08:41 PM Elliott Jeffrey Thomas Chief Financial Officer Feb 29 '24 Option Exercise 0.00 5,291 0 13,345 Mar 04 08:40 PM Cunningham Everett Chief Commercial Officer Feb 29 '24 Option Exercise 0.00 5,291 0 48,591 Mar 04 08:38 PM ORVILLE JACOB A General Manager, Screening Feb 29 '24 Option Exercise 0.00 4,724 0 16,478 Mar 04 08:42 PM Conroy Kevin T President and CEO Feb 29 '24 Option Exercise 0.00 18,143 0 1,307,767 Mar 04 08:38 PM Baranick Brian Gen. Mgr., Precision Oncology Feb 29 '24 Option Exercise 0.00 4,724 0 16,418 Mar 04 08:36 PM Condella Sarah EVP, Human Resources Feb 29 '24 Option Exercise 0.00 3,779 0 77,511 Mar 04 08:37 PM Conroy Kevin T President and CEO Feb 27 '24 Sale 56.89 6,263 356,302 1,289,624 Feb 28 07:35 PM Cunningham Everett Chief Commercial Officer Feb 27 '24 Sale 56.89 3,648 207,535 43,300 Feb 28 07:37 PM Elliott Jeffrey Thomas Chief Financial Officer Feb 27 '24 Sale 56.89 2,710 154,172 8,054 Feb 28 07:36 PM Baranick Brian Gen. Mgr., Precision Oncology Feb 27 '24 Sale 56.89 2,027 115,316 11,694 Feb 28 07:34 PM Condella Sarah EVP, Human Resources Feb 27 '24 Sale 56.89 1,880 106,953 73,732 Feb 28 07:35 PM ORVILLE JACOB A General Manager, Screening Feb 27 '24 Sale 56.89 1,879 106,896 11,754 Feb 28 07:38 PM Herriott James General Counsel Feb 27 '24 Sale 56.89 784 44,602 8,097 Feb 28 07:38 PM Cunningham Everett Chief Commercial Officer Feb 26 '24 Option Exercise 0.00 7,678 0 46,948 Feb 28 07:37 PM ORVILLE JACOB A General Manager, Screening Feb 26 '24 Option Exercise 0.00 3,954 0 13,633 Feb 28 07:38 PM Herriott James General Counsel Feb 26 '24 Option Exercise 0.00 1,648 0 8,881 Feb 28 07:38 PM Elliott Jeffrey Thomas Chief Financial Officer Feb 26 '24 Option Exercise 0.00 5,701 0 10,764 Feb 28 07:36 PM Condella Sarah EVP, Human Resources Feb 26 '24 Option Exercise 0.00 3,954 0 75,612 Feb 28 07:35 PM Conroy Kevin T President and CEO Feb 26 '24 Option Exercise 0.00 13,181 0 1,295,887 Feb 28 07:35 PM Baranick Brian Gen. Mgr., Precision Oncology Feb 26 '24 Option Exercise 0.00 3,954 0 13,721 Feb 28 07:34 PM Conroy Kevin T President and CEO Feb 23 '24 Option Exercise 13.96 102,837 1,435,605 1,344,266 Feb 26 05:00 PM Condella Sarah EVP, Human Resources Feb 23 '24 Sale 59.72 1,021 60,974 71,658 Feb 26 05:00 PM Conroy Kevin T President and CEO Feb 22 '24 Sale 59.78 11,565 691,356 1,241,429 Feb 23 07:59 PM Elliott Jeffrey Thomas Chief Financial Officer Feb 22 '24 Sale 59.78 1,351 80,763 5,063 Feb 23 08:01 PM Cunningham Everett Chief Commercial Officer Feb 22 '24 Sale 59.78 1,350 80,703 39,270 Feb 23 08:00 PM Baranick Brian Gen. Mgr., Precision Oncology Feb 22 '24 Sale 59.78 1,093 65,340 9,767 Feb 23 07:57 PM Condella Sarah EVP, Human Resources Feb 22 '24 Sale 59.78 1,013 60,557 72,679 Feb 23 07:57 PM ORVILLE JACOB A General Manager, Screening Feb 22 '24 Sale 59.78 1,013 60,557 9,679 Feb 23 08:03 PM COWARD D SCOTT Director Feb 22 '24 Sale 59.78 663 39,634 44,493 Feb 23 07:59 PM Herriott James General Counsel Feb 22 '24 Sale 59.78 291 17,396 7,233 Feb 23 08:02 PM Conroy Kevin T President and CEO Feb 21 '24 Sale 61.50 4,975 305,962 1,229,756 Feb 22 07:37 PM Elliott Jeffrey Thomas Chief Financial Officer Feb 21 '24 Sale 61.50 1,493 91,820 3,703 Feb 22 07:38 PM Condella Sarah EVP, Human Resources Feb 21 '24 Sale 61.50 1,079 66,358 71,658 Feb 22 07:36 PM ORVILLE JACOB A General Manager, Screening Feb 21 '24 Sale 61.50 1,078 66,297 8,658 Feb 22 07:40 PM Baranick Brian Gen. Mgr., Precision Oncology Feb 21 '24 Sale 61.50 895 55,042 8,826 Feb 22 07:36 PM COWARD D SCOTT Director Feb 21 '24 Sale 61.50 706 43,419 43,122 Feb 22 07:38 PM Herriott James General Counsel Feb 21 '24 Sale 61.50 415 25,522 6,943 Feb 22 07:39 PM Conroy Kevin T President and CEO Feb 20 '24 Option Exercise 0.00 10,374 0 1,234,731 Feb 22 07:37 PM Elliott Jeffrey Thomas Chief Financial Officer Feb 20 '24 Option Exercise 0.00 3,112 0 5,196 Feb 22 07:38 PM COWARD D SCOTT Director Feb 20 '24 Option Exercise 0.00 2,248 0 43,828 Feb 22 07:38 PM Baranick Brian Gen. Mgr., Precision Oncology Feb 20 '24 Option Exercise 0.00 1,729 0 9,721 Feb 22 07:36 PM Condella Sarah EVP, Human Resources Feb 20 '24 Option Exercise 0.00 2,248 0 72,737 Feb 22 07:36 PM Herriott James General Counsel Feb 20 '24 Option Exercise 0.00 864 0 7,358 Feb 22 07:39 PM ORVILLE JACOB A General Manager, Screening Feb 20 '24 Option Exercise 0.00 2,248 0 9,736 Feb 22 07:40 PM Conroy Kevin T President and CEO Feb 15 '24 Sale 61.43 14,791 908,611 1,224,357 Feb 16 06:22 PM Elliott Jeffrey Thomas Chief Financial Officer Feb 15 '24 Sale 61.43 1,888 115,980 2,084 Feb 16 06:24 PM COWARD D SCOTT Director Feb 15 '24 Sale 61.43 1,376 84,528 41,580 Feb 16 06:23 PM ORVILLE JACOB A General Manager, Screening Feb 15 '24 Sale 61.43 966 59,341 7,488 Feb 16 06:26 PM Condella Sarah EVP, Human Resources Feb 15 '24 Sale 61.43 965 59,280 70,489 Feb 16 06:21 PM Herriott James General Counsel Feb 15 '24 Sale 61.43 421 25,862 6,494 Feb 16 06:25 PM Herriott James General Counsel Feb 14 '24 Option Exercise 0.00 883 0 6,915 Feb 16 06:25 PM Elliott Jeffrey Thomas Chief Financial Officer Feb 14 '24 Option Exercise 0.00 3,972 0 3,972 Feb 16 06:24 PM COWARD D SCOTT Director Feb 14 '24 Option Exercise 0.00 3,972 0 42,956 Feb 16 06:23 PM Condella Sarah EVP, Human Resources Feb 14 '24 Option Exercise 0.00 2,031 0 71,454 Feb 16 06:21 PM ORVILLE JACOB A General Manager, Screening Feb 14 '24 Option Exercise 0.00 2,031 0 8,454 Feb 16 06:26 PM Conroy Kevin T President and CEO Feb 14 '24 Option Exercise 0.00 31,133 0 1,239,148 Feb 16 06:22 PM Condella Sarah EVP, Human Resources Jan 02 '24 Sale 73.50 2,000 147,000 69,423 Jan 04 05:19 PM Baranick Brian Gen. Mgr., Precision Oncology Jan 02 '24 Sale 73.50 879 64,606 7,992 Jan 04 05:17 PM Condella Sarah EVP, Human Resources Dec 14 '23 Sale 70.00 2,000 140,000 71,423 Dec 18 07:49 PM Cunningham Everett Chief Commercial Officer Oct 12 '23 Sale 66.49 13,007 864,835 37,909 Oct 13 07:59 PM Cunningham Everett Chief Commercial Officer Oct 11 '23 Option Exercise 0.00 27,504 0 50,916 Oct 13 07:59 PM Condella Sarah EVP, Human Resources Sep 01 '23 Sale 84.36 4,500 379,620 75,814 Sep 06 04:04 PM Elliott Jeffrey Thomas Chief Financial Officer Aug 21 '23 Sale 82.92 30,210 2,505,013 0 Aug 23 04:08 PM Baranick Brian Gen. Mgr., Precision Oncology Aug 07 '23 Sale 85.04 1,350 114,804 8,871 Aug 08 04:09 PM Baranick Brian Gen. Mgr., Precision Oncology Aug 04 '23 Option Exercise 0.00 2,712 0 10,221 Aug 08 04:09 PM Doyle James Edward Director Jul 27 '23 Sale 97.42 2,000 194,840 52,110 Jul 28 04:06 PM Herriott James General Counsel Jul 19 '23 Sale 100.00 1,300 130,000 5,964 Jul 21 04:04 PM Zanotti Katherine S Director Jun 09 '23 Sale 90.51 3,027 273,974 64,629 Jun 12 04:17 PM Doyle James Edward Director Jun 09 '23 Sale 90.51 1,402 126,895 54,110 Jun 12 04:29 PM Herriott James General Counsel Jun 08 '23 Sale 90.00 1,300 117,000 7,264 Jun 12 04:14 PM Doyle James Edward Director May 26 '23 Sale 80.62 2,000 161,240 51,913 May 31 04:13 PM Condella Sarah EVP, Human Resources May 10 '23 Sale 80.00 6,087 486,960 80,314 May 12 04:11 PM ORVILLE JACOB A General Manager, Screening May 10 '23 Sale 80.00 5,000 400,000 6,423 May 12 04:09 PM Herriott James General Counsel May 10 '23 Sale 79.85 1,300 103,805 8,564 May 12 04:07 PM
Index RUT P/E 51.43 EPS (ttm) 0.62 Insider Own 13.90% Shs Outstand 95.73M Perf Week -1.00%
Market Cap 3.06B Forward P/E 31.79 EPS next Y 1.00 Insider Trans -4.87% Shs Float 95.47M Perf Month -10.65%
Income 62.04M PEG 3.65 EPS next Q 0.13 Inst Own 87.64% Short Float 6.92% Perf Quarter -18.85%
Sales 1.09B P/S 2.81 EPS this Y 12.19% Inst Trans -1.63% Short Ratio 7.60 Perf Half Y 4.24%
Book/sh 5.78 P/B 5.49 EPS next Y 43.46% ROA 9.48% Short Interest 6.60M Perf Year -6.98%
Cash/sh 3.85 P/C 8.25 EPS next 5Y 14.10% ROE 13.34% 52W Range 29.44 - 44.95 Perf YTD -14.69%
Dividend Est. - P/FCF 16.53 EPS past 5Y - ROI 10.87% 52W High -29.43% Beta 1.51
Dividend TTM - Quick Ratio 3.44 Sales past 5Y 61.75% Gross Margin 21.94% 52W Low 7.74% ATR (14) 0.98
Dividend Ex-Date - Current Ratio 3.44 EPS Y/Y TTM 98.39% Oper. Margin 5.71% RSI (14) 34.35 Volatility 3.05% 2.55%
Employees 566 Debt/Eq 0.04 Sales Y/Y TTM 38.34% Profit Margin 5.70% Recom 1.10 Target Price 47.10
Option/Short Yes / Yes LT Debt/Eq 0.03 EPS Q/Q 292.08% Payout 0.00% Rel Volume 0.87 Prev Close 32.07
Sales Surprise -1.51% EPS Surprise 20.93% Sales Q/Q 25.95% Earnings May 09 AMC Avg Volume 869.15K Price 31.72
SMA20 -4.93% SMA50 -9.96% SMA200 -11.72% Trades
Volume 760,420 Change -1.09%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-26-24 Initiated Leerink Partners
Outperform
$49
Jan-03-24 Initiated Barclays
Overweight
$48
Sep-27-23 Initiated Canaccord Genuity
Buy
$46
May-22-23 Initiated BTIG Research
Buy
$50
Apr-21-23 Initiated Cantor Fitzgerald
Overweight
$44
Jan-05-23 Downgrade SVB Leerink
Outperform → Mkt Perform
$34
Sep-16-22 Initiated KeyBanc Capital Markets
Overweight
$55
Sep-07-22 Initiated Truist
Buy
$56
Dec-02-21 Initiated Jefferies
Buy
$60
Nov-22-21 Downgrade Citigroup
Buy → Neutral
$60 → $64
Sep-30-21 Initiated Berenberg
Buy
$81
Aug-12-21 Initiated Barclays
Overweight
$64
Jun-02-21 Downgrade Guggenheim
Buy → Neutral
Apr-29-21 Resumed JP Morgan
Overweight
$65
Mar-10-21 Upgrade BofA Securities
Neutral → Buy
$53
Jul-01-20 Initiated SVB Leerink
Outperform
$35
Jun-02-20 Initiated Guggenheim
Buy
$30
Nov-19-19 Initiated SVB Leerink
Outperform
$28
Nov-19-19 Initiated Piper Jaffray
Overweight
$33
Nov-19-19 Initiated JP Morgan
Overweight
$26
Show Previous Ratings
May-03-24 02:48AM
Apr-25-24 02:00PM
Apr-17-24 09:23AM
Apr-13-24 12:18PM
Apr-04-24 08:59AM
07:01PM
Loading…
Apr-03-24 07:01PM
Mar-30-24 01:30AM
Mar-28-24 08:13AM
01:37AM
Mar-26-24 07:49AM
Mar-18-24 12:00PM
Mar-13-24 04:30PM
Mar-11-24 12:00PM
Feb-29-24 05:48PM
07:30AM
10:41AM
Loading…
Feb-28-24 10:41AM
10:15AM
09:01AM
07:19AM
(Thomson Reuters StreetEvents)
Feb-27-24 05:11PM
(Associated Press Finance)
04:34PM
04:01PM
Feb-13-24 04:30PM
Feb-08-24 03:06AM
Feb-05-24 11:30PM
Jan-24-24 01:36PM
Jan-17-24 09:30AM
Jan-16-24 06:10PM
Jan-12-24 09:23AM
05:03AM
09:01AM
Loading…
Jan-11-24 09:01AM
Jan-08-24 10:30AM
Jan-06-24 03:12AM
Jan-05-24 03:02AM
Dec-29-23 09:01PM
Dec-24-23 03:01AM
Dec-19-23 06:49AM
05:10AM
Nov-20-23 10:17AM
Nov-13-23 12:45PM
Nov-10-23 12:00PM
Nov-09-23 03:52PM
Nov-07-23 05:58PM
(Associated Press Finance)
04:49PM
04:05PM
Nov-02-23 06:04AM
Nov-01-23 11:27PM
10:01AM
09:00AM
Oct-31-23 10:01AM
Oct-27-23 09:45AM
Oct-24-23 02:00PM
Oct-10-23 11:34AM
Sep-27-23 10:16AM
Sep-26-23 07:35PM
Sep-01-23 12:45PM
Aug-29-23 10:46AM
Aug-22-23 11:56AM
Aug-16-23 12:45PM
07:57AM
Aug-11-23 12:00PM
Aug-10-23 06:28AM
Aug-07-23 08:29AM
(American City Business Journals)
Aug-05-23 09:24AM
Aug-04-23 09:01AM
06:47AM
(Thomson Reuters StreetEvents)
Aug-03-23 09:00PM
05:35PM
04:28PM
04:01PM
Jul-21-23 11:20AM
Jul-20-23 12:00PM
10:29AM
Jul-18-23 11:40AM
06:37AM
Jul-17-23 06:51PM
04:37AM
Jul-11-23 03:00PM
Jul-10-23 10:00AM
Jul-07-23 12:00PM
Jun-29-23 08:30AM
Jun-27-23 01:26PM
Jun-21-23 08:00PM
Jun-15-23 09:30AM
Jun-14-23 10:02AM
Jun-12-23 09:55AM
Jun-07-23 07:06AM
Jun-05-23 12:00PM
May-24-23 06:51AM
May-17-23 12:45PM
12:20PM
09:55AM
May-09-23 06:49AM
(Thomson Reuters StreetEvents) +8.46%
May-08-23 05:35PM
04:33PM
04:03PM
May-04-23 01:26PM
May-02-23 12:00PM
Apr-27-23 05:35AM
Apr-26-23 08:00PM
Progyny, Inc. is a fertility benefits management company. It provides fertility solutions to employers, managing IUI, in vitro fertilization (IVF), egg freezing, and other fertility treatments. It operates through one segment: fertility and pharmacy benefits solutions. It also delivers treatment services and access to the firm's network of fertility specialist. The company was founded on April 3, 2008 and is headquartered in New York, NY.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Payson Norman Director Nov 23 '24 Sale 56.29 200 11,258 580,656 Nov 26 04:34 PM Sturmer Michael E PRESIDENT May 01 '24 Sale 31.95 4,515 144,254 380,038 May 02 07:05 PM Livingston Mark S. CHIEF FINANCIAL OFFICER Apr 01 '24 Option Exercise 3.95 20,627 81,477 72,875 Apr 03 05:16 PM Schlanger David J Executive Chairman Apr 01 '24 Option Exercise 3.95 1,000 3,950 87,312 Apr 03 05:27 PM Livingston Mark S. CHIEF FINANCIAL OFFICER Apr 01 '24 Sale 37.62 11,165 419,979 50,119 Apr 03 05:16 PM Sturmer Michael E PRESIDENT Apr 01 '24 Sale 37.60 6,395 240,452 384,553 Apr 03 05:23 PM Schlanger David J Executive Chairman Apr 01 '24 Sale 37.52 1,000 37,522 83,631 Apr 03 05:27 PM Schlanger David J Executive Chairman Mar 27 '24 Option Exercise 3.95 71,272 281,845 157,584 Mar 29 07:01 PM Schlanger David J Executive Chairman Mar 27 '24 Sale 37.80 71,272 2,694,267 86,312 Mar 29 07:01 PM Schlanger David J Executive Chairman Mar 26 '24 Option Exercise 3.95 305 1,206 86,617 Mar 27 05:49 PM Schlanger David J Executive Chairman Mar 26 '24 Sale 37.50 305 11,439 86,312 Mar 27 05:49 PM Schlanger David J Executive Chairman Mar 25 '24 Option Exercise 3.95 2,597 10,270 88,909 Mar 27 05:49 PM Schlanger David J Executive Chairman Mar 25 '24 Sale 37.65 2,597 97,778 86,312 Mar 27 05:49 PM Schlanger David J Executive Chairman Mar 21 '24 Option Exercise 3.95 5,826 23,039 92,138 Mar 25 06:42 PM Schlanger David J Executive Chairman Mar 21 '24 Sale 37.74 5,826 219,877 86,312 Mar 25 06:42 PM Livingston Mark S. CHIEF FINANCIAL OFFICER Mar 01 '24 Option Exercise 3.95 22,000 86,900 65,647 Mar 05 05:04 PM Livingston Mark S. CHIEF FINANCIAL OFFICER Mar 01 '24 Sale 36.64 12,610 461,977 38,254 Mar 05 05:04 PM Sturmer Michael E PRESIDENT Mar 01 '24 Sale 36.63 11,009 403,260 141,738 Mar 05 04:57 PM Sturmer Michael E PRESIDENT Feb 06 '24 Sale 40.00 2,260 90,400 158,532 Feb 08 06:53 PM Schlanger David J Executive Chairman Feb 05 '24 Option Exercise 3.95 20,000 79,090 106,312 Feb 07 06:38 PM Schlanger David J Executive Chairman Feb 05 '24 Sale 38.50 20,000 769,928 86,312 Feb 07 06:38 PM Schlanger David J Executive Chairman Feb 02 '24 Option Exercise 3.95 30,000 118,635 116,312 Feb 05 06:51 PM Schlanger David J Executive Chairman Feb 02 '24 Sale 38.92 30,000 1,167,490 86,312 Feb 05 06:51 PM Schlanger David J Executive Chairman Feb 01 '24 Option Exercise 3.95 30,000 118,635 116,312 Feb 05 06:51 PM Livingston Mark S. CHIEF FINANCIAL OFFICER Feb 01 '24 Option Exercise 3.95 22,000 86,900 68,871 Feb 05 07:03 PM Schlanger David J Executive Chairman Feb 01 '24 Sale 38.29 30,000 1,148,635 86,312 Feb 05 06:51 PM Livingston Mark S. CHIEF FINANCIAL OFFICER Feb 01 '24 Sale 37.84 12,651 478,767 43,871 Feb 05 07:03 PM Sturmer Michael E PRESIDENT Feb 01 '24 Sale 37.89 6,395 242,307 160,792 Feb 05 06:57 PM Schlanger David J Executive Chairman Jan 08 '24 Option Exercise 3.95 66,002 261,005 152,314 Jan 10 06:31 PM Schlanger David J Executive Chairman Jan 08 '24 Sale 37.88 66,002 2,500,156 86,312 Jan 10 06:31 PM Livingston Mark S. CHIEF FINANCIAL OFFICER Jan 02 '24 Option Exercise 3.95 22,000 86,900 71,871 Jan 05 06:01 AM Schlanger David J Executive Chairman Jan 02 '24 Option Exercise 3.95 13,998 55,355 102,437 Jan 04 06:30 PM Schlanger David J Executive Chairman Jan 02 '24 Sale 37.58 13,998 526,024 88,439 Jan 04 06:30 PM Livingston Mark S. CHIEF FINANCIAL OFFICER Jan 02 '24 Sale 36.59 12,368 452,540 46,871 Jan 05 06:01 AM Sturmer Michael E PRESIDENT Jan 02 '24 Sale 36.81 6,395 235,400 167,187 Jan 04 06:42 PM Schlanger David J Executive Chairman Dec 27 '23 Option Exercise 3.95 76,031 300,665 164,470 Dec 28 08:19 PM Schlanger David J Executive Chairman Dec 27 '23 Sale 37.66 76,031 2,863,525 88,439 Dec 28 08:19 PM Schlanger David J Executive Chairman Dec 26 '23 Option Exercise 3.95 80,000 316,360 168,439 Dec 28 08:19 PM Schlanger David J Executive Chairman Dec 26 '23 Sale 37.93 80,000 3,034,760 88,439 Dec 28 08:19 PM Schlanger David J Executive Chairman Dec 22 '23 Option Exercise 3.95 80,000 316,360 168,439 Dec 22 04:40 PM Schlanger David J Executive Chairman Dec 22 '23 Sale 38.11 80,000 3,048,408 88,439 Dec 22 04:40 PM Schlanger David J Executive Chairman Dec 21 '23 Option Exercise 3.95 80,000 316,360 168,439 Dec 22 04:40 PM Schlanger David J Executive Chairman Dec 21 '23 Sale 37.65 80,000 3,011,952 88,439 Dec 22 04:40 PM Schlanger David J Executive Chairman Dec 20 '23 Option Exercise 3.95 2,906 11,492 91,345 Dec 22 04:40 PM Schlanger David J Executive Chairman Dec 20 '23 Sale 37.50 2,906 108,987 88,439 Dec 22 04:40 PM Schlanger David J Executive Chairman Dec 14 '23 Option Exercise 3.95 1,063 4,204 89,502 Dec 18 07:39 PM Schlanger David J Executive Chairman Dec 14 '23 Sale 37.53 1,063 39,894 88,439 Dec 18 07:39 PM GORDON KEVIN K Director Dec 11 '23 Sale 35.93 2,500 89,825 9,854 Dec 13 07:06 PM Livingston Mark S. CHIEF FINANCIAL OFFICER Dec 01 '23 Option Exercise 3.95 44,000 173,800 102,377 Dec 05 07:44 PM Livingston Mark S. CHIEF FINANCIAL OFFICER Dec 01 '23 Sale 34.62 25,087 868,512 49,983 Dec 05 07:44 PM Sturmer Michael E PRESIDENT Dec 01 '23 Sale 34.13 12,696 433,314 173,806 Dec 05 07:49 PM TPG GP A, LLC Former 10% Owner Aug 07 '23 Sale 41.08 2,900,000 119,132,000 6,350,000 Aug 09 04:42 PM Anevski Peter CHIEF EXECUTIVE OFFICER Jul 14 '23 Option Exercise 3.95 17,990 71,060 225,937 Jul 18 04:27 PM Anevski Peter CHIEF EXECUTIVE OFFICER Jul 14 '23 Sale 38.95 17,990 700,710 207,947 Jul 18 04:27 PM Anevski Peter CHIEF EXECUTIVE OFFICER Jul 14 '23 Sale 38.95 2,096 81,639 1 Jul 18 04:27 PM Anevski Peter CHIEF EXECUTIVE OFFICER Jul 13 '23 Option Exercise 3.95 32,000 126,400 239,947 Jul 14 04:01 PM Schlanger David J Executive Chairman Jul 13 '23 Option Exercise 0.91 67,457 61,386 138,263 Jul 14 04:02 PM Schlanger David J Executive Chairman Jul 13 '23 Sale 38.95 67,457 2,627,450 70,806 Jul 14 04:02 PM Anevski Peter CHIEF EXECUTIVE OFFICER Jul 13 '23 Sale 38.94 32,000 1,246,080 207,947 Jul 14 04:01 PM Anevski Peter CHIEF EXECUTIVE OFFICER Jul 13 '23 Sale 38.94 8,000 311,520 2,097 Jul 14 04:01 PM Anevski Peter CHIEF EXECUTIVE OFFICER Jul 12 '23 Option Exercise 3.95 23,572 93,109 231,519 Jul 14 04:01 PM Schlanger David J Executive Chairman Jul 12 '23 Option Exercise 0.91 38,687 35,205 109,493 Jul 14 04:02 PM Schlanger David J Executive Chairman Jul 12 '23 Sale 38.64 38,687 1,494,866 70,806 Jul 14 04:02 PM Anevski Peter CHIEF EXECUTIVE OFFICER Jul 12 '23 Sale 38.64 23,572 910,822 207,947 Jul 14 04:01 PM Anevski Peter CHIEF EXECUTIVE OFFICER Jul 12 '23 Sale 38.64 4,890 188,950 10,097 Jul 14 04:01 PM Anevski Peter CHIEF EXECUTIVE OFFICER Jul 03 '23 Option Exercise 3.95 6,439 25,434 222,363 Jul 06 04:01 PM Schlanger David J Executive Chairman Jul 03 '23 Option Exercise 0.91 18,856 17,159 92,343 Jul 06 04:02 PM Schlanger David J Executive Chairman Jul 03 '23 Sale 38.76 18,856 730,859 73,487 Jul 06 04:02 PM Anevski Peter CHIEF EXECUTIVE OFFICER Jul 03 '23 Sale 38.78 6,439 249,704 215,924 Jul 06 04:01 PM Anevski Peter CHIEF EXECUTIVE OFFICER Jul 03 '23 Sale 38.78 1,610 62,436 14,987 Jul 06 04:01 PM Scott Cheryl Director Jun 27 '23 Sale 37.27 1,170 43,606 9,744 Jul 07 05:15 PM Anevski Peter CHIEF EXECUTIVE OFFICER Jun 07 '23 Option Exercise 3.95 16,000 63,200 231,924 Jun 08 08:00 PM Anevski Peter CHIEF EXECUTIVE OFFICER Jun 07 '23 Sale 40.97 16,000 655,512 215,924 Jun 08 08:00 PM Anevski Peter CHIEF EXECUTIVE OFFICER Jun 07 '23 Sale 40.97 4,000 163,878 16,597 Jun 08 08:00 PM Anevski Peter CHIEF EXECUTIVE OFFICER Jun 06 '23 Option Exercise 3.95 16,000 63,200 231,924 Jun 07 06:22 PM Anevski Peter CHIEF EXECUTIVE OFFICER Jun 06 '23 Sale 41.01 16,000 656,086 215,924 Jun 07 06:22 PM Anevski Peter CHIEF EXECUTIVE OFFICER Jun 06 '23 Sale 41.01 4,000 164,021 20,597 Jun 07 06:22 PM Anevski Peter CHIEF EXECUTIVE OFFICER Jun 05 '23 Option Exercise 3.95 16,000 63,200 231,924 Jun 07 06:22 PM Schlanger David J Executive Chairman Jun 05 '23 Option Exercise 0.91 41,666 37,916 115,153 Jun 07 06:23 PM Schlanger David J Executive Chairman Jun 05 '23 Sale 40.00 41,666 1,666,824 73,487 Jun 07 06:23 PM Anevski Peter CHIEF EXECUTIVE OFFICER Jun 05 '23 Sale 40.00 16,000 640,057 215,924 Jun 07 06:22 PM Anevski Peter CHIEF EXECUTIVE OFFICER Jun 05 '23 Sale 40.00 4,000 160,014 24,597 Jun 07 06:22 PM Anevski Peter CHIEF EXECUTIVE OFFICER Jun 02 '23 Option Exercise 3.95 16,000 63,200 231,924 Jun 05 05:08 PM Schlanger David J Executive Chairman Jun 02 '23 Option Exercise 0.91 41,667 37,917 115,154 Jun 05 04:48 PM Schlanger David J Executive Chairman Jun 02 '23 Sale 38.68 41,667 1,611,680 73,487 Jun 05 04:48 PM Anevski Peter CHIEF EXECUTIVE OFFICER Jun 02 '23 Sale 38.67 16,000 618,720 215,924 Jun 05 05:08 PM Anevski Peter CHIEF EXECUTIVE OFFICER Jun 02 '23 Sale 38.67 4,000 154,680 28,597 Jun 05 05:08 PM Anevski Peter CHIEF EXECUTIVE OFFICER Jun 01 '23 Option Exercise 3.95 16,000 63,200 231,924 Jun 05 05:08 PM Schlanger David J Executive Chairman Jun 01 '23 Option Exercise 0.91 41,667 37,917 115,154 Jun 05 04:48 PM Schlanger David J Executive Chairman Jun 01 '23 Sale 37.55 41,667 1,564,431 73,487 Jun 05 04:48 PM Anevski Peter CHIEF EXECUTIVE OFFICER Jun 01 '23 Sale 37.55 16,000 600,850 215,924 Jun 05 05:08 PM Anevski Peter CHIEF EXECUTIVE OFFICER Jun 01 '23 Sale 37.55 4,000 150,212 32,597 Jun 05 05:08 PM GORDON KEVIN K Director May 24 '23 Sale 38.24 1,410 53,918 12,354 May 26 05:03 PM Anevski Peter CHIEF EXECUTIVE OFFICER May 16 '23 Option Exercise 3.95 4,608 18,202 220,532 May 18 07:21 PM Anevski Peter CHIEF EXECUTIVE OFFICER May 16 '23 Sale 35.94 4,608 165,612 215,924 May 18 07:21 PM Anevski Peter CHIEF EXECUTIVE OFFICER May 16 '23 Sale 35.94 1,153 41,439 36,597 May 18 07:21 PM Anevski Peter CHIEF EXECUTIVE OFFICER May 15 '23 Option Exercise 3.95 32,000 126,400 247,924 May 16 05:29 PM Anevski Peter CHIEF EXECUTIVE OFFICER May 15 '23 Sale 36.24 32,000 1,159,680 215,924 May 16 05:29 PM Anevski Peter CHIEF EXECUTIVE OFFICER May 15 '23 Sale 36.24 8,000 289,920 31,655 May 16 05:29 PM Anevski Peter CHIEF EXECUTIVE OFFICER May 12 '23 Option Exercise 3.95 32,000 126,400 247,924 May 16 05:29 PM
Index - P/E - EPS (ttm) -3.28 Insider Own 16.98% Shs Outstand 14.66M Perf Week -11.39%
Market Cap 14.23M Forward P/E - EPS next Y - Insider Trans -71.15% Shs Float 13.20M Perf Month -22.17%
Income -56.35M PEG - EPS next Q - Inst Own 4.28% Short Float 4.43% Perf Quarter -16.36%
Sales 7.71M P/S 1.85 EPS this Y - Inst Trans 5.76% Short Ratio 0.26 Perf Half Y -66.97%
Book/sh 18.58 P/B 0.05 EPS next Y - ROA -1.71% Short Interest 0.59M Perf Year -93.98%
Cash/sh 0.73 P/C 1.22 EPS next 5Y - ROE -29.50% 52W Range 0.65 - 17.48 Perf YTD -60.57%
Dividend Est. - P/FCF - EPS past 5Y - ROI -5.92% 52W High -94.88% Beta -2.21
Dividend TTM - Quick Ratio 0.47 Sales past 5Y -2.33% Gross Margin -6115.44% 52W Low 37.67% ATR (14) 0.18
Dividend Ex-Date - Current Ratio 0.47 EPS Y/Y TTM 42.28% Oper. Margin -7266.32% RSI (14) 45.01 Volatility 8.36% 23.30%
Employees 88 Debt/Eq 2.49 Sales Y/Y TTM -49.43% Profit Margin -731.32% Recom 1.00 Target Price 75.00
Option/Short Yes / Yes LT Debt/Eq 2.49 EPS Q/Q -2039.17% Payout - Rel Volume 0.15 Prev Close 0.92
Sales Surprise - EPS Surprise - Sales Q/Q -55.23% Earnings Nov 15 BMO Avg Volume 2.23M Price 0.89
SMA20 -18.45% SMA50 -6.62% SMA200 -64.52% Trades
Volume 340,716 Change -2.72%
Apr-18-24 08:42PM
06:06PM
Apr-15-24 12:53PM
06:55AM
Mar-03-24 09:47PM
08:17AM
Loading…
Jan-22-24 08:17AM
Nov-14-23 07:50PM
Oct-30-23 09:29AM
Oct-27-23 01:22PM
01:02AM
Oct-03-23 04:16PM
Sep-01-23 01:05PM
Aug-17-23 05:21PM
01:18PM
(American City Business Journals)
Aug-03-23 07:33PM
06:13PM
Loading…
Jul-26-23 06:13PM
May-24-23 04:45PM
Apr-24-23 07:45AM
Apr-16-23 11:00PM
Apr-05-23 09:20AM
Mar-30-23 04:15PM
04:15PM
Mar-29-23 04:05PM
Mar-20-23 04:05PM
Mar-10-23 08:02PM
MSP Recovery, Inc. engages in the development of healthcare recoveries and data analytics software. It also focuses on the identification and recoveries of improper payments made by medicare, medicaid, and commercial insurance spaces using data and analytics. The company was founded by John H. Ruiz, Frank C. Quesada, and Diana Diaz on July 8, 2014 and is headquartered in Coral Gables, FL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Cano Health, Inc. 10% Owner Apr 02 '24 Sale 0.88 1,109,500 976,360 903,655 Apr 03 04:34 PM Cano Health, Inc. 10% Owner Apr 01 '24 Sale 0.67 30,376 20,352 2,013,155 Apr 03 04:34 PM Cano Health, Inc. 10% Owner Mar 28 '24 Sale 0.69 25,778 17,787 2,043,531 Mar 29 04:30 PM Cano Health, Inc. 10% Owner Mar 27 '24 Sale 0.70 24,935 17,454 2,069,309 Mar 29 04:30 PM Cano Health, Inc. 10% Owner Mar 26 '24 Sale 0.73 20,000 14,600 2,094,244 Mar 26 08:00 PM Cano Health, Inc. 10% Owner Mar 25 '24 Sale 0.74 23,600 17,464 2,114,244 Mar 26 08:00 PM Cano Health, Inc. 10% Owner Mar 22 '24 Sale 0.75 52,502 39,376 2,137,844 Mar 26 08:00 PM Cano Health, Inc. 10% Owner Mar 21 '24 Sale 0.75 43,711 32,783 2,190,346 Mar 21 06:39 PM Cano Health, Inc. 10% Owner Mar 20 '24 Sale 0.76 46,246 35,147 2,234,057 Mar 21 06:39 PM Cano Health, Inc. 10% Owner Mar 19 '24 Sale 0.77 28,057 21,604 2,280,303 Mar 21 06:39 PM Cano Health, Inc. 10% Owner Mar 18 '24 Sale 0.79 41,937 33,130 2,308,360 Mar 18 08:56 PM Cano Health, Inc. 10% Owner Mar 15 '24 Sale 0.78 44,305 34,558 2,350,297 Mar 18 08:56 PM Cano Health, Inc. 10% Owner Mar 14 '24 Sale 0.77 60,745 46,774 2,394,602 Mar 18 08:56 PM Cano Health, Inc. 10% Owner Mar 13 '24 Sale 0.84 41,584 34,931 2,455,347 Mar 13 06:29 PM Cano Health, Inc. 10% Owner Mar 12 '24 Sale 0.90 52,259 47,033 2,496,931 Mar 13 06:29 PM Cano Health, Inc. 10% Owner Mar 11 '24 Sale 0.94 36,964 34,746 2,549,190 Mar 13 06:29 PM Cano Health, Inc. 10% Owner Mar 08 '24 Sale 0.96 22,694 21,786 2,586,154 Mar 08 05:56 PM Cano Health, Inc. 10% Owner Mar 07 '24 Sale 0.99 235,547 233,192 2,608,848 Mar 08 05:56 PM Cano Health, Inc. 10% Owner Mar 06 '24 Sale 1.02 133,518 136,188 2,844,395 Mar 08 05:56 PM Cano Health, Inc. 10% Owner Mar 05 '24 Sale 1.22 360,814 440,193 2,977,913 Mar 05 07:24 PM Ruiz John Hasan Chief Executive Officer Mar 04 '24 Buy 1.14 438,596 499,999 912,786 Mar 04 05:29 PM Cano Health, Inc. 10% Owner Mar 04 '24 Sale 1.23 774,400 952,512 3,338,727 Mar 05 07:24 PM Cano Health, Inc. 10% Owner Mar 01 '24 Sale 1.04 532,691 553,999 4,113,127 Mar 05 07:24 PM Cano Health, Inc. 10% Owner Feb 29 '24 Sale 0.84 45,547 38,259 4,645,818 Feb 29 05:46 PM Cano Health, Inc. 10% Owner Feb 28 '24 Sale 0.82 36,841 30,210 4,691,365 Feb 29 05:46 PM Cano Health, Inc. 10% Owner Feb 27 '24 Sale 0.81 12,000 9,720 4,728,206 Feb 29 05:46 PM Cano Health, Inc. 10% Owner Feb 26 '24 Sale 0.81 22,664 18,358 4,740,206 Feb 26 08:33 PM Cano Health, Inc. 10% Owner Feb 23 '24 Sale 0.81 27,936 22,628 4,762,870 Feb 26 08:33 PM Cano Health, Inc. 10% Owner Feb 22 '24 Sale 0.82 31,658 25,960 4,790,806 Feb 26 08:33 PM Cano Health, Inc. 10% Owner Feb 21 '24 Sale 0.83 23,115 19,185 4,822,464 Feb 21 05:26 PM Cano Health, Inc. 10% Owner Feb 20 '24 Sale 0.84 118,249 99,329 4,845,579 Feb 21 05:26 PM Cano Health, Inc. 10% Owner Feb 16 '24 Sale 0.81 83,888 67,949 4,963,828 Feb 21 05:26 PM Cano Health, Inc. 10% Owner Feb 15 '24 Sale 0.81 59,005 47,794 5,047,716 Feb 15 07:52 PM Cano Health, Inc. 10% Owner Feb 14 '24 Sale 0.79 105,911 83,670 5,106,721 Feb 15 07:52 PM Cano Health, Inc. 10% Owner Feb 13 '24 Sale 0.76 56,330 42,811 5,212,632 Feb 15 07:52 PM Cano Health, Inc. 10% Owner Feb 12 '24 Sale 0.77 22,767 17,531 5,268,962 Feb 12 06:44 PM Cano Health, Inc. 10% Owner Feb 09 '24 Sale 0.79 59,737 47,192 5,291,729 Feb 12 06:44 PM Cano Health, Inc. 10% Owner Feb 08 '24 Sale 0.78 42,419 33,087 5,351,466 Feb 12 06:44 PM Cano Health, Inc. 10% Owner Feb 07 '24 Sale 0.76 80,757 61,375 5,393,885 Feb 07 07:00 PM Cano Health, Inc. 10% Owner Feb 06 '24 Sale 0.82 65,945 54,075 5,474,642 Feb 07 07:00 PM Cano Health, Inc. 10% Owner Feb 05 '24 Sale 0.92 53,355 49,087 5,540,587 Feb 07 07:00 PM Cano Health, Inc. 10% Owner Feb 02 '24 Sale 1.07 41,219 44,104 5,593,942 Feb 02 08:22 PM Cano Health, Inc. 10% Owner Feb 01 '24 Sale 1.08 71,190 76,885 5,635,161 Feb 02 08:22 PM Cano Health, Inc. 10% Owner Jan 31 '24 Sale 1.10 53,279 58,607 5,706,351 Feb 02 08:22 PM Cano Health, Inc. 10% Owner Jan 30 '24 Sale 1.12 93,277 104,470 5,759,630 Jan 31 05:06 PM Cano Health, Inc. 10% Owner Jan 29 '24 Sale 1.21 43,972 53,206 5,852,907 Jan 31 05:06 PM Cano Health, Inc. 10% Owner Jan 26 '24 Sale 1.19 121,689 144,810 5,896,879 Jan 26 05:40 PM Cano Health, Inc. 10% Owner Jan 25 '24 Sale 1.18 35,165 41,495 6,018,568 Jan 26 05:40 PM Cano Health, Inc. 10% Owner Jan 24 '24 Sale 1.20 72,265 86,718 6,053,733 Jan 26 05:40 PM Cano Health, Inc. 10% Owner Jan 23 '24 Sale 1.26 470,882 593,311 6,125,998 Jan 24 05:06 PM Cano Health, Inc. 10% Owner Jan 22 '24 Sale 1.39 1,125,549 1,564,513 6,596,880 Jan 24 05:06 PM Cano Health, Inc. 10% Owner Jan 19 '24 Sale 1.22 19,692 24,024 7,722,429 Jan 19 06:09 PM Cano Health, Inc. 10% Owner Jan 18 '24 Sale 1.29 16,733 21,586 7,742,121 Jan 19 06:09 PM Cano Health, Inc. 10% Owner Jan 17 '24 Sale 1.30 15,200 19,760 7,758,854 Jan 19 06:09 PM Cano Health, Inc. 10% Owner Jan 16 '24 Sale 1.31 5,016 6,571 7,774,054 Jan 16 07:07 PM Cano Health, Inc. 10% Owner Jan 12 '24 Sale 1.51 29,969 45,253 7,779,070 Jan 16 07:07 PM Cano Health, Inc. 10% Owner Jan 11 '24 Sale 1.53 24,914 38,118 7,809,039 Jan 16 07:07 PM Cano Health, Inc. 10% Owner Jan 10 '24 Sale 1.69 38,141 64,458 7,833,952 Jan 10 05:57 PM Cano Health, Inc. 10% Owner Jan 09 '24 Sale 1.73 36,016 62,308 7,872,093 Jan 10 05:57 PM Cano Health, Inc. 10% Owner Jan 08 '24 Sale 1.92 51,891 99,631 7,908,109 Jan 10 05:57 PM Cano Health, Inc. 10% Owner Jan 03 '24 Sale 2.10 40,000 84,160 7,960,000 Jan 05 07:50 PM Ruiz John Hasan Chief Executive Officer Oct 26 '23 Buy 1.07 467,290 500,000 474,190 Oct 26 10:07 AM Quesada Frank Carlos Chief Legal Officer Sep 29 '23 Buy 0.22 6,868,132 1,500,000 7,007,041 Oct 02 05:04 PM
Index S&P 500 P/E 40.65 EPS (ttm) 4.95 Insider Own 0.39% Shs Outstand 84.29M Perf Week 1.47%
Market Cap 16.97B Forward P/E 12.61 EPS next Y 15.97 Insider Trans -15.18% Shs Float 83.96M Perf Month -4.68%
Income 433.10M PEG 4.74 EPS next Q 3.81 Inst Own 98.43% Short Float 2.70% Perf Quarter -9.13%
Sales 12.30B P/S 1.38 EPS this Y 9.40% Inst Trans -2.80% Short Ratio 2.84 Perf Half Y -1.29%
Book/sh 94.42 P/B 2.13 EPS next Y 7.63% ROA 2.17% Short Interest 2.26M Perf Year 3.70%
Cash/sh 1.18 P/C 170.89 EPS next 5Y 8.58% ROE 4.36% 52W Range 179.58 - 234.09 Perf YTD -11.43%
Dividend Est. 2.52 (1.25%) P/FCF 24.84 EPS past 5Y -11.14% ROI 3.70% 52W High -14.00% Beta 1.06
Dividend TTM 2.88 (1.43%) Quick Ratio 0.76 Sales past 5Y 2.87% Gross Margin 25.90% 52W Low 12.11% ATR (14) 4.24
Dividend Ex-Date May 28, 2024 Current Ratio 0.88 EPS Y/Y TTM -54.91% Oper. Margin 9.05% RSI (14) 42.37 Volatility 2.36% 1.91%
Employees 67000 Debt/Eq 0.75 Sales Y/Y TTM -16.64% Profit Margin 3.52% Recom 1.75 Target Price 241.38
Option/Short Yes / Yes LT Debt/Eq 0.47 EPS Q/Q 12.53% Payout 60.36% Rel Volume 0.70 Prev Close 200.25
Sales Surprise 1.88% EPS Surprise 5.61% Sales Q/Q -15.92% Earnings Apr 25 BMO Avg Volume 796.27K Price 201.32
SMA20 -1.31% SMA50 -4.35% SMA200 -5.42% Trades
Volume 555,653 Change 0.53%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-25-24 Upgrade Argus
Hold → Buy
$250
Feb-26-24 Initiated Leerink Partners
Outperform
$260
Feb-09-24 Initiated Evercore ISI
In-line
$240
Jan-03-24 Initiated Barclays
Equal Weight
$222
Sep-06-23 Initiated HSBC Securities
Hold
$210
Dec-12-22 Downgrade Citigroup
Buy → Neutral
$275 → $250
Sep-19-22 Downgrade Argus
Buy → Hold
Aug-22-22 Resumed Morgan Stanley
Overweight
$300
Jan-28-22 Downgrade Deutsche Bank
Buy → Hold
$330 → $294
Jan-11-21 Upgrade Argus
Hold → Buy
$245
Jan-11-21 Downgrade Wolfe Research
Peer Perform → Underperform
Jan-08-21 Downgrade Wolfe Research
Outperform → Peer Perform
Jul-14-20 Upgrade BofA Securities
Neutral → Buy
$194 → $220
Jul-13-20 Upgrade Wolfe Research
Peer Perform → Outperform
Jun-02-20 Resumed Deutsche Bank
Buy
$210
May-15-20 Upgrade Mizuho
Neutral → Buy
$158 → $186
Apr-29-20 Downgrade KeyBanc Capital Markets
Overweight → Sector Weight
Apr-27-20 Upgrade Wolfe Research
Underperform → Peer Perform
Apr-27-20 Upgrade Citigroup
Neutral → Buy
$204 → $214
Jan-08-20 Initiated Wells Fargo
Overweight
$210
Show Previous Ratings
May-02-24 02:22AM
May-01-24 01:03AM
Apr-30-24 01:58PM
08:41AM
Apr-29-24 10:17AM
07:00AM
Loading…
07:00AM
Apr-26-24 11:14AM
10:34AM
07:55AM
01:06AM
(Thomson Reuters StreetEvents)
Apr-25-24 01:41PM
01:11PM
12:45PM
10:18AM
09:30AM
09:22AM
Loading…
09:22AM
08:35AM
07:09AM
07:06AM
(Associated Press Finance)
06:58AM
Apr-24-24 10:25PM
10:23PM
09:27PM
09:19PM
Apr-22-24 09:16AM
Apr-19-24 05:34AM
Apr-18-24 12:10PM
10:01AM
Apr-16-24 08:42AM
Apr-15-24 07:00AM
09:10AM
Loading…
Apr-12-24 09:10AM
Apr-11-24 06:59AM
Apr-10-24 06:49AM
Apr-09-24 09:03AM
Apr-08-24 09:34AM
07:09AM
07:03AM
07:00AM
Apr-05-24 07:00AM
Apr-03-24 11:01AM
11:00AM
Apr-02-24 11:20AM
07:00AM
Apr-01-24 12:42PM
08:00AM
Mar-30-24 01:30AM
Mar-29-24 09:00AM
Mar-28-24 11:08PM
08:00AM
Mar-27-24 07:00AM
Mar-25-24 07:03AM
Mar-20-24 07:00AM
Mar-18-24 09:44AM
Mar-16-24 10:29AM
Mar-15-24 09:25AM
Mar-11-24 11:00AM
Mar-08-24 10:26AM
Mar-07-24 07:00AM
Mar-05-24 07:00AM
Feb-27-24 12:08AM
Feb-26-24 08:45AM
05:01AM
Feb-21-24 12:00PM
08:19AM
Feb-19-24 06:28AM
Feb-16-24 09:41AM
07:15AM
12:59AM
(Thomson Reuters StreetEvents)
Feb-15-24 03:29PM
12:48PM
09:30AM
08:10AM
07:37AM
07:35AM
07:30AM
(Associated Press Finance)
06:56AM
Feb-12-24 09:16AM
Feb-08-24 10:00AM
04:08AM
Feb-07-24 09:05AM
Feb-05-24 08:16AM
Feb-01-24 04:55PM
07:00AM
Jan-31-24 07:00AM
Jan-16-24 06:58AM
Jan-12-24 06:57AM
Jan-11-24 11:21AM
Jan-10-24 08:02AM
Jan-05-24 04:45AM
Jan-02-24 07:00AM
Dec-29-23 09:23AM
Dec-26-23 03:59PM
Dec-21-23 09:03AM
Dec-17-23 05:05AM
Nov-30-23 07:46PM
Nov-27-23 08:35AM
Nov-24-23 07:21AM
Nov-22-23 05:04AM
Nov-20-23 07:00AM
Nov-16-23 07:00AM
Laboratory Corp. of America Holdings operates as a life sciences company, which engages in the provision of vital information to help health professionals make clear and confident decisions. It operates through the Drug Development and Diagnostics segments. The Drug Development segment consists of lead optimization, preclinical safety assessment, analytical services, clinical trials, central laboratories, biomarkers, and companion diagnostics, market access, and technology solutions. The Diagnostics segment includes primary care, women's health, specialty medicine, oncology, ACOs, and hospitals and health systems. The company was founded in 1971 and is headquartered in Burlington, NC.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
ANDERSON KERRII B Director May 02 '24 Sale 200.10 250 50,025 15,722 May 02 04:29 PM ANDERSON KERRII B Director Apr 30 '24 Sale 204.13 250 51,034 15,972 May 02 04:29 PM Wilkinson Peter J SVP, Chief Accounting Officer Apr 29 '24 Sale 204.33 2,439 498,358 2,087 May 01 06:29 PM Schroeder Mark S EVP, Pres Diagnostics & COO Apr 01 '24 Sale 217.29 6,477 1,407,387 5,036 Apr 03 08:35 AM Summy Amy B. EVP, Chief Marketing Officer Apr 01 '24 Sale 217.29 3,500 760,515 3,975 Apr 03 08:34 AM van der Vaart Sandra D EVP, Chief Legal Officer Mar 28 '24 Sale 216.74 3,553 770,077 7,637 Mar 29 05:54 PM Schroeder Mark S EVP, Pres Diagnostics & COO Mar 07 '24 Option Exercise 117.09 2,119 248,114 10,084 Mar 11 08:59 AM Schroeder Mark S EVP, Pres Diagnostics & COO Mar 07 '24 Sale 218.45 5,048 1,102,736 5,036 Mar 11 08:59 AM Summy Amy B. EVP, Chief Marketing Officer Mar 07 '24 Sale 218.45 227 49,588 3,859 Mar 11 08:56 AM EISENBERG GLENN A Chief Financial Officer, EVP Feb 21 '24 Option Exercise 163.63 14,054 2,299,656 58,099 Feb 22 03:05 PM EISENBERG GLENN A Chief Financial Officer, EVP Feb 21 '24 Sale 215.97 34,504 7,451,866 23,595 Feb 22 03:05 PM DiVincenzo Jonathan P. EVP, Pres, Central Labs & Intl Feb 21 '24 Sale 215.49 500 107,745 3,401 Feb 22 03:04 PM van der Vaart Sandra D EVP, Chief Legal Officer Feb 13 '24 Sale 226.45 237 53,669 7,637 Feb 15 08:32 AM van der Vaart Sandra D EVP, Chief Legal Officer Feb 08 '24 Sale 222.06 259 57,514 7,637 Feb 09 12:19 PM van der Vaart Sandra D EVP, Chief Legal Officer Feb 05 '24 Sale 220.57 193 42,570 7,637 Feb 06 03:47 PM Wilkinson Peter J SVP, Chief Accounting Officer Nov 16 '23 Sale 210.71 1,384 291,627 2,087 Nov 20 12:23 PM ANDERSON KERRII B Director Aug 08 '23 Sale 211.57 5,000 1,057,832 15,275 Aug 10 08:55 AM van der Vaart Sandra D EVP, Chief Legal Officer Jun 29 '23 Sale 240.00 212 50,880 7,605 Jul 03 11:52 AM Kirchgraber Paul R CEO, Covance Drug Development May 19 '23 Option Exercise 182.51 4,300 784,793 17,246 May 23 08:06 AM Kirchgraber Paul R CEO, Covance Drug Development May 19 '23 Sale 216.91 4,300 932,707 12,946 May 23 08:06 AM Schroeder Mark S EVP, Pres Diagnostics & COO May 18 '23 Option Exercise 130.60 1,500 195,900 8,187 May 22 03:08 PM Schroeder Mark S EVP, Pres Diagnostics & COO May 18 '23 Sale 216.77 1,500 325,155 6,687 May 22 03:08 PM
Index RUT P/E - EPS (ttm) -1.02 Insider Own 1.67% Shs Outstand 75.07M Perf Week 5.39%
Market Cap 1.53B Forward P/E - EPS next Y -0.04 Insider Trans -1.57% Shs Float 73.81M Perf Month 0.89%
Income -74.40M PEG - EPS next Q -0.16 Inst Own 104.21% Short Float 4.93% Perf Quarter -18.04%
Sales 361.05M P/S 4.23 EPS this Y 74.73% Inst Trans 0.36% Short Ratio 5.28 Perf Half Y -3.37%
Book/sh 14.25 P/B 1.43 EPS next Y 84.39% ROA -6.40% Short Interest 3.64M Perf Year -5.44%
Cash/sh 2.88 P/C 7.06 EPS next 5Y - ROE -7.02% 52W Range 18.61 - 30.52 Perf YTD -26.03%
Dividend Est. - P/FCF 44.59 EPS past 5Y -10.52% ROI -7.08% 52W High -33.32% Beta 1.70
Dividend TTM - Quick Ratio 4.40 Sales past 5Y 34.42% Gross Margin 61.81% 52W Low 9.35% ATR (14) 0.88
Dividend Ex-Date - Current Ratio 4.66 EPS Y/Y TTM -99.73% Oper. Margin -3.22% RSI (14) 50.02 Volatility 4.94% 4.02%
Employees 815 Debt/Eq 0.01 Sales Y/Y TTM 21.76% Profit Margin -20.61% Recom 1.89 Target Price 30.83
Option/Short Yes / Yes LT Debt/Eq 0.01 EPS Q/Q -623.36% Payout - Rel Volume 0.67 Prev Close 20.19
Sales Surprise 6.77% EPS Surprise -288.45% Sales Q/Q 22.29% Earnings May 07 AMC Avg Volume 689.13K Price 20.35
SMA20 2.18% SMA50 -4.33% SMA200 -15.50% Trades
Volume 463,335 Change 0.79%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-23-24 Reiterated Needham
Buy
$30 → $33
Jan-18-23 Downgrade Raymond James
Outperform → Mkt Perform
Jan-05-23 Initiated Scotiabank
Sector Outperform
$33
Jan-07-22 Initiated Stephens
Overweight
$52
Nov-18-21 Resumed Goldman
Buy
$60
Jun-15-21 Initiated Raymond James
Outperform
$45
Feb-18-21 Resumed Needham
Buy
$88
Jan-28-21 Initiated Truist
Buy
$61
Nov-10-20 Initiated KeyBanc Capital Markets
Sector Weight
$48
Sep-09-20 Initiated Morgan Stanley
Underweight
$35
Jul-31-19 Initiated Lake Street
Buy
$35
Jul-02-19 Initiated Needham
Buy
$33
Nov-29-18 Downgrade Janney
Buy → Neutral
Oct-31-18 Upgrade Janney
Neutral → Buy
Nov-07-17 Downgrade Piper Jaffray
Overweight → Neutral
Nov-07-17 Downgrade Janney
Buy → Neutral
Aug-31-17 Resumed BTIG Research
Buy
$13
Nov-14-16 Resumed Leerink Partners
Outperform
$12
Dec-18-15 Initiated Cantor Fitzgerald
Buy
$13
Jun-11-15 Reiterated Leerink Partners
Outperform
$11 → $13
Show Previous Ratings
Apr-22-24 05:00PM
08:30AM
Apr-16-24 08:30AM
Apr-02-24 10:33AM
Feb-27-24 05:55PM
03:20PM
Loading…
Feb-26-24 03:20PM
Feb-23-24 11:10AM
07:43AM
07:37AM
(Thomson Reuters StreetEvents)
Feb-22-24 06:05PM
05:03PM
(Associated Press Finance)
04:40PM
04:05PM
Feb-21-24 05:00PM
Feb-08-24 08:00AM
08:15AM
Loading…
Feb-06-24 08:15AM
Jan-08-24 08:00AM
Dec-12-23 04:30PM
Dec-01-23 04:05PM
Nov-29-23 08:30AM
Nov-22-23 08:30AM
Nov-08-23 04:39PM
Nov-07-23 04:57PM
(Associated Press Finance)
04:05PM
04:00PM
Nov-02-23 08:15AM
Oct-27-23 08:30AM
Oct-26-23 02:50PM
Oct-17-23 08:15AM
Oct-16-23 10:43AM
09:00AM
Loading…
Oct-12-23 09:00AM
Oct-04-23 04:05PM
Sep-28-23 04:05PM
08:15AM
Sep-27-23 09:00AM
Sep-21-23 04:05PM
Sep-07-23 04:05PM
Sep-06-23 08:15AM
Sep-02-23 06:15AM
Aug-29-23 08:15AM
Aug-22-23 08:15AM
Aug-15-23 04:15PM
Aug-08-23 06:05PM
04:55PM
04:05PM
Aug-01-23 08:15AM
Jul-19-23 05:00PM
Jul-08-23 08:43PM
Jun-20-23 08:31AM
Jun-12-23 08:31AM
May-30-23 06:56AM
May-25-23 05:13PM
May-24-23 09:00AM
May-23-23 05:00PM
May-22-23 07:30AM
May-12-23 06:15AM
May-05-23 01:59PM
May-04-23 06:25PM
04:05PM
09:45AM
May-03-23 05:44PM
08:30AM
May-02-23 04:05PM
May-01-23 05:35PM
Apr-29-23 04:31PM
Apr-27-23 04:05PM
10:02AM
09:55AM
Apr-18-23 09:48AM
Apr-17-23 08:30AM
Apr-13-23 05:00PM
Apr-12-23 08:30AM
Mar-23-23 06:54AM
Mar-15-23 04:15PM
11:44AM
Mar-11-23 12:11PM
Mar-10-23 09:30AM
Feb-27-23 05:00PM
Feb-24-23 05:42AM
Feb-22-23 06:15PM
04:05PM
Feb-15-23 08:36AM
Feb-13-23 05:23PM
10:14AM
Feb-06-23 05:00PM
Feb-01-23 04:05PM
08:32AM
Jan-24-23 10:23AM
Jan-23-23 09:00AM
Jan-18-23 06:10AM
Dec-22-22 08:54AM
Dec-21-22 09:08AM
Dec-15-22 04:05PM
Dec-12-22 12:00PM
Dec-01-22 02:46PM
(Investor's Business Daily)
Nov-09-22 06:15AM
Nov-02-22 06:55PM
04:05PM
Nov-01-22 05:11PM
Oct-27-22 05:00PM
Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
EASTHAM KARIN Director Apr 01 '24 Option Exercise 13.19 10,000 131,900 43,125 Apr 02 04:17 PM EASTHAM KARIN Director Apr 01 '24 Sale 21.65 10,000 216,528 33,125 Apr 02 04:17 PM JONES EVAN/ FA Director Mar 01 '24 Option Exercise 13.19 10,000 131,900 47,601 Mar 05 05:28 PM JONES EVAN/ FA Director Mar 01 '24 Sale 24.36 10,000 243,599 37,601 Mar 05 05:28 PM JONES EVAN/ FA Director Jul 19 '23 Sale 30.17 3,090 93,232 35,173 Jul 24 05:06 PM JONES EVAN/ FA Director Jul 19 '23 Sale 30.14 838 25,257 37,601 Jul 24 05:06 PM BISHOP JOHN L Director Jul 18 '23 Option Exercise 6.37 10,000 63,700 43,125 Jul 19 08:35 PM BISHOP JOHN L Director Jul 18 '23 Sale 30.50 10,000 305,000 33,125 Jul 19 08:35 PM JONES EVAN/ FA Director Jul 18 '23 Sale 30.19 7,441 224,616 38,263 Jul 19 08:33 PM JONES EVAN/ FA Director Jul 18 '23 Sale 30.16 2,324 70,090 38,439 Jul 19 08:33 PM BISHOP JOHN L Director Jul 17 '23 Option Exercise 6.37 10,000 63,700 43,125 Jul 19 08:35 PM JONES EVAN/ FA Director Jul 17 '23 Sale 30.07 23,949 720,106 45,704 Jul 19 08:33 PM JONES EVAN/ FA Director Jul 17 '23 Sale 30.07 19,095 574,106 40,763 Jul 19 08:33 PM BISHOP JOHN L Director Jul 17 '23 Sale 30.00 10,000 300,002 33,125 Jul 19 08:35 PM Bhanji Muna Director Jun 16 '23 Sale 26.44 5,893 155,786 28,514 Jun 21 04:55 PM Bhanji Muna Director May 30 '23 Sale 25.91 1,539 39,875 24,733 Jun 01 05:06 PM
Index RUT P/E 25.59 EPS (ttm) 3.84 Insider Own 2.08% Shs Outstand 16.23M Perf Week 3.87%
Market Cap 1.61B Forward P/E 18.39 EPS next Y 5.34 Insider Trans -10.22% Shs Float 16.03M Perf Month -3.88%
Income 62.52M PEG 1.71 EPS next Q 1.11 Inst Own 94.18% Short Float 2.20% Perf Quarter 10.49%
Sales 1.06B P/S 1.52 EPS this Y 6.17% Inst Trans 2.51% Short Ratio 2.58 Perf Half Y 21.49%
Book/sh 43.55 P/B 2.25 EPS next Y 9.82% ROA 6.37% Short Interest 0.35M Perf Year 17.59%
Cash/sh 3.96 P/C 24.81 EPS next 5Y 15.00% ROE 9.33% 52W Range 77.30 - 104.61 Perf YTD 5.76%
Dividend Est. - P/FCF 15.64 EPS past 5Y 23.63% ROI 7.18% 52W High -6.13% Beta 0.99
Dividend TTM - Quick Ratio 1.38 Sales past 5Y 15.56% Gross Margin 31.09% 52W Low 27.04% ATR (14) 3.07
Dividend Ex-Date - Current Ratio 1.38 EPS Y/Y TTM 34.76% Oper. Margin 9.21% RSI (14) 52.89 Volatility 3.02% 3.21%
Employees 34846 Debt/Eq 0.25 Sales Y/Y TTM 11.31% Profit Margin 5.91% Recom 1.56 Target Price 109.12
Option/Short Yes / Yes LT Debt/Eq 0.23 EPS Q/Q 32.22% Payout 0.00% Rel Volume 0.86 Prev Close 98.41
Sales Surprise 0.69% EPS Surprise 12.60% Sales Q/Q 11.86% Earnings May 06 AMC Avg Volume 136.55K Price 98.20
SMA20 1.34% SMA50 0.39% SMA200 8.14% Trades
Volume 117,674 Change -0.21%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-23-24 Downgrade Barclays
Equal Weight → Underweight
$83
Mar-06-24 Initiated Barclays
Equal Weight
$88
Feb-05-24 Resumed William Blair
Outperform
Dec-12-23 Initiated TD Cowen
Outperform
$105
Jun-29-22 Initiated Stifel
Buy
$101
Apr-13-22 Initiated BofA Securities
Buy
$110
Oct-22-19 Resumed Stephens
Overweight
Jun-27-19 Initiated BMO Capital Markets
Market Perform
Feb-04-19 Upgrade Robert W. Baird
Neutral → Outperform
Oct-08-18 Initiated RBC Capital Mkts
Outperform
$81
Aug-21-18 Initiated Jefferies
Buy
$75
Aug-20-18 Initiated Raymond James
Outperform
$75
Sep-30-14 Upgrade Oppenheimer
Perform → Outperform
$24
Jul-16-13 Downgrade Robert W. Baird
Outperform → Neutral
$14 → $20
Apr-04-13 Downgrade Oppenheimer
Outperform → Perform
$12 → $13
Dec-07-09 Initiated Robert W. Baird
Outperform
$13
Dec-07-09 Initiated Oppenheimer
Outperform
$12
Show Previous Ratings
May-02-24 09:40AM
Apr-23-24 09:18AM
08:00AM
Apr-22-24 11:00AM
Apr-13-24 12:18PM
09:00AM
Loading…
Apr-09-24 09:00AM
Mar-05-24 11:00AM
Mar-04-24 09:15AM
Mar-01-24 08:30AM
Feb-29-24 12:00PM
Feb-27-24 11:00AM
Feb-26-24 06:30PM
04:54PM
(Associated Press Finance)
04:53PM
04:05PM
09:15AM
Loading…
Feb-21-24 09:15AM
Feb-12-24 11:00AM
Nov-22-23 09:55AM
Nov-17-23 05:05AM
Nov-06-23 09:55AM
Nov-01-23 12:37PM
11:00AM
Oct-30-23 05:50PM
05:43PM
04:50PM
(Associated Press Finance)
04:05PM
Oct-23-23 10:15AM
Oct-19-23 11:40AM
Oct-17-23 06:21AM
Oct-16-23 12:00PM
08:58AM
Loading…
08:58AM
Oct-10-23 09:40AM
Oct-03-23 11:40AM
Sep-25-23 03:21AM
Sep-24-23 10:30AM
Aug-02-23 04:05PM
Aug-01-23 08:00AM
Jul-31-23 06:25PM
05:12PM
04:05PM
Jul-29-23 11:30AM
Jul-24-23 10:00AM
Jul-23-23 09:03AM
Jul-20-23 12:10PM
Jul-17-23 01:00PM
Jul-03-23 01:01PM
Jun-29-23 08:00AM
Jun-21-23 08:00PM
Jun-14-23 09:53AM
Jun-09-23 01:39PM
Jun-08-23 12:44PM
Jun-07-23 01:53PM
12:52PM
Jun-06-23 10:20AM
Jun-05-23 02:12PM
11:45AM
11:40AM
Jun-02-23 12:44PM
Jun-01-23 11:28AM
11:17AM
10:14AM
May-31-23 12:04PM
May-29-23 09:55AM
May-26-23 10:55AM
May-25-23 02:30PM
09:35AM
May-24-23 01:42PM
11:00AM
May-23-23 11:23AM
11:01AM
May-22-23 11:13AM
10:48AM
May-19-23 11:39AM
10:48AM
May-18-23 01:12PM
01:09PM
11:40AM
10:50AM
May-17-23 02:15PM
May-11-23 09:40AM
May-09-23 11:00AM
09:35AM
May-02-23 11:16PM
(Thomson Reuters StreetEvents)
11:00AM
May-01-23 05:45PM
04:05PM
02:37PM
11:40AM
08:00AM
Apr-27-23 10:02AM
Apr-26-23 08:00PM
09:40AM
07:38AM
Apr-24-23 10:00AM
Apr-17-23 11:00AM
Apr-14-23 11:40AM
Apr-10-23 09:40AM
Mar-29-23 08:00AM
Mar-24-23 09:40AM
07:07AM
Addus HomeCare Corp. engages in the provision of in-home personal care services. It operates through the following segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. The Hospice segment includes physical, emotional, and spiritual care for people who are terminally ill as well as related services for its families. The Home Health segment offers services that are primarily medical in nature to individuals who may require assistance during an illness or after hospitalization and include skilled nursing and physical, occupational, and speech therapy. The company was founded on July 27, 2006 and is headquartered in Frisco, TX.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Stevenson Roberton James EVP & Chief HR Officer Apr 01 '24 Sale 103.93 109 11,328 10,434 Apr 02 04:05 PM RAINES MONICA EVP/CCO and Quality Officer Mar 04 '24 Sale 93.86 235 22,057 11,986 Mar 05 04:09 PM ALLISON R DIRK CEO and Chairman Feb 26 '24 Sale 85.95 8,021 689,405 79,397 Feb 27 04:10 PM BICKHAM W BRADLEY President and COO Feb 26 '24 Sale 85.95 5,212 447,971 48,000 Feb 27 04:10 PM POFF BRIAN EVP/Chief Financial Officer Feb 26 '24 Sale 85.95 4,814 413,763 31,544 Feb 27 04:10 PM Anderson Darby EVP/Chief Legislative Officer Feb 26 '24 Sale 85.94 1,763 151,512 40,754 Feb 27 04:10 PM GAFFNEY SEAN EVP/Chief Legal Officer Feb 26 '24 Sale 85.95 1,639 140,872 18,002 Feb 27 04:10 PM TUCKER DAVID W. EVP/Chief Strategy Officer Feb 26 '24 Sale 85.96 1,347 115,788 10,497 Feb 27 04:10 PM WATTENBARGER MICHAEL D. EVP/Chief Information Officer Feb 26 '24 Sale 85.95 1,176 101,077 9,132 Feb 27 04:10 PM Stevenson Roberton James EVP & Chief HR Officer Feb 26 '24 Sale 85.95 714 61,368 10,543 Feb 27 04:10 PM RAINES MONICA EVP/CCO and Quality Officer Feb 26 '24 Sale 85.96 538 46,246 12,221 Feb 27 04:10 PM Anderson Darby EVP/Chief Legislative Officer Nov 14 '23 Option Exercise 23.10 9,690 223,839 46,550 Nov 16 04:39 PM Anderson Darby EVP/Chief Legislative Officer Nov 14 '23 Sale 85.00 9,690 823,650 36,860 Nov 16 04:39 PM TUCKER DAVID W. EVP / Chief Strategy Officer Nov 08 '23 Sale 83.45 248 20,696 6,973 Nov 09 05:13 PM WATTENBARGER MICHAEL D. EVP/Chief Information Officer Nov 08 '23 Sale 83.45 235 19,611 5,987 Nov 09 05:14 PM Anderson Darby EVP/Chief Legislative Officer Nov 07 '23 Option Exercise 23.10 3,008 69,485 39,868 Nov 09 05:13 PM Anderson Darby EVP/Chief Legislative Officer Nov 07 '23 Sale 85.00 3,008 255,680 36,860 Nov 09 05:13 PM BICKHAM W BRADLEY President and COO Aug 07 '23 Sale 93.85 5,000 469,250 38,285 Aug 08 05:01 PM TUCKER DAVID W. EVP / Chief Strategy Officer Aug 07 '23 Sale 94.23 1,636 154,160 7,221 Aug 08 05:01 PM WATTENBARGER MICHAEL D. EVP/Chief Information Officer Aug 07 '23 Sale 93.96 750 70,470 6,222 Aug 08 05:02 PM POFF BRIAN EVP/Chief Financial Officer Aug 04 '23 Sale 93.55 4,140 387,316 22,217 Aug 04 05:30 PM ALLISON R DIRK CEO and Chairman Aug 03 '23 Sale 94.39 24,922 2,352,473 52,850 Aug 04 05:29 PM Stevenson Roberton James EVP & Chief HR Officer Jun 15 '23 Sale 92.61 217 20,096 7,329 Jun 20 05:02 PM
Index - P/E 30.24 EPS (ttm) 18.57 Insider Own 2.25% Shs Outstand 15.03M Perf Week 0.22%
Market Cap 8.50B Forward P/E 22.12 EPS next Y 25.39 Insider Trans -9.44% Shs Float 14.80M Perf Month -10.75%
Income 283.40M PEG 2.69 EPS next Q 5.59 Inst Own 95.35% Short Float 2.95% Perf Quarter -6.56%
Sales 2.29B P/S 3.71 EPS this Y 14.83% Inst Trans 1.15% Short Ratio 5.20 Perf Half Y -2.49%
Book/sh 78.46 P/B 7.16 EPS next Y 8.92% ROA 17.94% Short Interest 0.44M Perf Year 2.05%
Cash/sh 20.70 P/C 27.14 EPS next 5Y 11.25% ROE 27.47% 52W Range 492.84 - 654.62 Perf YTD -3.95%
Dividend Est. 1.64 (0.29%) P/FCF 28.12 EPS past 5Y 7.95% ROI 21.96% 52W High -14.20% Beta 0.47
Dividend TTM 1.58 (0.28%) Quick Ratio 1.88 Sales past 5Y 4.95% Gross Margin 32.77% 52W Low 13.96% ATR (14) 11.95
Dividend Ex-Date Feb 23, 2024 Current Ratio 1.91 EPS Y/Y TTM 17.00% Oper. Margin 14.83% RSI (14) 28.72 Volatility 1.53% 1.77%
Employees 15087 Debt/Eq 0.13 Sales Y/Y TTM 5.96% Profit Margin 12.36% Recom 1.25 Target Price 689.88
Option/Short Yes / Yes LT Debt/Eq 0.09 EPS Q/Q 18.34% Payout 8.70% Rel Volume 0.84 Prev Close 559.65
Sales Surprise -0.38% EPS Surprise -5.11% Sales Q/Q 5.19% Earnings Apr 24 AMC Avg Volume 83.97K Price 561.65
SMA20 -6.37% SMA50 -9.50% SMA200 -1.21% Trades
Volume 70,750 Change 0.36%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-11-20 Upgrade RBC Capital Mkts
Sector Perform → Outperform
$448 → $535
Nov-01-19 Upgrade JMP Securities
Mkt Perform → Mkt Outperform
$490
Sep-06-19 Reiterated BofA/Merrill
Buy
$470 → $500
Oct-12-18 Initiated BofA/Merrill
Buy
$390
Aug-28-17 Initiated KeyBanc Capital Mkts
Sector Weight
Nov-01-16 Reiterated RBC Capital Mkts
Sector Perform
$162 → $148
Jul-27-16 Reiterated RBC Capital Mkts
Sector Perform
$136 → $162
May-02-16 Reiterated RBC Capital Mkts
Sector Perform
$135 → $136
Oct-26-15 Reiterated RBC Capital Mkts
Sector Perform
$129 → $154
Oct-26-15 Reiterated Oppenheimer
Outperform
$150 → $152
Sep-22-15 Reiterated Oppenheimer
Outperform
$147 → $150
Jul-27-15 Reiterated RBC Capital Mkts
Sector Perform
$110 → $129
Feb-19-15 Reiterated Oppenheimer
Outperform
$122 → $123
Sep-23-14 Reiterated Oppenheimer
Outperform
$110 → $115
Jun-10-14 Reiterated RBC Capital Mkts
Sector Perform
$70 → $74
May-01-14 Reiterated Oppenheimer
Outperform
$90 → $92
Sep-10-13 Reiterated Deutsche Bank
Hold
$70 → $63
Mar-04-11 Reiterated Barclays Capital
Underweight
$65 → $9
Feb-17-11 Reiterated RBC Capital Mkts
Sector Perform
$53 → $67
Feb-17-11 Reiterated Oppenheimer
Outperform
$67 → $72
Show Previous Ratings
Apr-30-24 12:15PM
Apr-26-24 12:35PM
03:17AM
Apr-25-24 11:37PM
(Thomson Reuters StreetEvents) -7.22%
08:27AM
06:10PM
Loading…
Apr-24-24 06:10PM
05:35PM
05:14PM
05:05PM
(Associated Press Finance)
04:15PM
Apr-17-24 10:26AM
10:00AM
Apr-03-24 04:29AM
Apr-01-24 03:00PM
12:00PM
11:30AM
Loading…
Mar-28-24 11:30AM
Mar-22-24 03:00PM
Mar-18-24 09:45AM
Mar-14-24 09:00AM
Mar-13-24 09:00AM
Mar-08-24 12:00PM
Mar-04-24 12:45PM
Feb-29-24 09:03AM
06:37AM
12:15AM
(Thomson Reuters StreetEvents)
Feb-27-24 08:00PM
07:15PM
06:20PM
(Associated Press Finance)
04:53PM
04:15PM
12:27PM
Loading…
Feb-16-24 12:27PM
Feb-14-24 12:00PM
Feb-05-24 10:59AM
Jan-22-24 08:29AM
Jan-08-24 11:24AM
Dec-29-23 12:00PM
Dec-25-23 07:14AM
Dec-22-23 04:18PM
Dec-18-23 01:20PM
Dec-14-23 09:05PM
Nov-30-23 03:00PM
Nov-28-23 05:04AM
Nov-24-23 11:31AM
Nov-17-23 09:55AM
Nov-15-23 10:10PM
Nov-13-23 07:33PM
Nov-08-23 10:33AM
Nov-06-23 09:00AM
Nov-03-23 04:15PM
11:28AM
05:03AM
Nov-02-23 01:03AM
Oct-27-23 03:04PM
08:08AM
12:31AM
(Thomson Reuters StreetEvents)
Oct-25-23 09:30PM
06:50PM
06:26PM
05:47PM
(Associated Press Finance)
04:15PM
Oct-20-23 11:40AM
Oct-11-23 12:00PM
Oct-04-23 11:40AM
Sep-25-23 07:25AM
Sep-18-23 11:40AM
Sep-14-23 10:48AM
Aug-31-23 11:40AM
Aug-15-23 01:20PM
Aug-08-23 06:28AM
Aug-07-23 07:08AM
Aug-04-23 11:56AM
Jul-27-23 08:23AM
Jul-26-23 10:00PM
06:45PM
05:43PM
04:15PM
Jul-21-23 09:56AM
Jul-20-23 11:40AM
Jul-12-23 12:00PM
Jul-10-23 08:25AM
Jun-21-23 08:00PM
Jun-14-23 09:53AM
Jun-06-23 08:40AM
Jun-05-23 08:56AM
Jun-01-23 12:00PM
May-24-23 09:03AM
May-15-23 02:43PM
May-10-23 12:00PM
11:40AM
May-09-23 06:40AM
May-03-23 12:00PM
May-02-23 03:14PM
06:39AM
Apr-30-23 09:13AM
Apr-28-23 11:24AM
Apr-27-23 11:47AM
10:45AM
09:33AM
06:11AM
Apr-26-23 08:00PM
Chemed Corp. engages in the provision of healthcare and maintenance services. It operates through the VITAS and Roto-Rooter segments. The VITAS segment offers hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers. The Roto-Rooter segment includes plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers. The company was founded in 1970 and is headquartered in Cincinnati, OH.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
LEE SPENCER S executive vice president Mar 28 '24 Option Exercise 106.59 13,000 1,385,670 33,760 Apr 01 11:43 AM LEE SPENCER S executive vice president Mar 28 '24 Sale 641.65 2,000 1,283,300 20,760 Apr 01 11:43 AM Witzeman Michael D VP & Chief Financial Officer Mar 21 '24 Sale 643.14 2,650 1,704,321 2,882 Mar 22 01:21 PM Judkins Brian C VP and Chief Legal Officer Mar 20 '24 Option Exercise 443.22 11,958 5,300,013 12,580 Mar 22 11:26 AM Witzeman Michael D VP & Chief Financial Officer Mar 20 '24 Option Exercise 413.19 2,600 1,074,294 5,887 Mar 22 01:21 PM Judkins Brian C VP and Chief Legal Officer Mar 20 '24 Sale 645.00 11,158 7,196,910 1,422 Mar 22 11:26 AM HUTTON THOMAS C vice president Mar 06 '24 Option Exercise 449.03 3,267 1,466,992 39,592 Mar 07 12:59 PM MCNAMARA KEVIN J president and CEO Feb 16 '24 Option Exercise 586.49 2,704 1,585,869 114,172 Feb 20 11:28 AM Westfall Nicholas Michael Executive Vice President Feb 16 '24 Option Exercise 586.49 785 460,395 8,461 Feb 20 03:12 PM LEE SPENCER S executive vice president Feb 16 '24 Option Exercise 586.49 480 281,515 23,048 Feb 20 03:15 PM Witzeman Michael D VP & Chief Financial Officer Feb 16 '24 Option Exercise 586.49 433 253,950 3,417 Feb 20 03:09 PM Judkins Brian C VP and Chief Legal Officer Feb 16 '24 Option Exercise 586.49 368 215,828 843 Feb 20 03:22 PM HUTTON THOMAS C vice president Feb 16 '24 Option Exercise 586.49 210 123,163 36,402 Feb 20 03:49 PM MCNAMARA KEVIN J president and CEO Dec 11 '23 Sale 572.77 1,500 859,155 111,468 Dec 13 11:56 AM LEE SPENCER S executive vice president Nov 27 '23 Sale 579.73 1,000 579,730 22,568 Nov 27 12:33 PM WILLIAMS DAVID PATRICK executive vice president & CFO Nov 14 '23 Sale 586.08 1,186 695,091 5,826 Nov 15 11:27 AM WILLIAMS DAVID PATRICK executive vice president & CFO Nov 13 '23 Sale 586.32 3,814 2,236,224 7,012 Nov 15 11:27 AM WILLIAMS DAVID PATRICK executive vice president & CFO Nov 10 '23 Sale 580.79 5,000 2,903,950 10,826 Nov 13 12:25 PM Witzeman Michael D vice president and controller Nov 08 '23 Option Exercise 413.19 3,300 1,363,527 5,669 Nov 08 02:43 PM WILLIAMS DAVID PATRICK executive vice president & CFO Nov 07 '23 Sale 583.85 6,000 3,503,100 15,826 Nov 08 11:26 AM LEE SPENCER S executive vice president Nov 07 '23 Sale 583.85 1,217 710,545 23,633 Nov 08 11:29 AM WILLIAMS DAVID PATRICK executive vice president & CFO Nov 03 '23 Option Exercise 460.80 35,235 16,236,196 52,967 Nov 06 01:28 PM WILLIAMS DAVID PATRICK executive vice president & CFO Nov 01 '23 Sale 568.87 5,000 2,844,350 17,732 Nov 02 03:45 PM MCNAMARA KEVIN J president and CEO Oct 31 '23 Option Exercise 433.67 15,700 6,808,683 131,615 Nov 01 03:37 PM WILLIAMS DAVID PATRICK executive vice president & CFO Oct 31 '23 Option Exercise 413.19 15,100 6,239,169 22,732 Nov 02 03:45 PM MCNAMARA KEVIN J president and CEO Oct 31 '23 Sale 560.68 5,000 2,803,400 112,968 Nov 01 03:37 PM MCNAMARA KEVIN J president and CEO Aug 04 '23 Option Exercise 413.19 3,000 1,239,570 118,571 Aug 07 10:28 AM MCNAMARA KEVIN J president and CEO Aug 03 '23 Sale 516.43 4,000 2,065,720 115,571 Aug 07 10:28 AM Westfall Nicholas Michael Executive Vice President Jun 01 '23 Option Exercise 413.19 12,670 5,235,117 20,346 Jun 05 03:10 PM Westfall Nicholas Michael Executive Vice President Jun 01 '23 Option Exercise 413.19 1,330 549,543 7,676 Jun 01 02:36 PM Westfall Nicholas Michael Executive Vice President Jun 01 '23 Sale 533.70 12,670 6,761,979 7,676 Jun 05 03:10 PM Westfall Nicholas Michael Executive Vice President May 30 '23 Sale 540.34 1,330 718,652 6,346 Jun 01 02:36 PM GRACE PATRICK P Director May 26 '23 Sale 544.24 294 160,007 3,270 May 30 01:52 PM
Index - P/E - EPS (ttm) -1.16 Insider Own 45.15% Shs Outstand 30.74M Perf Week 0.93%
Market Cap 353.38M Forward P/E - EPS next Y -0.97 Insider Trans -1.67% Shs Float 17.86M Perf Month 15.67%
Income -36.24M PEG - EPS next Q -0.27 Inst Own 34.75% Short Float 1.31% Perf Quarter 41.64%
Sales 0.31M P/S 1139.95 EPS this Y 13.06% Inst Trans 0.26% Short Ratio 1.16 Perf Half Y 523.56%
Book/sh 2.21 P/B 4.90 EPS next Y 3.55% ROA -34.23% Short Interest 0.23M Perf Year 214.49%
Cash/sh 1.51 P/C 7.20 EPS next 5Y - ROE -42.86% 52W Range 1.52 - 12.35 Perf YTD 81.44%
Dividend Est. - P/FCF - EPS past 5Y -21.21% ROI -51.05% 52W High -12.18% Beta 1.34
Dividend TTM - Quick Ratio 2.51 Sales past 5Y 109.61% Gross Margin -379.08% 52W Low 613.82% ATR (14) 0.75
Dividend Ex-Date - Current Ratio 2.51 EPS Y/Y TTM 18.61% Oper. Margin -12980.72% RSI (14) 57.71 Volatility 9.29% 7.39%
Employees 57 Debt/Eq 0.03 Sales Y/Y TTM 14.18% Profit Margin -11843.79% Recom 1.67 Target Price 2.75
Option/Short Yes / Yes LT Debt/Eq 0.01 EPS Q/Q 19.70% Payout - Rel Volume 0.24 Prev Close 10.63
Sales Surprise -56.24% EPS Surprise 3.10% Sales Q/Q -36.92% Earnings May 08 AMC Avg Volume 202.14K Price 10.85
SMA20 6.58% SMA50 13.45% SMA200 112.34% Trades
Volume 48,858 Change 2.07%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-30-22 Downgrade Citigroup
Buy → Neutral
$18 → $4
Nov-19-21 Initiated Oppenheimer
Outperform
$19
Oct-15-21 Resumed Cowen
Outperform
Apr-29-24 02:15PM
Mar-29-24 01:32AM
Mar-27-24 01:27AM
Mar-25-24 12:00PM
Mar-21-24 09:57AM
08:54PM
Loading…
Mar-20-24 08:54PM
05:33PM
05:20PM
04:05PM
Mar-12-24 11:40AM
Mar-04-24 08:30AM
Feb-29-24 11:14AM
Dec-11-23 12:00PM
Dec-06-23 01:19PM
08:30AM
01:00PM
Loading…
Nov-22-23 01:00PM
Nov-12-23 10:59AM
Nov-08-23 06:29PM
04:05PM
Oct-25-23 08:30AM
Sep-21-23 08:30AM
Aug-31-23 09:35AM
Aug-30-23 09:35AM
Aug-09-23 05:50PM
04:05PM
Jul-31-23 08:30AM
May-25-23 04:15PM
May-15-23 05:15PM
May-10-23 06:05PM
04:05PM
07:31AM
Loading…
May-04-23 07:31AM
Apr-27-23 08:30AM
Apr-24-23 09:35AM
Mar-27-23 12:00PM
02:27AM
Mar-24-23 06:29AM
Mar-22-23 05:35PM
04:05PM
Mar-09-23 04:05PM
Feb-23-23 04:20PM
Feb-18-23 07:43AM
Feb-15-23 08:30AM
Nov-29-22 08:30AM
Nov-15-22 08:30AM
Nov-09-22 06:15PM
04:05PM
Nov-04-22 04:00PM
Oct-04-22 08:30AM
Sep-22-22 08:30AM
Sep-20-22 07:19AM
Aug-11-22 07:00AM
Aug-10-22 05:55PM
04:05PM
Aug-03-22 10:00AM
Jul-28-22 08:30AM
Jun-06-22 02:15PM
May-19-22 04:15PM
May-18-22 03:03PM
May-10-22 04:05PM
May-05-22 08:30AM
May-02-22 08:30AM
Apr-12-22 08:30AM
Mar-30-22 07:30AM
Mar-29-22 04:00PM
Mar-18-22 12:00PM
07:00AM
Mar-03-22 08:30AM
Feb-17-22 08:30AM
Feb-07-22 08:30AM
Feb-01-22 08:30AM
Dec-15-21 08:30AM
Dec-02-21 08:00AM
Dec-01-21 11:40AM
Nov-30-21 08:00AM
Nov-10-21 09:01AM
Nov-09-21 04:01PM
Nov-08-21 04:20PM
Nov-04-21 08:00AM
Nov-03-21 08:00AM
Nov-02-21 08:00AM
Oct-27-21 08:30AM
Oct-15-21 10:59AM
Sep-28-21 08:30AM
Sep-20-21 08:30AM
Sep-15-21 08:00AM
Sep-14-21 08:00AM
Sep-13-21 08:00AM
Aug-30-21 04:05PM
Aug-17-21 08:00AM
Jul-14-21 09:03PM
Sera Prognostics, Inc. engages in the provision of personalized diagnostics to predict and manage pregnancy complications. It focuses on developing blood tests to predict the risks of preterm birth, preeclampsia and other pregnancy complications. The company was founded by Steven W. Graves, Dennis Farrar and M. Sean Esplin in 2008 and is headquartered in Salt Lake City, UT.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Boniface John J. Chief Scientific Officer Mar 28 '24 Option Exercise 0.91 24,474 22,271 164,245 Mar 28 05:56 PM Boniface John J. Chief Scientific Officer Mar 28 '24 Sale 9.04 24,474 221,245 139,771 Mar 28 05:56 PM Boniface John J. Chief Scientific Officer Mar 27 '24 Option Exercise 0.91 48,909 44,507 188,680 Mar 28 05:56 PM Boniface John J. Chief Scientific Officer Mar 27 '24 Sale 9.62 52,662 506,608 139,771 Mar 28 05:56 PM Lindgardt Zhenya Chief Executive Officer Mar 26 '24 Sale 9.37 38,899 364,484 908,104 Mar 26 08:00 PM Boniface John J. Chief Scientific Officer Mar 26 '24 Sale 9.55 21,438 204,733 143,524 Mar 26 05:38 PM Aerts Austin Chief Financial Officer Mar 26 '24 Sale 9.37 8,092 75,822 322,488 Mar 26 08:00 PM Boniface John J. Chief Scientific Officer Mar 25 '24 Sale 9.10 22,163 201,683 164,962 Mar 26 04:20 PM Harrison Robert Gardner Chief Information Officer Mar 06 '24 Sale 9.02 2,138 19,285 145,697 Mar 07 04:15 PM Jackson Benjamin General Counsel Mar 06 '24 Sale 9.02 1,856 16,741 150,179 Mar 07 04:15 PM Boniface John J. Chief Scientific Officer Mar 06 '24 Sale 9.02 1,664 15,009 187,125 Mar 07 04:16 PM Kearney Paul Chief Data Officer Mar 06 '24 Sale 9.02 1,028 9,273 159,038 Mar 07 04:16 PM Aerts Austin Chief Financial Officer Mar 06 '24 Sale 9.02 444 4,005 330,580 Mar 07 04:16 PM Lindgardt Zhenya Chief Executive Officer Feb 06 '24 Sale 8.03 27,997 224,816 947,003 Feb 07 04:56 PM Aerts Austin Chief Financial Officer Feb 06 '24 Sale 8.03 9,786 78,582 331,024 Feb 07 04:56 PM Boniface John J. Chief Scientific Officer Feb 06 '24 Sale 8.03 5,665 45,490 188,789 Feb 07 04:57 PM Jackson Benjamin General Counsel Feb 06 '24 Sale 8.03 5,665 45,490 152,035 Feb 07 04:57 PM Harrison Robert Gardner Chief Information Officer Feb 06 '24 Sale 8.03 5,665 45,490 147,835 Feb 07 04:56 PM Kearney Paul Chief Data Officer Feb 06 '24 Sale 8.03 4,984 40,022 160,066 Feb 07 04:56 PM Jackson Benjamin General Counsel Dec 07 '23 Sale 5.22 10,000 52,200 157,700 Dec 07 09:35 PM Boniface John J. Chief Scientific Officer Dec 07 '23 Sale 4.80 5,000 24,000 194,454 Dec 07 09:35 PM Harrison Robert Gardner Chief Information Officer Jun 05 '23 Sale 3.23 5,000 16,150 28,500 Jun 06 04:07 PM
Index S&P 500 P/E 15.34 EPS (ttm) 20.07 Insider Own 27.61% Shs Outstand 265.54M Perf Week 0.35%
Market Cap 80.61B Forward P/E 13.30 EPS next Y 23.14 Insider Trans -0.03% Shs Float 189.60M Perf Month -5.35%
Income 5.47B PEG 1.55 EPS next Q 4.90 Inst Own 66.13% Short Float 1.39% Perf Quarter -0.54%
Sales 66.72B P/S 1.21 EPS this Y 9.40% Inst Trans -2.51% Short Ratio 2.56 Perf Half Y 36.56%
Book/sh -6.14 P/B - EPS next Y 11.27% ROA 9.98% Short Interest 2.64M Perf Year 10.62%
Cash/sh 5.27 P/C 58.45 EPS next 5Y 9.88% ROE - 52W Range 215.96 - 335.83 Perf YTD 13.70%
Dividend Est. 2.62 (0.85%) P/FCF 14.84 EPS past 5Y 12.21% ROI 14.60% 52W High -8.36% Beta 1.70
Dividend TTM 2.46 (0.80%) Quick Ratio 1.02 Sales past 5Y 6.95% Gross Margin 14.62% 52W Low 42.51% ATR (14) 7.46
Dividend Ex-Date Jun 14, 2024 Current Ratio 1.16 EPS Y/Y TTM 0.27% Oper. Margin 14.62% RSI (14) 41.65 Volatility 1.92% 2.23%
Employees 310000 Debt/Eq - Sales Y/Y TTM 9.59% Profit Margin 8.20% Recom 1.73 Target Price 345.84
Option/Short Yes / Yes LT Debt/Eq - EPS Q/Q 22.37% Payout 12.66% Rel Volume 1.01 Prev Close 308.84
Sales Surprise 3.14% EPS Surprise 6.01% Sales Q/Q 11.21% Earnings Apr 26 BMO Avg Volume 1.03M Price 307.76
SMA20 -2.64% SMA50 -3.90% SMA200 10.21% Trades
Volume 1,039,218 Change -0.35%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-06-24 Initiated Barclays
Overweight
$356
Jan-04-24 Downgrade Bernstein
Outperform → Mkt Perform
$277 → $301
Dec-11-23 Downgrade Goldman
Buy → Neutral
$271
Apr-21-23 Initiated Cantor Fitzgerald
Overweight
$304
Apr-19-23 Resumed JP Morgan
Neutral
$257 → $283
Jul-06-22 Downgrade BMO Capital Markets
Market Perform → Underperform
$233 → $160
Jun-17-22 Initiated Loop Capital
Buy
$240
May-27-22 Upgrade Bernstein
Mkt Perform → Outperform
$273 → $271
Mar-29-22 Initiated Wells Fargo
Equal Weight
$267
Jan-10-22 Resumed Citigroup
Buy
$274 → $306
Dec-21-21 Downgrade JP Morgan
Overweight → Neutral
$270
Sep-27-21 Initiated SVB Leerink
Outperform
$320
Sep-24-21 Initiated UBS
Buy
$312
Sep-10-21 Initiated Cowen
Outperform
$293
Aug-12-21 Downgrade Barclays
Overweight → Equal Weight
$275 → $267
Jul-09-21 Initiated Seaport Global Securities
Buy
$235
May-13-21 Resumed Citigroup
Neutral
$215
Apr-26-21 Downgrade Citigroup
Buy → Neutral
$191 → $215
Dec-15-20 Initiated Goldman
Buy
$191
Dec-14-20 Upgrade JP Morgan
Neutral → Overweight
$194
Show Previous Ratings
May-03-24 06:11AM
01:07AM
May-02-24 10:02AM
May-01-24 12:05PM
Apr-30-24 09:40AM
09:00AM
Loading…
09:00AM
07:01AM
Apr-29-24 09:29AM
09:22AM
09:00AM
08:34AM
06:44AM
04:39AM
Apr-26-24 11:50PM
(Thomson Reuters StreetEvents)
01:44PM
12:55PM
Loading…
12:55PM
12:30PM
11:52AM
09:32AM
09:30AM
08:40AM
08:12AM
07:47AM
07:45AM
07:39AM
(Associated Press Finance)
07:36AM
07:30AM
Apr-25-24 09:02AM
Apr-24-24 11:27AM
09:45AM
09:30AM
Loading…
09:30AM
07:00AM
Apr-23-24 09:30AM
09:30AM
09:15AM
09:06AM
Apr-22-24 06:08PM
06:00PM
08:30AM
07:00AM
(The Wall Street Journal)
Apr-19-24 10:00AM
09:30AM
Apr-17-24 06:15PM
Apr-16-24 09:40AM
Apr-15-24 09:40AM
Apr-11-24 06:00PM
Apr-09-24 02:24PM
09:00AM
04:26AM
Apr-08-24 10:10AM
09:40AM
Apr-05-24 05:45PM
Apr-03-24 09:00AM
08:30AM
Apr-01-24 09:50AM
07:54AM
04:30AM
Mar-29-24 09:30AM
09:30AM
08:59AM
Mar-28-24 09:40AM
08:30AM
Mar-27-24 05:45PM
04:12AM
Mar-25-24 08:30AM
Mar-22-24 09:45AM
09:13AM
09:00AM
01:10AM
12:28AM
Mar-21-24 09:40AM
Mar-20-24 05:45PM
10:13AM
Mar-19-24 10:22AM
06:41AM
(Thomson Reuters StreetEvents)
Mar-18-24 09:30AM
Mar-17-24 09:50AM
Mar-13-24 04:40PM
(The Wall Street Journal)
09:30AM
12:21AM
Mar-12-24 11:23PM
05:45PM
08:30AM
Mar-08-24 09:40AM
Mar-07-24 09:50AM
09:00AM
Mar-06-24 06:29PM
09:45AM
Mar-05-24 12:05PM
Mar-04-24 05:45PM
08:30AM
Feb-29-24 07:41PM
(Investor's Business Daily)
04:30PM
12:56PM
11:30AM
09:40AM
Feb-26-24 05:45PM
09:30AM
Feb-23-24 01:23PM
09:40AM
HCA Healthcare, Inc. is a health care services company engaged in operating hospitals, freestanding surgery centers and emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, physician practices, home health, hospice, outpatient physical therapy home and community-based services providers, and various other facilities. The firm operates general and acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services, and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was founded by Dr. Thomas F. Frist, Jr in 1968 and is headquartered in Nashville, TN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Wasserman Chad J SVP and CIO Mar 20 '24 Sale 330.25 876 289,299 1,576 Mar 20 05:16 PM Wasserman Chad J SVP and CIO Mar 18 '24 Option Exercise 101.16 2,100 212,436 4,020 Mar 20 05:16 PM Wasserman Chad J SVP and CIO Mar 18 '24 Sale 321.97 344 110,758 2,452 Mar 20 05:16 PM Whalen Kathleen M SVP & Chief Ethics Officer Feb 09 '24 Sale 306.21 4,262 1,305,074 10,250 Feb 13 07:03 PM Torres Kathryn A. SVP-Payer Contracting & Align. Feb 06 '24 Option Exercise 173.12 2,092 362,167 21,717 Feb 08 07:13 PM RUTHERFORD BILL B CFO and EVP Feb 06 '24 Sale 310.63 6,000 1,863,780 8,448 Feb 06 06:34 PM Whalen Kathleen M SVP & Chief Ethics Officer Feb 05 '24 Option Exercise 82.82 8,550 708,084 18,800 Feb 07 07:45 PM Wyatt Christopher F. SVP & Controller Feb 05 '24 Sale 312.42 4,000 1,249,680 37,383 Feb 07 07:45 PM Mosier Sammie S SVP & Chief Nurse Executive Feb 05 '24 Sale 312.00 1,645 513,240 7,646 Feb 06 06:29 PM Mosier Sammie S SVP & Chief Nurse Executive Feb 02 '24 Option Exercise 231.79 6,298 1,459,806 14,315 Feb 06 06:29 PM RUTHERFORD BILL B CFO and EVP Feb 02 '24 Option Exercise 69.58 19,100 1,328,978 25,469 Feb 06 06:34 PM Wasserman Chad J SVP and CIO Feb 02 '24 Sale 312.04 652 203,451 290 Feb 06 06:28 PM Torres Kathryn A. SVP-Payer Contracting & Align. Feb 01 '24 Option Exercise 184.24 12,994 2,393,958 28,893 Feb 02 06:51 PM Wyatt Christopher F. SVP & Controller Jan 31 '24 Option Exercise 96.75 11,680 1,130,093 47,759 Feb 02 06:53 PM Torres Kathryn A. SVP-Payer Contracting & Align. Jan 31 '24 Sale 307.00 3,861 1,185,327 15,899 Feb 02 06:51 PM Cuffe Michael S. EVP and Chief Clinical Officer Jan 31 '24 Sale 306.79 3,200 981,734 24,929 Feb 02 06:38 PM Akdamar Erol R Group President Nov 13 '23 Option Exercise 47.97 26,825 1,286,795 26,825 Nov 15 05:37 PM Torres Kathryn A. SVP-Payer Contracting & Align. Aug 14 '23 Sale 269.12 5,204 1,400,516 19,760 Aug 16 05:12 PM Cohen Jeffrey E. SVP-Government Relations Aug 11 '23 Sale 270.00 1,500 405,000 4,414 Aug 15 05:20 PM Whalen Kathleen M SVP & Chief Ethics Officer Aug 03 '23 Sale 270.00 2,916 787,320 10,250 Aug 07 04:39 PM
Index RUT P/E - EPS (ttm) -4.28 Insider Own 4.79% Shs Outstand 121.63M Perf Week 8.82%
Market Cap 2.30B Forward P/E - EPS next Y -3.02 Insider Trans -0.07% Shs Float 116.04M Perf Month 4.02%
Income -479.45M PEG - EPS next Q -0.87 Inst Own 92.67% Short Float 8.24% Perf Quarter -14.92%
Sales 563.95M P/S 4.08 EPS this Y 23.51% Inst Trans 1.90% Short Ratio 4.96 Perf Half Y -27.97%
Book/sh 1.30 P/B 14.47 EPS next Y 7.83% ROA -28.23% Short Interest 9.56M Perf Year -18.13%
Cash/sh 9.59 P/C 1.97 EPS next 5Y 27.80% ROE -438.13% 52W Range 15.81 - 41.06 Perf YTD -30.20%
Dividend Est. - P/FCF - EPS past 5Y -8.88% ROI -32.30% 52W High -54.02% Beta 1.04
Dividend TTM - Quick Ratio 6.24 Sales past 5Y 49.27% Gross Margin 59.59% 52W Low 19.42% ATR (14) 1.06
Dividend Ex-Date - Current Ratio 6.54 EPS Y/Y TTM 33.21% Oper. Margin -99.80% RSI (14) 55.17 Volatility 4.85% 5.43%
Employees 1779 Debt/Eq 8.53 Sales Y/Y TTM 25.45% Profit Margin -85.02% Recom 1.43 Target Price 37.11
Option/Short Yes / Yes LT Debt/Eq 8.36 EPS Q/Q -15.63% Payout - Rel Volume 0.53 Prev Close 18.58
Sales Surprise 3.65% EPS Surprise -83.27% Sales Q/Q 22.19% Earnings May 09 AMC Avg Volume 1.93M Price 18.88
SMA20 6.53% SMA50 2.45% SMA200 -27.34% Trades
Volume 1,023,823 Change 1.61%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-24-24 Resumed Craig Hallum
Buy
$28
Dec-14-23 Initiated Guggenheim
Neutral
Dec-13-23 Initiated Wolfe Research
Peer Perform
Nov-13-23 Upgrade Raymond James
Mkt Perform → Outperform
$27
Sep-28-23 Initiated Bernstein
Outperform
$34
Sep-27-23 Upgrade Piper Sandler
Neutral → Overweight
$40
Jul-05-23 Resumed JP Morgan
Overweight
$65
May-26-23 Upgrade Citigroup
Neutral → Buy
$28 → $40
May-05-23 Initiated UBS
Buy
$40
Mar-09-23 Downgrade Citigroup
Buy → Neutral
$60 → $33
Jan-05-23 Initiated Scotiabank
Sector Outperform
$36
Nov-01-22 Downgrade Piper Sandler
Overweight → Neutral
$65 → $50
Oct-19-22 Initiated Craig Hallum
Buy
$88
Oct-06-22 Initiated Stephens
Overweight
$99
Aug-25-22 Initiated Credit Suisse
Outperform
$80
Jun-03-22 Initiated Piper Sandler
Overweight
$65
Apr-28-22 Resumed BTIG Research
Buy
$135 → $115
Feb-24-22 Reiterated Wells Fargo
Overweight
$150 → $115
Feb-24-22 Reiterated SVB Leerink
Outperform
$170 → $140
Feb-24-22 Reiterated Stifel
Buy
$160 → $130
Show Previous Ratings
Apr-29-24 04:01PM
11:18AM
Apr-22-24 08:52AM
Apr-18-24 04:05PM
Apr-03-24 08:05AM
04:02PM
Loading…
Apr-02-24 04:02PM
(Investor's Business Daily)
Apr-01-24 08:35AM
Mar-30-24 07:43PM
Mar-13-24 05:09PM
(Associated Press Finance)
05:00PM
Mar-06-24 04:30PM
Mar-01-24 05:30AM
Feb-28-24 06:46PM
Feb-26-24 02:13AM
Feb-23-24 11:48AM
07:00PM
Loading…
Feb-22-24 07:00PM
06:20PM
05:23PM
(Associated Press Finance)
04:38PM
04:05PM
09:55AM
Feb-16-24 03:10AM
Feb-15-24 04:05PM
10:00AM
Feb-07-24 09:00AM
Feb-02-24 09:35AM
Feb-01-24 04:05PM
09:35AM
Jan-31-24 07:08PM
Jan-30-24 09:02AM
09:25AM
Loading…
Jan-28-24 09:25AM
Jan-17-24 08:05AM
Jan-08-24 02:48PM
09:00AM
05:52AM
02:30AM
Jan-02-24 11:00AM
Dec-21-23 09:00AM
Dec-20-23 04:07PM
04:05PM
Dec-19-23 04:05PM
Dec-05-23 01:05AM
Dec-04-23 05:00AM
Nov-30-23 08:05AM
Nov-29-23 06:41PM
Nov-15-23 04:05PM
03:00AM
Nov-12-23 07:00PM
Nov-08-23 11:03AM
(Morningstar Research) -9.81%
Nov-07-23 10:59AM
08:21AM
(Thomson Reuters StreetEvents)
Nov-06-23 06:30PM
05:32PM
04:43PM
(Associated Press Finance)
04:05PM
Nov-03-23 08:00AM
Oct-31-23 08:05AM
Oct-30-23 05:25AM
Oct-23-23 03:45AM
Oct-17-23 09:15AM
Oct-16-23 04:05PM
Oct-11-23 09:53AM
Oct-10-23 05:18PM
Oct-09-23 02:03AM
Oct-08-23 07:30AM
Sep-29-23 08:23AM
Sep-28-23 04:22PM
11:25AM
Sep-27-23 12:10PM
11:40AM
10:00AM
Sep-22-23 11:45AM
Sep-18-23 12:12PM
Sep-15-23 06:44PM
Sep-14-23 12:58PM
Sep-09-23 07:31PM
Sep-06-23 08:05AM
Sep-05-23 08:05AM
Sep-03-23 10:24PM
Sep-01-23 03:46PM
Aug-31-23 04:05PM
Aug-30-23 11:41AM
Aug-22-23 05:51PM
Aug-17-23 04:05PM
Aug-10-23 09:53AM
Aug-07-23 03:28PM
(Investor's Business Daily)
Aug-05-23 06:55AM
Aug-04-23 10:45PM
(Morningstar Research) +6.42%
Aug-03-23 10:46PM
05:45PM
04:40PM
04:05PM
Aug-01-23 04:05PM
Jul-29-23 12:12AM
Jul-21-23 07:33AM
Jul-20-23 08:05AM
Jul-19-23 08:52AM
Jul-18-23 09:55AM
Jul-12-23 04:05PM
Jul-07-23 06:51AM
Guardant Health, Inc. is a precision oncology company engaged in the treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in 2011 and is headquartered in Palo Alto, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Krognes Steve E. Director Apr 30 '24 Option Exercise 0.00 154 0 3,393 May 02 05:03 PM Tariq Musa Director Apr 15 '24 Option Exercise 0.00 249 0 3,247 Apr 16 06:36 PM Saia John G. Chief Legal Officer Apr 15 '24 Option Exercise 0.00 7,569 0 28,366 Apr 16 06:35 PM POTTER MYRTLE S Director Apr 15 '24 Option Exercise 0.00 68 0 7,582 Apr 16 06:33 PM Joyce Meghan V. Director Apr 04 '24 Option Exercise 0.00 67 0 4,588 Apr 05 06:29 PM Saia John G. Chief Legal Officer Apr 01 '24 Option Exercise 0.00 974 0 22,305 Apr 02 06:09 PM Kalia Kumud Chief Information Officer Apr 01 '24 Option Exercise 0.00 1,607 0 14,329 Apr 02 06:08 PM Freeman Chris Chief Commercial Officer Apr 01 '24 Option Exercise 0.00 1,929 0 16,502 Apr 02 06:06 PM EAGLE CRAIG Chief Medical Officer Apr 01 '24 Option Exercise 0.00 1,714 0 12,073 Apr 02 06:05 PM Chudova Darya Chief Technology Officer Apr 01 '24 Option Exercise 0.00 1,340 0 36,831 Apr 02 06:04 PM Krognes Steve E. Director Mar 31 '24 Option Exercise 0.00 154 0 3,239 Apr 01 05:25 PM Talasaz AmirAli Co-Chief Executive Officer Mar 31 '24 Option Exercise 0.00 11,461 0 1,913,806 Apr 01 05:23 PM Eltoukhy Helmy Co-Chief Executive Officer Mar 31 '24 Option Exercise 0.00 11,461 0 2,097,470 Apr 01 05:20 PM Kalia Kumud Chief Information Officer Mar 18 '24 Buy 17.82 2,187 38,963 12,722 Mar 19 05:29 PM Tariq Musa Director Mar 15 '24 Option Exercise 0.00 2,998 0 2,998 Mar 18 06:16 PM POTTER MYRTLE S Director Mar 15 '24 Option Exercise 0.00 68 0 7,514 Mar 18 06:14 PM Bell Michael Brian Chief Financial Officer Mar 15 '24 Option Exercise 0.00 1,233 0 12,882 Mar 18 06:12 PM Joyce Meghan V. Director Mar 04 '24 Option Exercise 0.00 66 0 4,621 Mar 05 08:01 PM Joyce Meghan V. Director Mar 04 '24 Sale 19.05 100 1,905 4,521 Mar 05 08:01 PM Saia John G. Chief Legal Officer Mar 01 '24 Option Exercise 0.00 263 0 21,439 Mar 04 06:39 PM Merrill Amelia SVP, People Mar 01 '24 Option Exercise 0.00 158 0 27,540 Mar 04 06:37 PM Kalia Kumud Chief Information Officer Mar 01 '24 Option Exercise 0.00 710 0 10,789 Mar 04 06:35 PM Chudova Darya Chief Technology Officer Mar 01 '24 Option Exercise 0.00 316 0 35,621 Mar 04 06:34 PM Krognes Steve E. Director Feb 29 '24 Option Exercise 0.00 154 0 3,085 Mar 01 05:08 PM POTTER MYRTLE S Director Feb 15 '24 Option Exercise 0.00 69 0 7,446 Feb 16 07:10 PM Joyce Meghan V. Director Feb 04 '24 Option Exercise 0.00 66 0 4,555 Feb 05 08:12 PM Krognes Steve E. Director Jan 31 '24 Option Exercise 0.00 155 0 2,931 Feb 01 05:38 PM Chudova Darya Chief Technology Officer Jan 16 '24 Option Exercise 8.80 6,626 58,309 35,305 Jan 16 07:44 PM POTTER MYRTLE S Director Jan 15 '24 Option Exercise 0.00 68 0 7,377 Jan 16 07:43 PM Bell Michael Brian Chief Financial Officer Jan 15 '24 Option Exercise 0.00 3,308 0 13,005 Jan 16 07:41 PM Kalia Kumud Chief Information Officer Jan 07 '24 Option Exercise 0.00 5,376 0 12,250 Jan 08 07:45 PM Joyce Meghan V. Director Jan 04 '24 Option Exercise 0.00 67 0 4,489 Jan 05 04:58 PM Kalia Kumud Chief Information Officer Jan 01 '24 Option Exercise 0.00 1,607 0 7,533 Jan 03 07:48 PM Freeman Chris Chief Commercial Officer Jan 01 '24 Option Exercise 0.00 1,928 0 15,207 Jan 03 07:45 PM EAGLE CRAIG Chief Medical Officer Jan 01 '24 Option Exercise 0.00 1,714 0 11,062 Jan 03 07:44 PM Saia John G. Chief Legal Officer Jan 01 '24 Option Exercise 0.00 974 0 21,576 Jan 03 07:51 PM Merrill Amelia SVP, People Jan 01 '24 Option Exercise 0.00 482 0 27,580 Jan 03 07:49 PM Chudova Darya Chief Technology Officer Jan 01 '24 Option Exercise 0.00 1,339 0 29,228 Jan 03 07:42 PM Krognes Steve E. Director Dec 31 '23 Option Exercise 0.00 154 0 2,776 Jan 02 06:06 PM Bell Michael Brian Chief Financial Officer Dec 15 '23 Option Exercise 0.00 1,233 0 10,124 Dec 18 05:37 PM POTTER MYRTLE S Director Dec 15 '23 Option Exercise 0.00 69 0 7,309 Dec 18 05:39 PM Joyce Meghan V. Director Dec 04 '23 Option Exercise 0.00 66 0 4,522 Dec 05 05:01 PM Joyce Meghan V. Director Dec 04 '23 Sale 26.34 100 2,634 4,422 Dec 05 05:01 PM Kalia Kumud Chief Information Officer Dec 01 '23 Option Exercise 0.00 710 0 12,079 Dec 04 06:25 PM Chudova Darya Chief Technology Officer Dec 01 '23 Option Exercise 0.00 315 0 27,998 Dec 04 06:24 PM Saia John G. Chief Legal Officer Dec 01 '23 Option Exercise 0.00 263 0 20,733 Dec 04 06:28 PM Merrill Amelia SVP, People Dec 01 '23 Option Exercise 0.00 158 0 27,153 Dec 04 06:26 PM Kalia Kumud Chief Information Officer Dec 01 '23 Sale 26.37 5,800 152,954 5,926 Dec 04 06:25 PM Krognes Steve E. Director Nov 30 '23 Option Exercise 0.00 154 0 2,622 Dec 04 06:22 PM Chudova Darya Chief Technology Officer Nov 15 '23 Option Exercise 8.80 4,000 35,200 27,683 Nov 16 05:04 PM POTTER MYRTLE S Director Nov 15 '23 Option Exercise 0.00 68 0 7,240 Nov 16 05:02 PM Joyce Meghan V. Director Nov 04 '23 Option Exercise 0.00 66 0 4,456 Nov 06 05:40 PM Krognes Steve E. Director Oct 31 '23 Option Exercise 0.00 154 0 2,468 Nov 01 08:07 PM POTTER MYRTLE S Director Oct 15 '23 Option Exercise 0.00 68 0 7,172 Oct 16 06:28 PM Joyce Meghan V. Director Oct 04 '23 Option Exercise 0.00 67 0 4,390 Oct 05 06:02 PM Merrill Amelia SVP, People Oct 01 '23 Option Exercise 0.00 1,928 0 27,662 Oct 02 05:24 PM Kalia Kumud Chief Information Officer Oct 01 '23 Option Exercise 0.00 6,428 0 14,241 Oct 02 05:22 PM Freeman Chris Chief Commercial Officer Oct 01 '23 Option Exercise 0.00 7,713 0 15,407 Oct 02 05:20 PM EAGLE CRAIG Chief Medical Officer Oct 01 '23 Option Exercise 0.00 6,856 0 11,719 Oct 02 05:18 PM Chudova Darya Chief Technology Officer Oct 01 '23 Option Exercise 0.00 5,356 0 25,536 Oct 02 05:16 PM Saia John G. Chief Legal Officer Oct 01 '23 Option Exercise 0.00 3,895 0 21,817 Oct 02 05:25 PM Krognes Steve E. Director Sep 30 '23 Option Exercise 0.00 155 0 2,314 Oct 02 05:14 PM Chudova Darya Chief Technology Officer Sep 28 '23 Option Exercise 8.80 4,500 39,600 20,180 Sep 29 06:36 PM POTTER MYRTLE S Director Sep 15 '23 Option Exercise 0.00 69 0 7,104 Sep 19 07:07 PM Bell Michael Brian Chief Financial Officer Sep 15 '23 Option Exercise 0.00 1,233 0 9,318 Sep 19 07:04 PM Kalia Kumud Chief Information Officer Sep 12 '23 Sale 32.59 2,125 69,254 7,813 Sep 13 07:11 PM Merrill Amelia SVP, People Sep 09 '23 Option Exercise 0.00 1,047 0 26,097 Sep 11 05:57 PM Kalia Kumud Chief Information Officer Sep 09 '23 Option Exercise 0.00 6,544 0 12,201 Sep 11 05:55 PM Chudova Darya Chief Technology Officer Sep 09 '23 Option Exercise 0.00 2,908 0 16,686 Sep 11 05:52 PM Joyce Meghan V. Director Sep 05 '23 Sale 35.01 100 3,501 4,323 Sep 06 05:46 PM Joyce Meghan V. Director Sep 04 '23 Option Exercise 0.00 66 0 4,423 Sep 06 05:46 PM Chudova Darya Chief Technology Officer Sep 01 '23 Option Exercise 0.00 316 0 13,888 Sep 05 04:59 PM Saia John G. Chief Legal Officer Sep 01 '23 Option Exercise 0.00 263 0 18,315 Sep 05 04:56 PM Merrill Amelia SVP, People Sep 01 '23 Option Exercise 0.00 158 0 25,105 Sep 05 04:54 PM Kalia Kumud Chief Information Officer Sep 01 '23 Option Exercise 0.00 710 0 5,903 Sep 05 04:52 PM Krognes Steve E. Director Aug 31 '23 Option Exercise 0.00 154 0 2,159 Sep 05 04:46 PM POTTER MYRTLE S Director Aug 15 '23 Option Exercise 0.00 68 0 7,035 Aug 16 06:57 PM Merrill Amelia SVP, People Aug 15 '23 Option Exercise 0.00 631 0 25,166 Aug 16 06:56 PM Joyce Meghan V. Director Aug 04 '23 Option Exercise 0.00 66 0 4,357 Aug 07 05:13 PM Chudova Darya Chief Technology Officer Aug 01 '23 Option Exercise 0.00 1,440 0 14,070 Sep 05 04:59 PM Merrill Amelia SVP, People Aug 01 '23 Option Exercise 0.00 1,371 0 25,010 Aug 02 05:53 PM Krognes Steve E. Director Jul 31 '23 Option Exercise 0.00 154 0 2,005 Aug 01 06:08 PM POTTER MYRTLE S Director Jul 15 '23 Option Exercise 0.00 69 0 6,967 Jul 17 04:51 PM Joyce Meghan V. Director Jul 04 '23 Option Exercise 0.00 67 0 4,291 Jul 05 05:01 PM Krognes Steve E. Director Jun 30 '23 Option Exercise 0.00 1,851 0 1,851 Jul 05 04:59 PM Freeman Chris Chief Commercial Officer Jun 15 '23 Option Exercise 0.00 4,879 0 9,040 Jun 16 06:16 PM Bell Michael Brian Chief Financial Officer Jun 15 '23 Option Exercise 0.00 1,233 0 8,512 Jun 16 06:14 PM POTTER MYRTLE S Director Jun 15 '23 Option Exercise 0.00 68 0 6,898 Jun 16 06:12 PM Joyce Meghan V. Director Jun 15 '23 Sale 37.55 2,766 103,863 4,224 Jun 16 06:06 PM Joyce Meghan V. Director Jun 14 '23 Option Exercise 0.00 5,531 0 6,990 Jun 16 06:06 PM Gadde Vijaya Director Jun 14 '23 Option Exercise 0.00 5,531 0 12,048 Jun 16 06:05 PM CLARK IAN T Director Jun 14 '23 Option Exercise 0.00 6,703 0 8,901 Jun 16 06:03 PM POTTER MYRTLE S Director Jun 14 '23 Option Exercise 0.00 5,531 0 6,830 Jun 16 06:12 PM Kaul Samir Director Jun 14 '23 Option Exercise 0.00 5,531 0 11,404 Jun 16 06:08 PM Kalia Kumud Chief Information Officer Jun 09 '23 Buy 32.71 2,981 97,498 5,193 Jun 13 05:42 PM Joyce Meghan V. Director Jun 04 '23 Option Exercise 0.00 66 0 1,459 Jun 05 05:50 PM Kalia Kumud Chief Information Officer Jun 01 '23 Option Exercise 0.00 710 0 2,458 Jun 05 05:45 PM Saia John G. Chief Legal Officer Jun 01 '23 Option Exercise 0.00 263 0 18,143 Jun 05 05:49 PM Merrill Amelia SVP, People Jun 01 '23 Option Exercise 0.00 158 0 23,694 Jun 05 05:47 PM Chudova Darya Chief Technology Officer Jun 01 '23 Option Exercise 0.00 316 0 12,740 Sep 05 04:59 PM
Index - P/E - EPS (ttm) -5.25 Insider Own 37.76% Shs Outstand 25.98M Perf Week 77.44%
Market Cap 514.11M Forward P/E - EPS next Y -0.68 Insider Trans -7.20% Shs Float 16.27M Perf Month 117.24%
Income -135.02M PEG - EPS next Q -0.48 Inst Own 42.38% Short Float 6.57% Perf Quarter 411.98%
Sales 221.85M P/S 2.32 EPS this Y 65.21% Inst Trans -11.90% Short Ratio 3.00 Perf Half Y 945.74%
Book/sh 7.93 P/B 2.48 EPS next Y 62.29% ROA -28.73% Short Interest 1.07M Perf Year 142.18%
Cash/sh 4.32 P/C 4.55 EPS next 5Y - ROE -50.41% 52W Range 1.16 - 21.49 Perf YTD 614.91%
Dividend Est. - P/FCF - EPS past 5Y - ROI -41.99% 52W High -8.52% Beta 2.26
Dividend TTM - Quick Ratio 2.99 Sales past 5Y 5.08% Gross Margin 38.95% 52W Low 1594.83% ATR (14) 1.81
Dividend Ex-Date - Current Ratio 3.22 EPS Y/Y TTM 88.17% Oper. Margin -53.62% RSI (14) 76.31 Volatility 18.94% 12.85%
Employees 1000 Debt/Eq 0.58 Sales Y/Y TTM -0.91% Profit Margin -60.86% Recom 2.00 Target Price 15.25
Option/Short Yes / Yes LT Debt/Eq 0.55 EPS Q/Q 74.45% Payout - Rel Volume 2.01 Prev Close 19.50
Sales Surprise 26.23% EPS Surprise 62.83% Sales Q/Q 44.70% Earnings Apr 29 AMC Avg Volume 356.39K Price 19.66
SMA20 66.26% SMA50 94.41% SMA200 270.80% Trades
Volume 716,717 Change 0.82%
Apr-30-24 07:31AM
Apr-29-24 08:55PM
05:50PM
04:05PM
Apr-23-24 08:30AM
04:05PM
Loading…
Apr-04-24 04:05PM
Mar-21-24 09:55AM
Mar-14-24 08:30AM
Feb-26-24 04:05PM
Feb-21-24 08:33AM
Feb-20-24 04:26PM
Feb-01-24 04:30PM
Jan-24-24 04:30PM
Jan-08-24 08:55AM
Dec-01-23 08:30AM
04:05PM
Loading…
Nov-28-23 04:05PM
Nov-20-23 04:05PM
Nov-10-23 09:55AM
Nov-05-23 12:10PM
Oct-31-23 08:19AM
(Thomson Reuters StreetEvents) -30.34%
Oct-30-23 06:02PM
04:05PM
Oct-09-23 04:05PM
Sep-22-23 04:05PM
Sep-13-23 01:01PM
Sep-11-23 08:00AM
Sep-06-23 08:00AM
Aug-21-23 07:00AM
Aug-09-23 08:16AM
07:59AM
(Thomson Reuters StreetEvents)
08:05PM
Loading…
Aug-08-23 08:05PM
04:05PM
Aug-07-23 08:00AM
Jul-19-23 07:05AM
Jul-18-23 04:05PM
Jun-28-23 07:00AM
Jun-26-23 04:01PM
Jun-20-23 07:00AM
May-24-23 04:05PM
May-23-23 07:00AM
May-22-23 04:05PM
May-15-23 09:35AM
May-09-23 04:05PM
May-04-23 07:00AM
May-03-23 01:06PM
Apr-28-23 06:39PM
08:10AM
07:04AM
Apr-18-23 04:05PM
12:55PM
Apr-03-23 08:30AM
Mar-22-23 04:36PM
Mar-20-23 09:07PM
08:45AM
Mar-18-23 06:48PM
Mar-16-23 08:45AM
Mar-14-23 04:16PM
Mar-01-23 07:30AM
Feb-28-23 08:30AM
Feb-21-23 04:30PM
Feb-16-23 08:30AM
Jan-31-23 04:15PM
Jan-30-23 08:30AM
Jan-27-23 06:00AM
Jan-26-23 04:53PM
GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
PFENNIGER RICHARD C JR Director May 02 '24 Option Exercise 0.00 918 0 21,836 May 03 04:04 PM Feeley Kevin CHIEF FINANCIAL OFFICER Apr 29 '24 Option Exercise 0.00 3,013 0 31,940 Apr 30 04:27 PM Stueland Katherine Chief Executive Officer Apr 29 '24 Option Exercise 0.00 15,496 0 82,194 Apr 30 04:30 PM Stueland Katherine Chief Executive Officer Apr 29 '24 Sale 11.04 6,325 69,808 75,869 Apr 30 04:30 PM Feeley Kevin CHIEF FINANCIAL OFFICER Apr 29 '24 Sale 11.04 1,104 12,185 30,836 Apr 30 04:27 PM Stueland Katherine CHIEF EXECUTIVE OFFICER Mar 18 '24 Sale 10.59 8,559 90,661 66,698 Mar 19 04:15 PM Feeley Kevin CHIEF FINANCIAL OFFICER Mar 18 '24 Sale 10.59 3,253 34,455 28,927 Mar 19 04:14 PM Saad Kareem CHIEF TRANSFORMATION OFFICER Mar 18 '24 Sale 10.59 2,008 21,269 29,517 Mar 19 04:14 PM Stueland Katherine CHIEF EXECUTIVE OFFICER Mar 16 '24 Option Exercise 0.00 18,750 0 75,257 Mar 19 04:15 PM Feeley Kevin CHIEF FINANCIAL OFFICER Mar 16 '24 Option Exercise 0.00 7,197 0 32,180 Mar 19 04:14 PM Saad Kareem CHIEF TRANSFORMATION OFFICER Mar 16 '24 Option Exercise 0.00 5,114 0 31,525 Mar 19 04:14 PM Stueland Katherine CHIEF EXECUTIVE OFFICER Mar 12 '24 Sale 9.21 2,618 24,111 56,507 Mar 13 04:24 PM Feeley Kevin CHIEF FINANCIAL OFFICER Mar 12 '24 Sale 9.21 931 8,574 24,983 Mar 13 04:28 PM Saad Kareem CHIEF TRANSFORMATION OFFICER Mar 12 '24 Sale 9.21 897 8,261 26,411 Mar 13 04:22 PM Feeley Kevin CHIEF FINANCIAL OFFICER Mar 09 '24 Option Exercise 0.00 2,462 0 25,914 Mar 12 05:27 PM Stueland Katherine CHIEF EXECUTIVE OFFICER Mar 09 '24 Option Exercise 0.00 6,547 0 59,125 Mar 12 05:26 PM Saad Kareem CHIEF TRANSFORMATION OFFICER Mar 09 '24 Option Exercise 0.00 2,841 0 27,308 Mar 12 05:25 PM Casdin Capital, LLC Director Mar 05 '24 Buy 8.83 900 7,944 2,703,509 Mar 06 07:32 PM Casdin Capital, LLC Director Mar 04 '24 Buy 8.74 40,000 349,708 2,702,609 Mar 06 07:32 PM Saad Kareem CHIEF TRANSFORMATION OFFICER Jan 22 '24 Sale 3.24 193 625 24,467 Jan 23 04:10 PM Saad Kareem CHIEF TRANSFORMATION OFFICER Jan 19 '24 Option Exercise 0.00 546 0 24,660 Jan 23 04:10 PM Saad Kareem Chief Transformation Officer Jan 03 '24 Sale 2.58 105 271 24,114 Jan 04 05:03 PM Saad Kareem Chief Transformation Officer Jan 01 '24 Option Exercise 0.00 273 0 24,219 Jan 03 04:25 PM Ryan Jason Executive Chairman Dec 31 '23 Option Exercise 0.00 67,780 0 73,614 Jan 03 04:23 PM Stueland Katherine Chief Executive Officer Dec 18 '23 Sale 2.16 11,734 25,338 52,578 Dec 19 09:26 PM Feeley Kevin Chief Financial Officer Dec 18 '23 Sale 2.16 2,948 6,366 23,035 Dec 19 09:24 PM Saad Kareem Chief Transformation Officer Dec 18 '23 Sale 2.16 1,700 3,671 23,946 Dec 19 09:25 PM Stueland Katherine Chief Executive Officer Dec 16 '23 Option Exercise 0.00 18,750 0 64,312 Dec 19 09:26 PM Feeley Kevin Chief Financial Officer Dec 16 '23 Option Exercise 0.00 7,197 0 25,983 Dec 19 09:24 PM Saad Kareem Chief Transformation Officer Dec 16 '23 Option Exercise 0.00 5,114 0 25,646 Dec 19 09:25 PM Stueland Katherine Chief Executive Officer Dec 11 '23 Sale 1.61 3,673 5,915 45,562 Dec 12 04:06 PM Feeley Kevin Chief Financial Officer Dec 11 '23 Sale 1.61 908 1,462 18,786 Dec 12 04:04 PM Saad Kareem Chief Transformation Officer Dec 11 '23 Sale 1.61 850 1,369 20,532 Dec 12 04:05 PM Saad Kareem Chief Transformation Officer Dec 09 '23 Option Exercise 0.00 2,841 0 21,382 Dec 12 04:05 PM Stueland Katherine Chief Executive Officer Dec 09 '23 Option Exercise 0.00 6,546 0 49,235 Dec 12 04:06 PM Feeley Kevin Chief Financial Officer Dec 09 '23 Option Exercise 0.00 2,462 0 19,694 Dec 12 04:04 PM Feeley Kevin Chief Financial Officer Dec 04 '23 Sale 1.77 270 478 17,232 Dec 05 04:45 PM Ryan Jason Executive Chairman Nov 17 '23 Buy 1.54 58,000 89,181 114,742 Nov 20 04:32 PM Ryan Jason Executive Chairman Nov 16 '23 Buy 1.27 56,742 72,187 56,742 Nov 20 04:32 PM Meister Keith A. Director Nov 15 '23 Sale 1.29 883,742 1,140,027 3,011,066 Nov 17 04:18 PM PFENNIGER RICHARD C JR Director Nov 08 '23 Buy 1.49 10,000 14,889 20,918 Nov 08 07:19 PM Saad Kareem Chief Transformation Officer Oct 20 '23 Sale 3.44 164 564 18,541 Oct 23 05:52 PM Ryan Jason Executive Chairman Oct 17 '23 Sale 3.19 42 134 5,834 Oct 18 04:59 PM Saad Kareem Chief Transformation Officer Oct 03 '23 Sale 3.56 85 303 18,159 Oct 03 04:19 PM Stueland Katherine Chief Executive Officer Sep 18 '23 Sale 4.16 10,752 44,749 42,689 Sep 19 06:09 PM Feeley Kevin Chief Financial Officer Sep 18 '23 Sale 4.16 2,742 11,409 16,785 Sep 19 06:08 PM Saad Kareem Chief Transformation Officer Sep 18 '23 Sale 4.16 1,580 6,575 17,971 Sep 19 06:08 PM Feeley Kevin Chief Financial Officer Sep 16 '23 Option Exercise 0.00 7,197 0 19,527 Sep 19 06:08 PM Stueland Katherine Chief Executive Officer Sep 11 '23 Sale 4.62 2,675 12,369 34,691 Sep 12 06:42 PM Feeley Kevin Chief Financial Officer Sep 11 '23 Sale 4.62 904 4,180 12,330 Sep 12 06:40 PM Saad Kareem Chief Transformation Officer Sep 11 '23 Sale 4.62 846 3,912 14,437 Sep 12 06:41 PM Feeley Kevin Chief Financial Officer Sep 09 '23 Option Exercise 0.00 2,462 0 13,234 Sep 12 06:40 PM Feeley Kevin Chief Financial Officer Sep 05 '23 Sale 4.38 269 1,178 10,772 Sep 06 04:56 PM PFENNIGER RICHARD C JR Director Aug 17 '23 Buy 5.10 5,000 25,523 10,918 Aug 18 05:10 PM White Karen Ann Chief People Officer Jul 26 '23 Sale 7.41 61 452 4,761 Jul 27 04:12 PM Saad Kareem Chief Transformation Officer Jul 20 '23 Sale 7.85 163 1,280 12,442 Jul 21 09:58 PM Saad Kareem Chief Transformation Officer Jul 03 '23 Sale 5.99 83 497 12,059 Jul 05 05:16 PM White Karen Ann Chief People Officer Jul 03 '23 Sale 5.99 45 270 4,685 Jul 05 05:18 PM Stueland Katherine Chief Executive Officer Jun 20 '23 Sale 6.37 7,965 50,727 30,819 Jun 21 04:05 PM Feeley Kevin Chief Financial Officer Jun 20 '23 Sale 6.37 2,744 17,473 10,324 Jun 21 04:06 PM White Karen Ann Chief People Officer Jun 20 '23 Sale 6.37 1,549 9,865 4,631 Jun 21 04:05 PM Saad Kareem Chief Transformation Officer Jun 20 '23 Sale 6.37 1,221 7,774 11,869 Jun 21 04:04 PM Feeley Kevin Chief Financial Officer Jun 16 '23 Option Exercise 0.00 7,197 0 13,068 Jun 21 04:06 PM Feeley Kevin Chief Financial Officer Jun 13 '23 Sale 6.49 903 5,860 5,871 Jun 13 05:19 PM Stueland Katherine Chief Executive Officer Jun 12 '23 Sale 6.49 2,674 17,354 20,034 Jun 13 05:23 PM Saad Kareem Chief Transformation Officer Jun 12 '23 Sale 6.49 845 5,484 7,976 Jun 13 05:22 PM White Karen Ann Chief People Officer Jun 12 '23 Sale 6.49 828 5,374 2,770 Jun 13 05:25 PM Feeley Kevin Chief Financial Officer Jun 09 '23 Option Exercise 0.00 2,462 0 6,774 Jun 13 05:19 PM Feeley Kevin Chief Financial Officer Jun 02 '23 Sale 7.00 263 1,841 4,312 Jun 05 04:42 PM PFENNIGER RICHARD C JR Director May 18 '23 Buy 5.90 5,000 29,500 5,918 May 22 04:59 PM Stueland Katherine Chief Executive Officer May 16 '23 Sale 6.50 8,685 56,439 16,162 May 18 07:21 PM Feeley Kevin Chief Financial Officer May 16 '23 Sale 6.50 1,516 9,852 3,856 May 18 07:22 PM
Index - P/E - EPS (ttm) -0.53 Insider Own 26.31% Shs Outstand 406.39M Perf Week -3.40%
Market Cap 1.99B Forward P/E - EPS next Y -0.16 Insider Trans 0.02% Shs Float 302.91M Perf Month -0.21%
Income -215.05M PEG - EPS next Q -0.01 Inst Own 84.82% Short Float 15.19% Perf Quarter -20.56%
Sales 4.56B P/S 0.44 EPS this Y 33.29% Inst Trans 1.84% Short Ratio 9.59 Perf Half Y -71.37%
Book/sh 1.63 P/B 2.97 EPS next Y 50.77% ROA -11.59% Short Interest 46.02M Perf Year -79.64%
Cash/sh 1.20 P/C 4.01 EPS next 5Y - ROE -23.40% 52W Range 4.41 - 26.75 Perf YTD -61.51%
Dividend Est. - P/FCF - EPS past 5Y 7.65% ROI -30.50% 52W High -81.94% Beta 0.52
Dividend TTM - Quick Ratio 1.51 Sales past 5Y 53.71% Gross Margin 1.10% 52W Low 9.52% ATR (14) 0.41
Dividend Ex-Date Jun 20, 2008 Current Ratio 1.51 EPS Y/Y TTM -104.64% Oper. Margin -5.19% RSI (14) 43.80 Volatility 7.65% 8.23%
Employees 1117 Debt/Eq 0.08 Sales Y/Y TTM 68.26% Profit Margin -4.72% Recom 2.41 Target Price 7.30
Option/Short Yes / Yes LT Debt/Eq 0.07 EPS Q/Q -228.39% Payout - Rel Volume 0.83 Prev Close 4.83
Sales Surprise 1.90% EPS Surprise -48.01% Sales Q/Q 53.10% Earnings May 07 AMC Avg Volume 4.80M Price 4.83
SMA20 -5.61% SMA50 -11.19% SMA200 -59.63% Trades
Volume 3,995,948 Change 0.00%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-22-24 Initiated Citigroup
Neutral
$6
Mar-06-24 Initiated Barclays
Underweight
$5
Feb-26-24 Downgrade TD Cowen
Outperform → Market Perform
$12 → $6.50
Feb-26-24 Downgrade Jefferies
Buy → Hold
$25 → $6.50
Jan-08-24 Downgrade Wolfe Research
Outperform → Peer Perform
Jan-08-24 Downgrade Stifel
Buy → Hold
Jan-08-24 Downgrade Leerink Partners
Outperform → Market Perform
Jan-05-24 Downgrade Truist
Buy → Hold
$23 → $10
Jan-05-24 Downgrade JP Morgan
Overweight → Neutral
Dec-11-23 Downgrade Goldman
Buy → Neutral
$14
Dec-06-23 Initiated JMP Securities
Mkt Outperform
$18
Nov-21-23 Downgrade Deutsche Bank
Buy → Hold
$27 → $12
Oct-20-23 Initiated The Benchmark Company
Buy
$28
Jun-13-23 Initiated Evercore ISI
In-line
$22.50
Dec-09-22 Initiated Stifel
Buy
$23
Sep-14-22 Initiated RBC Capital Mkts
Outperform
$33
Sep-12-22 Initiated Goldman
Buy
$38
Sep-07-22 Resumed Truist
Buy
$33 → $29
Jun-24-22 Initiated BTIG Research
Neutral
Mar-30-22 Initiated Guggenheim
Buy
$32
Show Previous Ratings
Apr-16-24 04:00PM
Apr-15-24 07:15AM
Apr-08-24 06:25AM
Apr-07-24 11:45PM
Apr-03-24 05:45AM
02:27AM
Loading…
Mar-31-24 02:27AM
Mar-08-24 01:33AM
Feb-28-24 10:23AM
Feb-27-24 06:00PM
05:20PM
04:44PM
04:28PM
(Associated Press Finance)
04:00PM
09:00AM
Feb-26-24 09:16AM
04:00PM
Loading…
Feb-21-24 04:00PM
Feb-20-24 10:00AM
Feb-09-24 04:00PM
Feb-08-24 04:00PM
Feb-06-24 02:57PM
Jan-26-24 09:00PM
Jan-09-24 05:26AM
Jan-05-24 01:09PM
10:39AM
06:05AM
06:00AM
Jan-03-24 11:46AM
Dec-21-23 04:00PM
Dec-01-23 12:21PM
09:05AM
04:00PM
Loading…
Nov-07-23 04:00PM
Nov-06-23 10:08AM
Nov-02-23 07:04PM
05:30PM
04:00PM
Nov-01-23 04:00PM
Oct-23-23 04:10PM
Oct-11-23 04:30PM
Sep-14-23 01:28PM
Aug-24-23 04:01PM
Aug-03-23 10:30PM
05:15PM
04:11PM
(Associated Press Finance)
04:00PM
Jul-27-23 12:18PM
Jul-12-23 04:05PM
Jun-26-23 08:30AM
Jun-22-23 09:00AM
Jun-12-23 10:12AM
May-31-23 08:30AM
May-29-23 09:06AM
May-25-23 04:30PM
May-16-23 02:15AM
May-15-23 04:18PM
May-09-23 05:35PM
04:27PM
04:01PM
May-08-23 06:35AM
May-03-23 04:15PM
May-02-23 08:30AM
Apr-26-23 05:46AM
Apr-20-23 04:21PM
Apr-17-23 10:03AM
Mar-31-23 08:42AM
Mar-30-23 07:30AM
07:30AM
Mar-20-23 07:48AM
Mar-15-23 04:15PM
Mar-06-23 01:07AM
Mar-01-23 05:15PM
04:01PM
04:00PM
Feb-28-23 08:30AM
Feb-22-23 08:30AM
Feb-17-23 10:50AM
Feb-15-23 08:30AM
Feb-09-23 08:33AM
Jan-31-23 04:30PM
Jan-24-23 08:30AM
Dec-21-22 04:15PM
Dec-19-22 08:35AM
Nov-07-22 04:15PM
Nov-03-22 07:45PM
04:10PM
Oct-10-22 04:15PM
01:20PM
Sep-10-22 10:39AM
Sep-04-22 10:00AM
(The Wall Street Journal)
Aug-29-22 04:15PM
Aug-10-22 04:33PM
Aug-09-22 09:00AM
Aug-07-22 08:14AM
Aug-05-22 04:00AM
Aug-04-22 04:10PM
Jul-12-22 04:15PM
08:04AM
Jul-11-22 01:16PM
(Investor's Business Daily)
Jun-28-22 09:00AM
Jun-01-22 04:15PM
May-31-22 10:27AM
Agilon Health, Inc. engages in providing healthcare services. It also provides the technology, people, capital, process, and access to a peer network of primary care physicians. The company was founded by Ronald A. Williams and Veeral Desai in 2016 and is headquartered in Austin, TX.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
WILLIAMS RONALD A Director Jan 05 '24 Option Exercise 1.27 1,100,000 1,400,000 3,564,414 Jan 09 04:54 PM Schwaneke Jeffrey A. Director Nov 29 '23 Buy 11.22 22,300 250,206 31,931 Nov 30 05:04 PM Shaker Benjamin Chief Markets Officer Sep 13 '23 Option Exercise 3.79 18,750 71,062 98,293 Sep 14 04:37 PM Shaker Benjamin Chief Markets Officer Sep 13 '23 Sale 18.00 18,750 337,455 79,543 Sep 14 04:37 PM Shaker Benjamin Chief Markets Officer Sep 12 '23 Option Exercise 3.79 18,750 71,062 98,293 Sep 14 04:37 PM Shaker Benjamin Chief Markets Officer Sep 12 '23 Sale 18.05 18,750 338,481 79,543 Sep 14 04:37 PM Gertsch Timothy Chief Accounting Officer Sep 11 '23 Option Exercise 7.49 26,250 196,700 34,621 Sep 13 06:03 PM Gertsch Timothy Chief Accounting Officer Sep 11 '23 Sale 18.61 26,250 488,616 17,121 Sep 13 06:03 PM Shaker Benjamin Chief Markets Officer Aug 15 '23 Option Exercise 3.79 18,750 71,062 98,293 Aug 16 04:17 PM Shaker Benjamin Chief Markets Officer Aug 15 '23 Sale 18.10 18,750 339,309 79,543 Aug 16 04:17 PM Shaker Benjamin Chief Markets Officer Aug 14 '23 Option Exercise 3.79 18,750 71,062 98,293 Aug 16 04:17 PM Shaker Benjamin Chief Markets Officer Aug 14 '23 Sale 18.72 18,750 351,082 79,543 Aug 16 04:17 PM Shaker Benjamin Chief Markets Officer Jul 13 '23 Option Exercise 3.79 18,750 71,062 98,293 Jul 14 04:28 PM Shaker Benjamin Chief Markets Officer Jul 13 '23 Sale 16.93 18,750 317,424 79,543 Jul 14 04:28 PM Shaker Benjamin Chief Markets Officer Jul 12 '23 Option Exercise 3.79 18,750 71,062 98,293 Jul 14 04:28 PM Shaker Benjamin Chief Markets Officer Jul 12 '23 Sale 16.97 18,750 318,182 79,543 Jul 14 04:28 PM Shaker Benjamin Chief Markets Officer Jun 15 '23 Option Exercise 3.79 18,750 71,062 98,293 Jun 16 04:14 PM Shaker Benjamin Chief Markets Officer Jun 15 '23 Sale 18.73 18,750 351,103 79,543 Jun 16 04:14 PM Shaker Benjamin Chief Markets Officer Jun 14 '23 Option Exercise 3.71 18,750 69,600 95,342 Jun 16 04:14 PM Shaker Benjamin Chief Markets Officer Jun 14 '23 Sale 18.57 18,750 348,146 79,543 Jun 16 04:14 PM CD&R Investment Associates IX, 10% Owner May 18 '23 Sale 20.80 94,173,804 1,958,937,549 100,000,000 May 18 04:05 PM Shaker Benjamin Chief Markets Officer May 16 '23 Option Exercise 3.00 25,000 75,000 104,543 May 17 04:46 PM Shaker Benjamin Chief Markets Officer May 16 '23 Sale 23.14 25,000 578,535 79,543 May 17 04:46 PM Shaker Benjamin Chief Markets Officer May 15 '23 Option Exercise 3.00 25,000 75,000 104,543 May 17 04:46 PM Shaker Benjamin Chief Markets Officer May 15 '23 Sale 23.79 25,000 594,732 79,543 May 17 04:46 PM Desai Veeral Chief Strategy & Dev. Officer May 09 '23 Option Exercise 3.00 4,500 13,500 304,085 May 11 04:52 PM Desai Veeral Chief Strategy & Dev. Officer May 09 '23 Sale 26.15 4,500 117,666 299,585 May 11 04:52 PM
Index RUT P/E 55.62 EPS (ttm) 0.06 Insider Own 16.97% Shs Outstand 104.06M Perf Week 0.00%
Market Cap 368.33M Forward P/E 9.62 EPS next Y 0.38 Insider Trans 0.18% Shs Float 84.71M Perf Month -5.25%
Income 6.86M PEG 1.79 EPS next Q 0.08 Inst Own 47.79% Short Float 10.93% Perf Quarter 4.94%
Sales 624.29M P/S 0.59 EPS this Y 407.04% Inst Trans 20.05% Short Ratio 9.20 Perf Half Y -40.72%
Book/sh 2.89 P/B 1.25 EPS next Y 23.40% ROA 1.55% Short Interest 9.26M Perf Year -58.02%
Cash/sh 0.58 P/C 6.21 EPS next 5Y 31.07% ROE 2.39% 52W Range 2.78 - 10.82 Perf YTD -35.42%
Dividend Est. - P/FCF - EPS past 5Y - ROI 2.17% 52W High -66.64% Beta 0.96
Dividend TTM - Quick Ratio 1.99 Sales past 5Y 106.22% Gross Margin 28.66% 52W Low 29.86% ATR (14) 0.21
Dividend Ex-Date - Current Ratio 1.99 EPS Y/Y TTM -81.04% Oper. Margin 2.41% RSI (14) 51.78 Volatility 5.19% 6.27%
Employees 4100 Debt/Eq 0.15 Sales Y/Y TTM 41.72% Profit Margin 1.10% Recom 1.00 Target Price 9.67
Option/Short Yes / Yes LT Debt/Eq 0.05 EPS Q/Q -7.61% Payout 0.00% Rel Volume 1.15 Prev Close 3.51
Sales Surprise 2.59% EPS Surprise -25.37% Sales Q/Q 83.16% Earnings May 08 AMC Avg Volume 1.01M Price 3.61
SMA20 3.45% SMA50 -2.18% SMA200 -33.71% Trades
Volume 1,161,573 Change 2.85%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-18-23 Initiated BTIG Research
Buy
$15
Apr-21-23 Initiated Cantor Fitzgerald
Overweight
$11
Apr-19-22 Initiated Deutsche Bank
Buy
$11
Jan-19-22 Initiated Stifel
Buy
$14
Dec-21-21 Initiated Canaccord Genuity
Buy
$13
Dec-07-21 Initiated Needham
Buy
$14
May-01-24 10:01AM
Apr-29-24 10:02AM
Apr-25-24 11:07PM
Apr-22-24 07:35AM
Apr-10-24 02:13PM
11:00AM
Loading…
Apr-02-24 11:00AM
Mar-20-24 07:35AM
Mar-14-24 07:35AM
Feb-29-24 09:33AM
Feb-28-24 04:47PM
04:05PM
Feb-20-24 07:35AM
Feb-14-24 10:25AM
Feb-13-24 07:35AM
Feb-12-24 11:40AM
01:54PM
Loading…
Feb-08-24 01:54PM
Feb-05-24 07:35AM
Feb-01-24 04:39PM
Jan-31-24 07:35AM
Jan-26-24 09:00PM
Jan-25-24 12:42PM
Jan-18-24 09:00PM
11:21AM
Jan-16-24 07:35AM
Jan-10-24 03:59PM
02:44PM
12:00PM
Jan-09-24 07:35AM
Jan-04-24 01:04PM
(The Wall Street Journal)
Dec-21-23 07:35AM
07:45AM
Loading…
Dec-19-23 07:45AM
Dec-12-23 09:51PM
Dec-01-23 07:20PM
Nov-28-23 07:15PM
Nov-08-23 02:26PM
08:00AM
07:35AM
Nov-06-23 10:15PM
04:33PM
04:05PM
Nov-04-23 08:00AM
Oct-23-23 07:35AM
Oct-18-23 07:35AM
Oct-17-23 05:34PM
Oct-13-23 09:00PM
Oct-11-23 07:35AM
Oct-09-23 07:35AM
Oct-04-23 07:35AM
Sep-28-23 07:35AM
Sep-18-23 08:15AM
Sep-05-23 07:35AM
Aug-15-23 07:35AM
Aug-11-23 06:03AM
Aug-07-23 04:05PM
Jul-31-23 07:35AM
Jul-26-23 01:30PM
Jul-24-23 07:35AM
Jul-20-23 07:35AM
Jun-14-23 07:35AM
May-24-23 07:30AM
May-08-23 04:05PM
May-05-23 07:35AM
May-03-23 02:00PM
May-02-23 07:35AM
Apr-25-23 07:37AM
07:35AM
Apr-04-23 07:35AM
Mar-31-23 07:00AM
(Investor's Business Daily)
Mar-28-23 07:30AM
Mar-13-23 04:06PM
04:05PM
Feb-27-23 07:35AM
Feb-21-23 07:35AM
Jan-12-23 07:35AM
Jan-03-23 07:35AM
Dec-29-22 07:35AM
Dec-19-22 07:35AM
Dec-06-22 07:35AM
Nov-22-22 07:35AM
Nov-14-22 07:35AM
Nov-11-22 07:35AM
Nov-09-22 09:15AM
Nov-07-22 04:35PM
Nov-02-22 07:35AM
Nov-01-22 07:35AM
Oct-26-22 04:35PM
07:35AM
Oct-20-22 07:35AM
Oct-12-22 06:19AM
Oct-11-22 07:35AM
Oct-04-22 07:35AM
Sep-20-22 07:35AM
Sep-07-22 07:35AM
Aug-29-22 08:00AM
Aug-16-22 07:35AM
Aug-15-22 07:35AM
Aug-11-22 07:35AM
Aug-08-22 04:05PM
Aug-03-22 07:35AM
Jul-27-22 07:35AM
DocGo, Inc. engages in the provision of mobile health services. It operates through the following segments: Transportation Services, Mobile Health Solutions, and Corporate. The Transportation Services segment offers on-demand medical mobility solutions which are marketed under the Ambulnz brand. The Mobile Health Solutions segment includes on-site evaluations, diagnostics, triage, treatment, and medicine administration. The Corporate segment consists of information technology expenses. The company was founded in 2015 by Stanley Vashovsky and is headquartered in New York, NY.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
KATZ STEVEN Director Mar 15 '24 Buy 3.64 13,500 49,140 69,534 Mar 18 04:38 PM ROSENBERG NORMAN CFO and Treasurer Mar 14 '24 Buy 3.61 10,000 36,100 274,222 Mar 18 04:32 PM Burdiek Michael J Director Mar 14 '24 Buy 3.61 10,000 36,100 571,595 Mar 14 04:47 PM Burdiek Michael J Director Dec 15 '23 Option Exercise 0.00 23,088 0 561,595 Dec 18 05:11 PM TRAVERS JAMES M Director Dec 15 '23 Option Exercise 0.00 23,088 0 56,034 Dec 18 07:19 PM Sugrue Stephen Chief Compliance Officer Nov 28 '23 Sale 5.75 2,859 16,439 32,257 Nov 28 05:28 PM Bienstock Lee Chief Executive Officer Oct 16 '23 Sale 5.89 1,667 9,819 299,037 Oct 17 05:31 PM Tendler Ely D General Counsel and Secretary Oct 02 '23 Option Exercise 1.59 10,000 15,900 33,088 Oct 04 05:32 PM Tendler Ely D General Counsel and Secretary Oct 02 '23 Sale 5.29 10,000 52,900 23,088 Oct 04 05:32 PM Tendler Ely D General Counsel and Secretary Sep 15 '23 Option Exercise 1.59 10,000 15,900 33,088 Sep 19 05:33 PM Tendler Ely D General Counsel and Secretary Sep 15 '23 Sale 5.91 10,000 59,100 23,088 Sep 19 05:33 PM Bienstock Lee Chief Executive Officer Sep 15 '23 Sale 6.32 1,667 10,535 300,704 Sep 19 05:37 PM Capone Anthony Chief Executive Officer Sep 01 '23 Sale 9.00 2,000 18,000 404,275 Sep 06 09:51 PM Tendler Ely D General Counsel and Secretary Aug 22 '23 Option Exercise 1.59 10,000 15,900 33,088 Aug 24 05:02 PM Tendler Ely D General Counsel and Secretary Aug 22 '23 Sale 8.75 10,000 87,500 23,088 Aug 24 05:02 PM Capone Anthony Chief Executive Officer Aug 16 '23 Sale 10.01 15,000 150,150 406,275 Aug 17 04:30 PM Bienstock Lee President & COO Aug 16 '23 Sale 10.19 1,667 16,987 302,371 Aug 17 04:30 PM Oberholzer Adriaan Stephanus See Remarks Aug 15 '23 Sale 10.33 79,029 816,370 1,114,384 Aug 16 04:30 PM Oberholzer Adriaan Stephanus See Remarks Aug 14 '23 Sale 10.15 50,000 507,500 1,193,413 Aug 16 04:30 PM Capone Anthony Chief Executive Officer Jun 08 '23 Sale 9.50 5,400 51,300 421,275 Jun 09 04:30 PM Oberholzer Adriaan Stephanus See Remarks Jun 01 '23 Sale 9.07 42,497 385,448 1,243,413 Jun 01 07:09 PM Oberholzer Adriaan Stephanus See Remarks May 31 '23 Sale 9.01 22,366 201,518 1,285,910 Jun 01 07:09 PM Oberholzer Adriaan Stephanus See Remarks May 30 '23 Sale 9.02 16,271 146,764 1,308,276 Jun 01 07:09 PM Oberholzer Adriaan Stephanus See Remarks May 25 '23 Sale 9.07 300 2,721 1,324,547 May 25 06:48 PM Oberholzer Adriaan Stephanus See Remarks May 24 '23 Sale 9.14 40,000 365,600 1,324,847 May 25 06:48 PM Oberholzer Adriaan Stephanus See Remarks May 23 '23 Sale 9.11 7,595 69,190 1,364,847 May 25 06:48 PM Sugrue Stephen Chief Compliance Officer May 19 '23 Option Exercise 3.25 16,129 52,419 32,257 May 23 04:01 PM TRAVERS JAMES M Director May 17 '23 Sale 8.51 65,000 553,150 391,028 May 18 04:30 PM TRAVERS JAMES M Director May 16 '23 Sale 8.55 60,000 513,000 456,028 May 18 04:30 PM
Index RUT P/E - EPS (ttm) - Insider Own 69.16% Shs Outstand 171.19M Perf Week 8.70%
Market Cap 1.97B Forward P/E 14.00 EPS next Y 0.82 Insider Trans 0.09% Shs Float 52.79M Perf Month 11.76%
Income - PEG - EPS next Q 0.18 Inst Own 0.87% Short Float 27.74% Perf Quarter 3.60%
Sales - P/S - EPS this Y 150.01% Inst Trans - Short Ratio 7.74 Perf Half Y -
Book/sh 9.16 P/B 1.26 EPS next Y 25.38% ROA - Short Interest 14.64M Perf Year -
Cash/sh 0.34 P/C 33.92 EPS next 5Y - ROE - 52W Range 7.85 - 12.14 Perf YTD 4.55%
Dividend Est. - P/FCF - EPS past 5Y 12.91% ROI - 52W High -5.27% Beta -
Dividend TTM - Quick Ratio 0.96 Sales past 5Y 14.32% Gross Margin - 52W Low 46.50% ATR (14) 0.45
Dividend Ex-Date - Current Ratio 1.26 EPS Y/Y TTM - Oper. Margin 3.91% RSI (14) 66.92 Volatility 4.97% 4.05%
Employees 600 Debt/Eq 1.84 Sales Y/Y TTM - Profit Margin - Recom 1.00 Target Price 15.95
Option/Short Yes / Yes LT Debt/Eq 1.75 EPS Q/Q -101.51% Payout - Rel Volume 0.81 Prev Close 11.06
Sales Surprise 11.41% EPS Surprise 220.00% Sales Q/Q 30.04% Earnings May 02 BMO Avg Volume 1.89M Price 11.50
SMA20 9.31% SMA50 16.28% SMA200 12.90% Trades
Volume 1,534,236 Change 3.98%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-06-24 Initiated HSBC Securities
Buy
$13
Feb-27-24 Upgrade Deutsche Bank
Hold → Buy
$11.50
Feb-20-24 Initiated Wells Fargo
Overweight
$15
Feb-20-24 Initiated UBS
Buy
$15
Feb-20-24 Initiated Morgan Stanley
Overweight
$18
Feb-20-24 Initiated Leerink Partners
Outperform
$15
Feb-20-24 Initiated Jefferies
Buy
$18
Feb-20-24 Initiated Guggenheim
Buy
$15
Feb-20-24 Initiated Goldman
Buy
$26
Feb-20-24 Initiated Deutsche Bank
Hold
$11.50
Feb-20-24 Initiated BofA Securities
Buy
$14
Show Previous Ratings
May-03-24 03:24AM
May-02-24 10:57AM
06:00AM
Apr-26-24 05:09PM
Apr-10-24 04:35PM
04:05PM
Loading…
Apr-09-24 04:05PM
Apr-04-24 07:30AM
Mar-26-24 07:30AM
Mar-21-24 07:30AM
Mar-20-24 04:35PM
Mar-14-24 04:45PM
Mar-01-24 08:42AM
Feb-29-24 06:30AM
Feb-15-24 04:35PM
Jan-26-24 04:50PM
04:20PM
Loading…
04:20PM
(The Wall Street Journal)
04:05PM
BrightSpring Health Services, Inc. engages in the provision of a platform of complementary health services delivering and pharmacy solutions for complex populations in home and community settings. It operates under the Pharmacy Solutions and Provider Services segments. The Pharmacy Solutions segment includes infusion and specialty pharmacy, and home and community pharmacy. The Provider Services segment is involved in home health care and community and rehab care. The company was founded in 1974 and is headquartered in Louisville, KY.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
ROUSSEAU JON B See Remarks Mar 15 '24 Buy 8.09 18,400 148,856 369,763 Mar 18 03:26 PM ROUSSEAU JON B See Remarks Mar 15 '24 Buy 8.09 18,400 148,856 1,025,636 Mar 18 03:26 PM Mattingly James F Jr See Remarks Mar 15 '24 Buy 8.26 6,080 50,221 134,780 Mar 18 03:27 PM Yowler Jennifer President, PharMerica Mar 15 '24 Buy 8.21 3,000 24,630 60,880 Mar 18 03:27 PM ROUSSEAU JON B See Remarks Mar 14 '24 Buy 8.12 37,405 303,729 39,352 Mar 15 05:33 PM Mattingly James F Jr See Remarks Mar 14 '24 Buy 8.18 12,280 100,450 128,700 Mar 15 05:34 PM Phipps Jennifer A Chief Accounting Officer Mar 14 '24 Buy 8.14 12,300 100,122 165,618 Mar 15 05:34 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
